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Abstract 
The Hedgehog (Hh) signalling pathway is an important mediator of many 
mammalian developmental processes and mutations in Hh genes cause 
serious developmental disorders and birth defects in both mice and 
humans. The role of Hh signalling in the development of αβTCR+ cells has 
been, and continues to be, explored by our and other laboratories. 
However, the impact of Hh signalling on unconventional T cells is not well 
characterised.  
 
Here, we aim to investigate the effect of Hh signalling on thymic and 
peripheral γδ T cells, both in mice and humans. Our study reveals that key 
components of the Hh pathway are present in the murine thymus and 
spleen and that γδ T cells are responsive to Hh signalling. Furthermore, 
flow cytometry of mutant mice revealed that Sonic (Shh) and Desert (Dhh) 
hedgehog affect γδ T cell biology in distinct ways. Our research detected 
numerous changes in cell numbers, key cytokine production, subtype 
differentiation, peripheral localization in both fetal and adult tissues and in 
a LPS-induced disease model. In humans, we expanded γδ thymocytes and 
assessed their responsiveness to Hh signalling.  
 
Furthermore, we investigated the role of Indian hedgehog (Ihh) in the 
transition from CD4-CD8- double negative (DN) to CD4+CD8+ double 
positive (DP) stage during αβ T cell development. Analysis of mice with 
conditional deletion of Indian hedgehog showed that Ihh negatively 
regulates DN to DP transition of αβTCR+ cells. Crossing of this conditional 
knockout (KO) to the male-specific antigen HY indicated that this effect is 
related to TCR rearrangement and signalling and thymic selection. 
Analysis of fetal and adult thymi also demonstrated that Ihh plays a role in 
DP to single positive (SP) transition too. Analysis of hydrocortisone (HC)-
treated heterozygous Ihh and RagKO conditional Ihh mice further 
elucidated the role of Ihh in αβ T cell development.  
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Oh sancta simplicitas! In what strange simplification and falsification man 
lives! One can never cease wondering once one has acquired eyes for this 
marvel! How we have made everything around us clear and free and easy 
and simple! How we have been able to give our senses a passport to 
everything superficial, our thoughts a divine desire for wanton leaps and 
wrong inferences! How from the beginning we have contrived to retain 
our ignorance in order to enjoy an almost inconceivable freedom, lack of 
scruple and caution, heartiness, and gaiety of life, in order to enjoy life! 
And only on this now solid, granite foundation of ignorance could 
knowledge rise so far, the will to knowledge on the foundation of a far 
more powerful will, the will to no knowledge, to uncertainty, to the 
untruth! Not as its opposite, but rather—as its refinement! Even if 
language, here as elsewhere, will not get over its awkwardness, and will 
continue to talk of opposites where there are only degrees and many 
subtleties of gradation; even if the inveterate Tartuffery of morals, which 
now belongs to our unconquerable "flesh and blood," infects the words 
even of those of us who know better: here and there we understand it and 
laugh at the way in which precisely science at its best seeks most to keep 
us in this simplified, thoroughly artificial, suitably constructed and suitably 
falsified world, at the way in which, willy-nilly, it loves error, because, 
being alive—it loves life!1 
                                                        
1  Friedrich Nietzsche, Beyond Good and Evil: The free spirit. 1886. 25-26   
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1.1 Murine T cell biology 
 
1.1.1 The thymus 
 
T lymphocytes are central players of the adaptive immune system. They 
take their name from the site of maturation, the primary lymphoid organ 
called the thymus, where the majority of T cells develop. Blood borne 
progenitors migrate to the thymus from the bone marrow (or fetal liver 
during embryonic development) (Moore and Zlotnik 1995), (Kawamoto, 
Wada et al. 2010). This thymic seeding begins at around embryonic day 
(E) 11 in mice and continues throughout adult life (Scollay, Smith et al. 
1986) (Jotereau, Heuze et al. 1987).  
The thymus provides a unique microenvironment with all the necessary 
cytokines, extra-cellular matrix components and cell-surface ligands 
needed to produce a functional repertoire of non-self reactive T cells. 
The thymus is a flat, bilobed organ situated just above the heart, in the 
upper right thorax. Each lobe is surrounded by a capsule and divided into 
lobules, separated from each other by connective tissue called trabeculae. 
Each lobule is organised into two compartments, the cortical region, which 
is densely packed with immature T cells and the inner medullary region. 
Embryologically, the tissue derives from the gut endoderm of the third 
pharyngeal pouch (Carpenter and Bosselut 2010). For T cells to develop 
successfully, thymocytes must dynamically relocate within the different 
microenvironments of the thymus during different developmental stages 
(Petrie and Zuniga-Pflucker 2007).  
1.1.2 αβ T cell development 
 
In adults, progenitors from the bone marrow enter the thymus through a 
narrow region of the perimedullary cortex, the cortico-medullary junction, 
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to give rise to the early thymic progenitor (ETP) population (Prockop and 
Petrie 2000). These progenitors do not express CD4 or CD8 and are 
referred to as Double Negative (DN). Based on the expression of the cell 
adhesion protein CD44 and IL-2 receptor chain CD25, the DN population 
can be subdivided into four sequential phenotypic subsets. DN1 is the 
earliest thymic subset and is characterised by expression of CD44 but not 
CD25. These pluripotent cells also express CD117 and steadily migrate 
towards the outer subcapsular region. Upon acquisition of CD25, 
thymocytes enter the DN2 stage. DN2 cells are more restricted in their 
differentiation potential and are thought to have lost their ability to 
develop into B cells but can still differentiate into NK cells and thymic 
dendritic cells (Wu, Li et al. 1996). Cells then lose CD44 expression to 
become DN3 cells. By this stage, developing cells are fully committed to 
the T cell lineage. The last DN stage, DN4, is marked by a CD25- and CD44- 
phenotype. DN4 cells proliferate rapidly and differentiate into Double 
Positive cells (DP), expressing both CD4 and CD8 co-receptors often via a 
CD8+ single positive intermediate (ISP) (MacDonald, Budd et al. 1988). DN 
cells account for only 1-3% of all thymocytes whereas around 80% of the 
adult thymus consists of cells in the DP stage (Takahama 2006). The final 
step of T cell development involves downregulating either CD4 or CD8. 
Fully functional and mature CD4+CD8- or CD4-CD8+ T cells have now been 
produced (Godfrey, Kennedy et al. 1993), ready to leave the thymus and 
migrate to the peripheral lymphoid organs via the circulatory system. 
About twice as many CD4 as CD8 cells will leave the thymus. Details and 
possible explanations regarding this phenomenon will be provided later in 
this chapter. These unprimed, naïve T cells that have not encountered an 
antigen and are not activated, are in G0 stage, contain little cytoplasm and 
show basic, low level transcriptional activity (Kindt T 2007b).  
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1.1.3 TCR Rearrangement 
 
TCR rearrangement is critical for developing thymocytes and only cells 
which have undergone a successful in-frame TCRβ rearrangement will 
proceed to the following stages of development, while the rest undergo 
apoptosis (Petrie, Pearse et al. 1990). This process, also called ‘’β-
selection’’, takes place during the DN3 stage of development. Rag1 and 
Rag2 genes are transiently expressed, leading to the rearrangement of the 
TCRβ chain locus (Godfrey, Kennedy et al. 1993), (Mallick, Dudley et al. 
1993). Rag1 and Rag2 deficient mice show a profound arrest at the DN3 
stage, indicating how essential TCRβ rearrangement is for differentiation 
to subsequent stages of development (Mombaerts, Iacomini et al. 1992), 
(Oettinger, Schatz et al. 1990), (Shinkai, Rathbun et al. 1992).  The 
rearranged TCRβ interacts on the cell surface with the 33-kDa pre-TCRα 
chain (pre-Tα) and associates with CD3, forming the pre-TCR complex. 
Succesfull formation of the pre-TCR complex supresses further 
rearrangment of the TCRβ chain, leading to allelic exclusion, and signals 
progression to the DP stage. The pre-TCR complex on developing cells 
shows considerable structural resemblance to the TCRαβ complex on 
mature T cells, as both rely on CD3 chains to transmit signals from the cell 
surface to the nucleus. On treatment with anti-CD3 antibody, Rag-/- 
thymocytes can reverse arrest at the DN3 stage and resume differentiation 
to form DP cells, highlighting the importance of crosslinking between CD3 
chains for the pre-TCR signal (Shinkai and Alt 1994). The notion that 
unlike TCRαβ, pre-TCR mediated signaling does not require a ligand 
(Irving, Alt et al. 1998) is currently under controversy (Mallis, Bai et al. 
2015). Importantly, cells lacking ligand-independent pre-TCR signalling 
fail to progress to the DP stage. Thymocytes entering the DP stage 
immediately undergo rapid proliferation but rearrangement of the TCRα 
chain occurs only after proliferation has stopped and Rag2 protein levels 
have increased. This mechanism allows the production of an extremely 
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diverse population because each clone of cells with a single TCRβ chain 
rearrangement can rearrange a different TCRα chain gene. Overall, this 
random TCR germ-line rearrangement can generate more than 1015 
different αβ receptors, able to recognize a great variety of antigens and 
major histocompatibility complex (MHC) molecules, both self and non-self 
(Robey and Fowlkes 1994).  
1.1.4 Positive and negative Selection 
 
Thymic selection reassures that only T cells, whose TCR recognizes a 
foreign antigen coupled to a self MHC molecule, will survive to leave the 
thymus. T cell selection is an extremely selective process with just 1-3% of 
all T cells managing to reach the last stage of development (Egerton, 
Scollay et al. 1990).  
Positive selection occurs in the thymic cortex and refers to the elimination 
of those developing T cells which fail to bind a self-MHC class I or class II 
molecule, resulting in MHC restriction (Jameson, Hogquist et al. 1995). The 
DP cells that recognize a MHC class I will develop into CD8 T cells whereas 
DP cells recognizing a MHC class II will develop into CD4 T cells. CD4/CD8 
lineage commitment is a topic of intense scientific interest and several 
hypotheses have been put forward in an attempt to explain the mode of 
action (Singer, Adoro et al. 2008). The TCR signal strength hypothesis 
suggests that recognition of either class I or class II MHC molecules and 
commitment to its subsequent cell fate is influenced by TCR signal 
strength. A stronger TCR signal favours commitment to the CD4 lineage 
and a weaker TCR signal favoring commitment to the CD8 lineage (Robey, 
Fowlkes et al. 1991). Another hypothesis implicates the duration rather 
than the strength of TCR signaling in the cell fate decision, where TCR 
signals of longer duration appears to terminate CD8 transcription. 
Alternatively, the stochastic model suggests that termination of 
transcription of one of the co-receptors occurs randomly and is followed 
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by a TCR-dependent rescue step in order to allow only SP thymocytes with 
appropriate co-receptors for their MHC restriction to survive (Chan, 
Cosgrove et al. 1993), (Davis, Killeen et al. 1993), (Itano, Kioussis et al. 
1994), (Leung, Thomson et al. 2001). Further research on this demanding 
topic will shed light on the details of lineage commitment. It is important 
to mention that DP TCRintCD5hi cells are asymmetric in their death rates, 
such that Class I MHC restricted cells undergo higher apoptosis, compared 
to Class II-restricted cells, despite similar levels of both cell types being 
initiated for development (Sinclair, Bains et al. 2013). This finding could 
explain why there is a 2:1-3:1 bias of CD4 to CD8 cells leaving the thymus. 
Positively selected thymocytes will migrate to the thymic medulla where 
negative selection occurs. Negative selection refers to the elimination of 
self-reactive T cells bearing high affinity TCRs for self-molecules, either 
antigens or MHC. It is a process that requires thymocyte-epithelium 
crosstalk. During negative selection, antigen presenting cells (APCs)  - 
macrophages and dendritic cells (DCs) - bearing class I and class II MHC 
molecules interact with developing thymocytes, exposing them to a wide 
range of antigenic products. Negative selection results in self-tolerance by 
clearing out potentially self-reactive T cells (Jameson, Hogquist et al. 
1995), (Goldrath and Bevan 1999).  
Early evidence for the elimination of self-reactive thymocytes came from 
experiments using the HY-TCR transgenic mouse model. The transgenic 
HY-TCR recognizes the Smcy gene-deriving, male-specific HY peptide in 
association with class I MHC H-2Db. In male HY-TCR transgenic severe 
combined immunodeficiency (SCID) mice, all transgenic CD8-expressing T 
cells were deleted (including DP cells), while in females where the HY 
peptide is not present, single positive CD8 cells survived (Kisielow, 
Bluthmann et al. 1988), (Markiewicz, Girao et al. 1998). 
Presentation of self-peptides to developing thymocytes is a key 
 26 
requirement for negative selection of self-reactive thymocytes. The 
Autoimmune Regulator (Aire) transcription factor has been identified to 
be the master-switch in the regulation of several ectopic peripheral 
proteins in medullary epithelial and monocyte populations (Anderson, 
Venanzi et al. 2002), (Kogawa, Nagafuchi et al. 2002), (Liston, Lesage et al. 
2003). 
1.1.5 αβ T cell activation 
 
Immune responses, either humoral or cell-mediated, require T cell 
activation and clonal expansion. The first necessary step for T cell 
activation is the interaction of the TCR-CD3 complex of an unprimed T cell 
with a processed antigen bound to the MHC class I or class II molecule on 
the surface of an APC. Antigen recognition is a necessary but not sufficient 
event for T cell activation. For full T cell activation, T cells require 
subsequent antigen-nonspecific co-stimulatory signals, provided primarily 
by interactions between CD28 on the T cell surface and members of the B7 
family on APCs (June, Bluestone et al. 1994). The two members of the B7 
family of protein receptors, glycoproteins CD80 and CD86, are 
constitutively expressed in dendritic cells and activated macrophages and 
B cells. Their ligands are CD28, which delivers a stimulatory signal to the T 
cell and promotes activation and proliferation and CTLA-4, also known as 
CD152, which shows the opposite effect and strongly inhibits T cell 
activation (Linsley, Brady et al. 1991). Only CD28 is present on the cell 
surface of resting T cells. CTLA-4, the expression of which interestingly 
relies on CD28 co-stimulatory signals, is detectable about 24h after T cell 
activation and peaks 2-3 days later. CTLA-4 shows a higher affinity to 
CD80 and CD86 than CD28. Therefore, in direct proportion to CD28 
stimulation, CTLA-4 provides a regulatory brake on T cell expansion 
(Azuma, Ito et al. 1993, Hathcock, Laszlo et al. 1993). CTLA-4 knockout 
(KO) mice show lymphadenopathy, splenomegaly and die 3-4 weeks after 
death (Kindt T 2007b). Clearly, the production of inhibitory signals by 
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engagement of CTLA-4 is important for lymphocyte homeostasis. T cells 
that experience antigen recognition but do not recieve the co-stimulatory 
signal via CD28 fail to activate properly and exhibit a state of 
nonresponsiveness, named clonal anergy (Chen and Flies 2013).  
T cell activation triggers several signal transduction pathways that result 
in gene transcription, proliferation and differentiation into memory or 
effector phenotypes. The most important of these cascades of biochemical 
events involve Phospholipase γ (PLCγ), Protein Kinase C (PKC), the 
Ras/MAP Kinase pathway, NfκΒ and calcium (Ca2+), whose release from 
the endoplasmic reticulum (ER) results in the phosphorylation of the 
transcription factor NFAT which promotes T cell growth and proliferation 
by supporting transcription of cytokine genes (Kindt T 2007b).  
During T cell activation, changes in gene transcription can be grouped 
according to their detection time upon antigen recognition. Immediate 
genes, expressed within 30 minutes after the initial interaction, encode 
mostly transcription factors such as c-Fos, c-Myc and Nf-κB. Early genes, 
expressed no more than two hours after antigen recognition, encode 
Interleukin 2 (IL-2), IL-3, IL-6, IL-2R and Interferon gamma (IFN-γ). Last, 
the so called late genes, whose expression is detected no earlier than two 
days after antigen recognition, involve mostly adhesion molecules (Kindt T 
2007b). 
The number of ligands a T cell must recognise for sufficient activation has 
been a very active research area for many years. Finally, experiments 
using antigenic compounds bound to biotin molecules, which emit light 
when a streptavidin-phycoerythrin conjugate is added, revealed that as 
little as 10 TCR-MHC interactions are sufficient in both CD4 and CD8 cells 
for T cell activation (Irvine, Purbhoo et al. 2002).  
Activated CD4 T cells differentiate into T helper (Th) effector cells and CD8 
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T cells into cytotoxic T cells. Activated CD8+ T cells particularly express 
tumor necrosis factor (TNF) and secrete IFNγ. CD4 Th cells are subdivided 
into several types according to cytokine production and function. More 
specifically, Th1 cells, whose differentiation is promoted by APC-secreted 
IL-12 and the transcription factor Tbx21, also known as Tbet, secrete IFNγ, 
IL-2 and tumor necrosis factor alpha (TNFα) which support pro-
inflammatory immunity against viral and intracellular bacterial pathogens. 
On the other hand, Th2 cells are promoted by IL4 and Gata3 and produce 
IL-4, IL-5, IL-9 and IL-13 (Constant and Bottomly 1997). Th2 cells play a 
key role in allergic inflammation as well as the protection against 
extracellular parasites. Not surprisingly, Th17 cells mainly produce IL-17 
and modulate protection against extracellular bacteria and fungi while 
also playing an important role in autoimmunity (Korn, Bettelli et al. 2009).  
Regulatory T (Treg) cells, with the distinct CD4+CD25+FoxP3+CD122- 
phenotype, negatively regulate immune responses and are therefore 
critical in maintaining lymphocyte homeostasis. Two major groups of 
Tregs have been identified, natural Tregs (nTregs) and inducible (iTregs), 
with the former differentiating in the thymus and the latter in the 
periphery (Curotto de Lafaille and Lafaille 2009). 
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Figure 1.1: αβ T cell development in murine thymus 
Blood borne lymphoid progenitors enter the thymus at the cortico-medullary 
junction and undergo a series of developmental stages and selection processes as 
they move to different thymic micro-environments. Different developmental stages 
can be classified according to expression of cell surface markers. Proliferation occurs 
at the DN2 stage and after pre-TCR signaling at the DN to DP stage. Selection takes 
place at several checkpoint stages; β selection occurs at the DN3 stage as the pre-
TCR is formed by joining a rearranged β chain with a pTa, αβ selection occurs at the 
DP stage as the TCR is formed by joining a β chain with a rearranged α chain, 
positive selection occurs at the DP stage as only cells with moderate MHC affinity 
progress to further developmental stages and negative selection occurs at the final 
SP stage when self-reactive cells are eliminated. Cells that fail any of the above 
selection steps undergo apoptosis. Thymocytes that have completed their thymic 
development successfully will leave the thymus to migrate to primary lymphoid 
organs in the periphery. 
DN – double negative, DP – double positive, SP – single positive, TCR – T cell 
receptor, MHC – major histocompatibility complex 
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1.1.6  γδ T cell lineage commitment 
 
Both αβ and γδ T cells derive from common thymic precursors. The timing 
of lineage divergence however is not well defined, largely due to the lack of 
definitive markers that allow cells commited to a γδ lineage to be 
distinguished prior to γδTCR expression (Ciofani and Zuniga-Pflucker 
2010). It appears that DN1 cells are uniformly bipotent, giving rise to both 
αβ and γδ lineage T cells (Ciofani, Knowles et al. 2006). In contrast, only 
half of DN2 cells retain bipotency, whereas by the DN3 stage, almost all 
cells appear to be lineage committed (Ciofani, Knowles et al. 2006).  
 
The mechanisms that regulate γδ cell fate commitment are also poorly 
understood. TCR signaling plays an important role in this stage but 
existing data does not support a deterministic role because the type of TCR 
initially produced by the T cell does not absolutely determine the lineage, 
and the presence of a γδTCR or a premature αβTCR can lead to either αβ 
or γδ lineage commitment (Garbe, Krueger et al. 2006). Support for the 
non-deterministic role of the TCR was provided by two studies in which 
αβ and γδ T cell lineage fate was mediated exclusively by a γδTCR 
transgene (Hayes, Li et al. 2005) (Haks, Lefebvre et al. 2005). It seems that 
TCR signal strength, rather than type of TCR, is crucial for lineage 
commitment, with a strong TCR signal promoting a γδ T cell fate and a 
weak signal an αβ T cell fate (Hayes, Li et al. 2005). A stronger TCR signal 
is associated with strong activation of the extracellular signal-regulated 
kinase (ERK), early growth response (EGR) and inhibitor of DNA binding 3 
(ID3) pathway (Haks, Lefebvre et al. 2005). In support of the signal 
strength hypothesis, γδ T lineage cells express higher levels of EGR1, EGF2 
and EGR3 transcription factors and also induce higher expression levels of 
ID3 compared to β-selected thymocytes. It is worth noting that TCRα and 
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TCRδ share the same gene locus and therefore, expression of rearranged 
segments is mutually exclusive (Satyanarayana, Hata et al. 1988).  
 
Other factors can also contribute to αβ versus γδ lineage determination.  In 
IL-7Rα deficient mice, development of γδ cells is completely abolished as a 
result of TCRγ chain absence as IL-7 is known to stimulate rearrangement 
and expression of the TCR γ genes (Perumal, Kenniston et al. 1997). 
Importantly, It has been shown that DN2 (CD25+C44+c-Kit+TCR-) 
thymocytes expressing high levels of IL-7R give rise to γδ T cells more 
frequently than thymocytes lacking or expressing low levels of IL-7R 
(Kang, Volkmann et al. 2001). IL-7Rhi DN2 cells showed a fivefold greater 
potential to develop into γδ T cells, indicating that a proportion of early 
DN thymocytes can be biased towards a γδ linage commitment before β-
selection and fully independently of TCR-mediated signals. 
 
In addition, the presence of the transcription factor SOX13 promotes a γδ 
T cell (Melichar, Narayan et al. 2007). Indeed, in a 2007 screen for 
transcription factors that are differentially expressed between αβ and γδ 
thymocytes, SOX13 was found to be the only γδ-specific gene. SOX13-
deficient mice produced normal functional mature αβ T cells yet γδ Τ cell 
development was severely impaired (Melichar, Narayan et al. 2007). It is 
believed that SOX13, whose expression precedes and is independent of 
TCR rearrangement, interacts with the developmentally important Wnt 
signaling pathway. This is possibly mediated by the antagonizing T cell 
factor (TCF), a high motility gene (HMG) transcription factor, which is 
induced by Wnt and seems to promote an αβ lineage by repressing TCRγ 
gene expression (Melichar, Narayan et al. 2007).  
 
Finally, the Notch pathway has also been implicated in γδ lineage 
specificity, although its contribution appears to be less crucial. It is worth 
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noting, however, that although Notch signaling promotes the formation of 
γδ T cells in humans (Van de Walle, De Smet et al. 2009), in contrast, it 
promotes the αβ T cell lineage in mice (Washburn, Schweighoffer et al. 
1997). 
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Figure 1.2: Murine γδ ΤCR ontogeny 
In the murine thymus, DN cells can rearrange γδ TCR at the DN3 or the DN4 stage 
under the influence of the γδ-specific transcription factor SOX13 and γδ T cells 
acquire their final functional fate according to the presence of an agonist signal. In the 
prenatal thymus, fetus-derived γδ cells that produce IFNγ express CD27 and IL-17-
producing γδ cells fail to express CD27. In the postnatal thymus, γδ development 
relies on a pool of bone marrow progenitors that give rise predominantly to naïve 
cells that do not show functional pre-programming, however some postnatally-
developed γδ cells that engage agonists are believed to give rise to intestinal 
intraepithelial lymphocytes (IEL), not shown here. It is also believed that IL-17-
producing γδ cells cannot be generated from bone marrow progenitors, indicating 
that γδ development of IL-17-producing cells is restricted in prenatal, fetus-derived 
thymocytes. 
DN – Double Negative, DP – double positive, SOX13 - SRY-related HMG-box, NK – 
natural killer, IL – interleukin, IFNγ – Interferon gamma, RORγt - Retinoid-Acid 
Receptor-related Orphan Receptor gamma
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1.1.7  Murine γδ thymic subtypes and effector fate 
 
The murine TCRγ chain was discovered in 1984 (Saito, Kranz et al. 1984) 
and its human counterpart just two years later (Brenner, McLean et al. 
1986). Nevertheless, many aspects regarding the ontogeny, function and 
diversity of γδ Τ cells remain unclear. 
 
Despite the presence of a TCR, it is difficult to categorize γδ cells as 
adaptive or innate because, depending on the particular context, γδ cells 
can share features of one or the other system. In fact, γδ cells are 
increasingly being classified as a third branch of the immune system 
altogether (Hayday 2000). 
 
In mice, the first wave of γδ T cell development appears in E14 and 
precedes aβ cells (Strominger 1989). Importantly, α and δ chains share the 
same locus and therefore expression of rearranged αTCR and δTCR are 
mutually exclusive (Satyanarayana, Hata et al. 1988).  In the postnatal 
murine thymus and peripheral blood, γδ T cells constitute only a small 
population, rarely more than 3% of nucleated cells. Yet, the percentage 
rises dramatically in peripheral tissues, especially the epithelium (Hayday 
2009). Five distinct γδ cell populations can be identified by expression of 
markers CD27, CD25, CD24 and CD44 markers (Ribot, deBarros et al. 
2009), (Prinz, Sansoni et al. 2006). The most immature γδTCR cells are 
CD27+CD25+CD24+CD44- with high proliferative potential (Ribot, deBarros 
et al. 2009), (Prinz, Sansoni et al. 2006) and express low TCR. These 
progenitors downregulate CD25 to become CD27+CD25-CD24+CD44- cells 
that make up the majority of thymic γδ cells and can possibly already 
colonise the periphery (Tough and Sprent 1998). They probably also 
represent precursors for three mature γδ thymocyte populations that lack 
surface expression of CD24. The CD27-CD44+ subset (Haas, Gonzalez et al. 
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2009) is already committed to IL-17 expression (Ribot, deBarros et al. 
2009). By contrast, mature CD27+CD44- γδ T cells have the potential to 
secrete IFN-γ and can be subdivided into the CD122+ and CD122- subsets. 
The former are largely NK1.1+ (Haas, Gonzalez et al. 2009) and express 
γδTCR poorly, exhibiting common characteristics and functional overlap 
with natural killer (NK) cells (Stewart, Walzer et al. 2007). Overall, the 
thymus generates distinct γδ T cell populations with clear phenotypic links 
to peripheral γδ subsets.  
 
Although conventional αβ Τ cells differentiate into effector subsets after 
encountering pathogens in peripheral tissues, the function of γδ T cell 
subtypes seems to be programmed in the thymus (Azuara, Levraud et al. 
1997), (Jensen, Su et al. 2008), (Ribot, deBarros et al. 2009). Jensen et al. 
introduced the concept that thymic TCR ligation determines the 
differentiation of γδ T cells into antigen-experienced IFN-γ-producing and 
antigen-naive IL-17-producing cells. The signals, however, that actually 
promote proinflammatory IL-17 or IFN-γ production by effector γδ T cells 
are poorly understood. It is known that they can produce IL-17 in 
response to IL-23 (Lockhart, Green et al. 2006) and IFN-γ in response to 
cooperative activation with IL-12 and IL-18 (Qureshi, Zhang et al. 1999).  
 
It is important to mention that a functional dichotomy between IFN-γ and 
IL-17-producing cells also exists in the spleen and lymph nodes of adult 
mice and has been largely attributed to thymic developmental 
preprogramming as opposed to peripheral plasticity (Jensen, Su et al. 
2008). Interestingly, however, the underlying mechanisms remain 
unresolved.  
 
Apart from cell surface markers, murine γδ Τ cell development can be 
classified according to Vγ and Vδ chains, where different subtypes migrate 
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to and populate different tissues and body surfaces (Prinz, Silva-Santos et 
al. 2013). For example, CD44+ Vγ6 T cells and CD44+ Vγ4 T cells are highly 
concentrated at the peritoneal cavity and the dermis respectively.  
CD27+CD44+ Vγ1 cells, able to secrete both IFNγ and IL-4 upon activation, 
are localized in the liver and the spleen. The first wave of γδ Τ cells to 
leave the thymus is believed to be CD44+ Vγ5 cells, detected by flow 
cytometry in the murine epidermis already by E15.  
 
Unlike αβ Τ cells, there is thymus-independent γδ T cell development. 
Patients with DiGeorge syndrome suffer from severe thymic hypoplasia 
and lack functional αβ T cell, yet they have normal γδ T cells (Borst and 
van Dongen 1990). The human fetal liver is one site of γδ T cell 
development, where Vγ9Vδ2 cells develop even before thymic formation 
(Wucherpfennig, Liao et al. 1993) (McVay and Carding 1996).  
 
Notably, intraepithelial γδ lymphocytes, mainly gut CD27+ Vγ7 T cells, 
exhibit strong cytolytic and immunoregulatory capacities and seemingly 
lack peptide–MHC restriction, indicating that they bypass the complex 
medullary developmental progression of DP cells (Hayday and Gibbons 
2008). Evidence that supports the concept of extrathymic γδ T cell 
development includes the rescue of intestinal γδ T cell development in IL-
7 KO mice by gut epithelium-specific IL-7 expression (Laky, Lefrancois et 
al. 2000) as well as detection of gut γδ T cell in athymic mice (Hayday, 
Theodoridis et al. 2001). 
 
γδ T cells recognize a plethora of molecules in a wide variety of contexts 
and understanding the different settings in which these ligands are 
presented to γδ Τ cells is essential to comprehend the range of functions 
carried out by γδ T cells. Phosphorylated isoprenoid precursors, 
collectively called phosphoantigens, are recognized by γδ TCR via TCR 
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binding. Phosphoantigens constitute the first description of a non-peptide 
T cell antigen (Tanaka, Sano et al. 1994). It is not clear yet how 
phosphoantigens are presented to γδ T cells. Soluble phosphoantigens fail 
to activate γδ T cells, and MHC class I or II, as well as cell-surface 
expression of CD1 are not required for successful presentation (Morita, 
Beckman et al. 1995). It is also known that γδ T cells can present 
phosphoantigens to other γδ Τ cells (Morita, Beckman et al. 1995). Some 
γδ T cells recognize proteins directly, without being processed. Examples 
include viral proteins (Sciammas, Johnson et al. 1994) and heat shock 
proteins (O'Brien, Happ et al. 1989). Some evidence suggests that γδ T 
cells can also recognize lipids (Azuara, Levraud et al. 1997). 
 
The main function of γδ T cells is not the recognition of MHC complexes 
(Strominger 1989). Instead, γδ T cells have been proposed to constitute a 
first line of defense against pathogens (Allison and Havran 1991, Hayday 
2000). In a study involving infection with Listeria, γδ T cells peaked 3 days 
after injection and αβ T cells 5 days later, suggesting that γδ T cells block 
the infection before αβ cells clear it at a later stage (Ohga, Yoshikai et al. 
1990). However, some γδ T cells in the lymph nodes and the spleen have 
been described to express CD8, exhibiting lytic activity in vivo, hence being 
called CD8+ cytotoxic γδ T cells (Lake, Pierce et al. 1991). Other γδ T-cells 
(1-4% of all peripheral T cells) co-express CD4 and secrete IL-4 (Wen, 
Barber et al. 1998). Finally, the existence of γδ regulatory T cells (Treg) 
has been proposed (Traxlmayr, Wesch et al. 2010). Taken together, it 
becomes clear that γδ T cells constitute a diverse arm of the immune 
system with different subsets playing distinct roles in immune responses.  
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Figure 1.3: Mouse γδ T cell subsets in the thymus and periphery 
Proposed developmental relationships between Vγ subsets, cell surface expression of key markers, potential for cytokine secretion and 
tissue localization are shown. IL-17 – interleukin 17; IFN-γ – interferon-γ  
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1.2 Human γδ T cell subtypes and effector fate 
 
In humans, γδ T cells are also a minor population in peripheral blood with 
numbers more predominant in epithelial layers. The current view suggests 
that although γδ T cell function is associated with Vγ chains in the mouse, 
it correlates with Vδ usage in humans (Pang, Neves et al. 2012). For 
identification purposes, human γδ T cells are divided into three major 
categories according to their Vδ chain; Vδ1, Vδ2, or nonVδ1-nonVδ2 chain 
(Hayday 2000).  
 
Vδ1 and nonVδ1-nonVδ2 are more abundant in mucosal surfaces such as 
the skin and intestine and can combine with several Vγ chains (Deusch, 
Luling et al. 1991, Ebert, Meuter et al. 2006). The most common Vδ1 T cell 
population in adult blood shows a CD45RA+ phenotype, which can be 
subdivided virtually evenly between two populations, IL-2-secreting 
CD27+CD11a- and IFNγ-secreting CD27-CD11a+ (De Rosa, Andrus et al. 
2004). 
 
Unlike Vδ2 cells, Vδ1 cells frequently express CD8 and show considerable 
cytotoxic activity, found to respond to a broad range of antigenic 
compounds including autologous and endogenous phospholipids 
(Russano, Bassotti et al. 2007), cytomegalovirus (Dechanet, Merville et al. 
1999), HIV (De Maria, Ferrazin et al. 1992), malaria (Hviid, Kurtzhals et al. 
2001) and a range of epithelial tumors (Maeurer, Martin et al. 1996). This 
is mediated possibly through recognition of the stress-induced MHC class I 
– related molecules MICA and MICB (Groh, Rhinehart et al. 1999). The 
percentage of Vδ1 cells circulating in the peripheral blood remains 
relatively constant until late middle age, suggesting a constant thymic 
production (De Rosa, Andrus et al. 2004). 
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On the other hand, Vδ2, which are almost exclusively Vγ9, dominate the 
peripheral blood (Strauss, Quertermous et al. 1987) and characteristically 
show substantial expansion during certain bacterial and parasitic 
infections - to the point they can become the majority of circulatory 
leukocytes (Morita, Jin et al. 2007). The investigation of Vγ9Vδ2 cells is 
largely problematic because this population is only shared between higher 
primates with the absence of murine counterparts making them a difficult 
population to study. 
 
Vγ9Vδ2 cells are unique in their recognition of non-peptide 
phosphoantigens such as (E)-4-hydroxy-3-methyl-but-2-
enylpyrophosphate (HBB-PP) and isopentenyl pyrophosphate (IPP) 
(Tanaka, Morita et al. 1995), (Wang, Sarikonda et al. 2011), both 
intermediate metabolites of microbial isoprenoid biosynthesis and human 
mevalonate pathway of isoprenoid synthesis, respectively. The mechanism 
of activation and the nature of the molecules that present 
phosphoantigens to γδ T cells remain unclear as MHC I or II and CD1 
expression are not required for successful phosphoantigen presentation 
and soluble, unprocessed phosphoantigens fail to activate γδ T cells 
(Morita, Beckman et al. 1995). 
 
The Vγ9Vδ2 can be further subdivided according to CD27 and CD45RA cell 
surface expression. Unlike mice, however, CD27 expression in humans 
does not signify capacity for robust IFNγ production and secretion. These 
two markers identify four distinct populations: CD27+CD45RA+ naïve 
(Tnaive), CD27+CD45RA- central memory (TCM), CD27-CD45RA- memory 
(TEM) and CD27- CD45RA+ effector memory (TEMRA) γδ T cells (Pang, Neves 
et al. 2012).  
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Naïve γδ Τ cells, the only Ag-inexperienced phenotype, are also CCR7+ and 
CD62L+, indicating migratory ability to lymph nodes. They can also 
proliferate rapidly upon IPP activation and do not secrete IFNγ (Dieli, 
Poccia et al. 2003), lacking cytotoxic function. Central memory cells retain 
the phenotype of naïve cells but switch expression of CD45RA for CD45RO. 
In healthy individuals, TCM cells account for ≤50% of γδ cells in peripheral 
blood and around 25% in lymph nodes. TCM cells can become activated in 
very low concentrations of IPP and secrete low levels of IFNγ (Dieli, Poccia 
et al. 2003). Approximately 2 weeks after IPP activation, TCM cells give rise 
to TEM, with a distinct phenotype CD45RO+CCR7-CD62L- and positive for 
the tissue-associated chemokine receptors CCR2, CCR5, CCR6 and CXCR3. 
These cells show reduced proliferative capacity compared to CD62L+ 
Vγ9Vδ2 subtypes, but upon IPP activation can secrete abundant IFNγ as 
well as TNFα. IL-15 is believed to upregulate CD45RA in TEM  cells, 
generating TEMRA γδ cells (Caccamo, Meraviglia et al. 2005) which are 
unresponsive to further TCR engagement and show little proliferative 
capacity. Nevertheless, TEMRA cells, although minor contributor of IFNγ, 
exhibit strong cytolytic activity due to ample production of perforin and 
granulysin (Pang, Neves et al. 2012). TEM and TEMRA γδ cells strongly 
express the adhesion molecule CD11α, aiding their migration into sites of 
inflammation (Angelini, Borsellino et al. 2004).  
It is noteworthy that one study has shown evidence of extrathymic 
selection for the Vδ2 T cell subset (Parker, Groh et al. 1990). More 
specifically, they showed that the percentage of Vδ2 cells was higher in the 
periphery than the thymus whereas Vδ1 cells declined. The change 
increased proportionally with age of donors and it was not accompanied 
by a similar change in the thymus, strongly suggesting peripheral 
selection. Another interesting finding is that different human populations 
show preference for different Vδs. For example, Vδ1 cells predominate in 
West African communities (Hviid, Akanmori et al. 2000) whereas Vδ2 cells 
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are more prominent in people living in Europe and the US, including 
African Americans in the US (De Rosa, Andrus et al. 2004).  
 
The functional plasticity of Vγ9Vδ2 does not stop here. Expression of 
FoxP3 and regulatory activity has been demonstrated in Vδ2Vγ6 cells 
treated with IL-15 and TGFβ1 (Casetti, Agrati et al. 2009) whereas several 
studies report antigen-presenting activity either to other γδ cells in vivo 
(Morita, Beckman et al. 1995) or to αβ T cells in vitro (Brandes, Willimann 
et al. 2005), along with surface expression of MHC class II, CD80 and CD86. 
Unlike all other adaptive lymphocytes, γδ T cells can acquire pseudopodia 
similarly to myeloid cells when, for example, they engulf E.coli (Wu, Wu et 
al. 2009). Opsonization of γδ cells seems to be one means by which they 
become professional APCs (Himoudi, Morgenstern et al. 2012). 
 
There are considerable differences between murine γδ T cells and human 
Vδ2 T cells beyond their cell surface markers. One example is IL-17 
production, which is usually abundant in mice within inflamed tissues but 
very difficult to demonstrate in humans. The only IL-17-producing human 
Vγ9Vδ2 γδ Τ cells which form a subtype of non-cytotoxic CD45RA+CD27- 
TEMRA cells have been identified in psoriasis (O'Brien and Born 2015). 
Furthermore, as described above, murine γδ T cells are believed to acquire 
their effector fate during development in the thymus whereas human 
Vδ2Vγ6 γδ Τ cells show remarkable plasticity upon activation.  
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Figure 1.4: Human Vδ2 T cells 
Vδ2Vγ9 cells are divided into four distinct subtypes according to cell surface 
expression of CD45RA and CD27.  Naïve Vδ2 γδ cells, expressing CCR7, are the major 
subtype in the lymph nodes, capable of robust proliferation upon IPP activation. Naïve 
cells that downregulate CD27 become Central Memory cells that can be found in 
virtually equal numbers in the lymph nodes and peripheral blood. These cells, which 
are also able to proliferate extensively, show low IFNγ-secreting capacity. 
Downregulation of CD62L gives rise to Effector Memory cells, positive for CCR2, CCR5 
and CCR6. These cells are absent from the lymph nodes and abundant in peripheral 
blood and inflammatory sites. They show decreased proliferative capacity and secrete 
ample IFNγ and TNFα. Finally, IL-15-induced activation of Effector Memory cells gives 
rise to a CD45RA Effector Memory subset that expresses CCR5 and shows strong 
killing capacity by robust production of perforin and granulysin and little IFNγ. These 
cells show minimal proliferative capacity and are unresponsive to TCR signaling.  
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1.3 The Hedgehog (Hh) signalling pathway 
 
1.3.1 The Hedgehog proteins 
 
In 1980, a large scale phenotype-driven screening was conducted to 
identify mutations that impair development in Drosophila melanogaster 
(fruit flies) (Nusslein-Volhard and Wieschaus 1980). The hedgehog gene 
was identified revealing its role in controlling the development of the 
larval body plan (Nusslein-Volhard and Wieschaus 1980). In Hh mutants, 
each larvae segment was entirely covered by spikes, hence the name. Later 
studies revealed that Hh genes are conserved in all vertebrates and that 
the family of Hh proteins affect a wide variety of functions in embryonic 
development including cell differentiation, survival and cell fate (Jiang and 
Hui 2008).   
Three mammalian Hh proteins have been discovered, sharing about 90% 
homology to each other (Shimeld 1999): Sonic (Shh), Indian (Ihh) and 
Desert (Dhh) hedgehog. All three hedgehogs share the same canonical 
pathway although different expression patterns result in non-redundant 
roles during development (Ingham and McMahon 2001). 
1.3.2 Hh signalling 
 
The crucial receptor for the mammalian Hh pathway is known as Patched 
(Ptch), a 12-span transmembrane protein. Two Ptch homologues exist in 
mammals, Ptch1 and Ptch2 (Goodrich, Johnson et al. 1996),(Stone, Hynes 
et al. 1996), (Motoyama, Takabatake et al. 1998). 
In the absence of Hh proteins, Ptch suppresses Smoothened (Smo), a 7-
span transmembrane protein, disabling any downstream transcriptional 
activity (Alcedo, Ayzenzon et al. 1996). The exact mechanism of inhibition 
is unclear although recent evidence suggests that Ptch inhibits the 
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synthesis of Phosphatidylinsositol-4-phosphate, an essential protein for 
Smo activation (Yang and Lin 2010). 
Binding of Hh with Ptch results in Ptch relieving its inhibitory effect on 
Smo, which then acts as the central transducer of the Hh signaling pathway 
and activates the gliomablastoma-associated (Gli1, Gli2 and Gli3) protein 
family of transcription factors (Matise and Joyner 1999) (Crompton, 
Outram et al. 2007). Gli proteins are then transported to the nucleus to 
promote target gene transcription. Gli proteins bind defined DNA 
consensus sequences, with Gli1 and Gli3 recognizing GACCACCCA and Gli2 
recognizing GAAACCACCCA (Tanimura, Dan et al. 1998), (Vortkamp, 
Gessler et al. 1995). 
Interestingly, Gli transcription factors are found even in the most primitive 
metazoan and thus seem to predate Hh itself (Srivastava, Simakov et al. 
2010).  
Gli1 lacks the N-terminal repressor domain and acts as a constitutive 
activator of Hh target genes (Marigo, Johnson et al. 1996). Gli1 is also a 
target gene of the Hh signaling pathway, so that detection of its 
transcription levels indicates the degree of Hh signaling in a population of 
cells (Crompton, Outram et al. 2007). By contrast, Gli2 and Gli3 can 
function as both transcriptional activators and transcriptional repressors, 
if they undergo cleavage of their C-terminal activation domain (Sasaki, 
Nishizaki et al. 1999) (Aza-Blanc, Lin et al. 2000). The ratio of the Gli 
activator to Gli repressor forms of the protein is affected by the Hh signal 
gradient received by the target cell. Cells closer to the Hh source will 
increase the amount of activator forms of Gli protein whereas the 
repressor forms of Gli proteins will be inhibited and vice versa (Stamataki, 
Ulloa et al. 2005) (Crompton, Outram et al. 2007).  
On the contrary, if Hh signalling is completely absent, kinase recognition 
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motifs near the C- termini of Gli proteins are phosphorylated by Protein 
Kinase-A (PKA), Glycogen Synthase Kinase-3 (GSK3) and Casein Kinase-I 
(CKI) (Pan, Wang et al. 2009), (Pan, Wang et al. 2009), (Price and Kalderon 
2002) marking them for ubiquitylation, catalyzed by Btrcp proteins 
(Zhang, Zhao et al. 2005, Tempe, Casas et al. 2006). For ubiquitylation to 
occur, the above proteins must associate with the scaffolding protein Kif7, 
which together with a serine/threonine kinase called Fused (Fu), form the 
hedgehog signaling complex. The mode of action of Kif7, the orthologue of 
fruit fly’s Costal2 (Cos2) suggests that the hedgehog signalling complex 
regulates the processing of Gli proteins by controlling intracellular 
localization (Endoh-Yamagami, Evangelista et al. 2009), (Sisson, Ho et al. 
1997), (Zhang, Zhao et al. 2005). Another important cell surface receptor, 
Hedgehog-interacting protein (Hhip) inhibits the Hh pathway by 
sequestering the Hh ligand, although it does not seem to have an active 
role in signal transduction itself (Beachy, Hymowitz et al. 2010).  
Mutant mice studies have revealed that the three Gli proteins possess 
individual and partially overlapping functions. Gli1 KO are viable (Park, 
Bai et al. 2000), however, Gli2 and Gli3 KO mice are both embryonic lethal 
(Bai, Auerbach et al. 2002). The Gli2 KO embryos are small in size, suffer 
from teeth defects, cleft palate, flattened head and craniofacial 
abnormalities (Mo, Freer et al. 1997) while Gli3 KO have polysyndactyly 
(extra toes) and severe skeletal defects (Bai, Auerbach et al. 2002). Double 
mutants of Gli1 and Gli2 or Gli2 and Gli3 show more severe phenotypes. 
Gli1 expression under the control of Gli2 promoter can partially rescue 
Gli2KO mice, indicating functional redundancies (Bai and Joyner 2001). 
In humans, loss of Gli2 results in serious defects in anterior pituitary 
formation and pan-hypopituitarism with or without cleft-palate (Roessler, 
Du et al. 2003), whereas mutations in Gli3 lead to severe skeletal and lung 
abnormalities, including Greig’s Cephalopolysyndactyly (Vortkamp, 
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Gessler et al. 1991), (Hui and Joyner 1993).  
Hedgehog signalling is also implicated in a number of cancers. Ptch 
mutations have been identified in the aetiology of a number of childhood 
cancers including medulloblastoma (Wolter, Reifenberger et al. 1997), 
rhabdomyosarcoma (Endoh-Yamagami, Evangelista et al. 2009). Ptch 
mutations are also the main cause of Gorlin syndrome, which increases 
pre-disposition to Basal Cell Carcinoma (BCC) (Gorlin 1995). An 
abnormally steep increase in Gli1 and Gli2 expression is found in nearly all 
cases of BCC (Dahmane, Lee et al. 1997), (Regl, Neill et al. 2002). Moreover, 
abnormal Hh signalling is involved in many malignant tumours such as 
pancreatic, prostate and lung cancer (Thayer, di Magliano et al. 2003), 
(Karhadkar, Bova et al. 2004), (Chi, Huang et al. 2006).  
1.3.3  The regulation of Hh activity 
 
Hh proteins act as morphogens. Studies have confirmed that the Hh-
induced effect is regulated in a concentration-dependent manner, allowing 
responding cells to be exposed to different concentrations of Hh proteins 
during different stages of development (Harfe, Scherz et al. 2004) 
(Varjosalo and Taipale 2008). Hh also acts in a duration-dependent 
method, where duration of signal influences outcome (Briscoe and Ericson 
1999). Thus, Hh controls cellular development dependent on the 
responding cell type, the concentration and the duration of exposure to Hh 
by target cells.  
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Figure 1.5 The mammalian Hedgehog signaling pathway    
In the absence of a member of the Hedgehog family of proteins (Sonic, Indian, 
Desert), Patched inhibits the constitutive activity of Smoothened, allowing Gli 
proteins to be recruited to the scaffolding protein Kif7, which also recruits 
serine/threonine kinases to form the Hedgehog signalling complex. This enables 
PKA to phosphorylate Gli proteins generating repressor forms of Gli2 and Gli3 
that inhibit downstream transcriptional activation. In the presence of a Hedgehog 
protein, Patched relieves the inhibition on Smo. Smo signals for the 
phosphorylation of Kif7, allowing the Gli multiprotein complex to dissociate from 
the microtubule. Activator forms of Gli proteins are released and translocate to 
the nucleus, leading to transcription of Hedgehog-specific target genes. The 
middle black dashed line separates the two conditions. The outer membrane 
represents the cell surface and the inner the nuclear membrane. A blunt ended 
line indicates inhibition.  
 
Shh - Sonic Hedgehog, Ihh – Indian Hedgehog, Dhh – Desert Hedgehog, Ptc – 
Patched, Smo – Smoothened, PKA - Protein Kinase A, Fu – Fused, Sufu - 
Suppressor of Fused, Hhip – Hedgehog inhibiting protein, BMP - bone 
morphogenetic protein  
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1.3.4 The role of Shh in T cell development 
 
Shh is the most abundant Hh protein in mammals and plays an important 
role in many developmental processes, where it controls cellular 
proliferation and differentiation (Varjosalo and Taipale 2008). Shh signaling 
is also crucial in organogenesis, most notably in ear, eye and kidney 
development. It is also essential in embryogenesis, where Shh is expressed 
in midline tissues, regulating the patterning of embryonic tissue, including 
the spinal cord, axial skeleton and limbs (Chiang, Litingtung et al. 1996). Not 
surprisingly, aberrations in Shh signaling cause serious developmental 
damage in vertebrates and lead to embryonic lethality (Heussler and Suri 
2003).  
 
The first evidence showing that the Hh signaling pathway mediates 
development of immune cells was provided by our lab (Outram, Varas et al. 
2000).  
In terms of T cell development, Shh is a negative regulator of pre-TCR-
induced differentiation from DN to DP cells (Outram, Varas et al. 2000). In 
this study, mouse fetal thymus organ cultures (FTOCs) treated with 
recombinant Shh (rShh) showed a developmental arrest in the DN stage, 
whereas addition of a Hh-neutralising antibody and subsequent 
neutralization of endogenous Shh resulted in an expansion of DP cells. In 
2004, we also showed that Shh signaling regulates differentiation, survival, 
and proliferation of the earliest double-negative (DN) thymocytes, as thymi 
from Shh-/- mice contain approximately 10 times fewer thymocytes with a 
partial arrest at the DN1 to DN2 stage compared to WT littermates (Shah, 
Hager-Theodorides et al. 2004). The duration and concentration of the Shh-
induced signal is believed to account for the dual function of Shh in the DN to 
DP transition (Crompton, Outram et al. 2007).  
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More specifically, when Hedgehog signaling was reduced in the Shh-/- and 
Gli2-/- thymus or by T lineage-specific transgenic expression of a 
transcriptional-repressor form of Gli2 (Gli2C2), differentiation to DP cell 
after pre-TCR signal transduction was increased (Rowbotham, Furmanski et 
al. 2008). In contrast, when Hh signaling was constitutively activated in 
thymocytes by transgenic expression of a constitutive transcriptional-
activator form of Gli2 (Gli2N2), the production of DP cells was decreased 
(Rowbotham, Furmanski et al. 2008).  
Shh is also important in later stages of T-cell development. DP thymocytes 
are Hh-responsive and thymocyte-intrinsic Shh signaling was recently 
shown to decrease the CD4:CD8 SP thymocyte ratio (Furmanski, Saldana et 
al. 2012).  In the thymus, Shh is produced by epithelial cells in the medulla, 
sub-capsular region and in the cortico- medullary region (Outram, Varas et 
al. 2000), (Virts, Phillips et al. 2006).  
 
1.3.5  The role of Ihh in T cell development 
 
Defects in Ihh signalling have a dramatic effect on bone formation with 
conditional Ihh KO mice showing reduced proliferation of chondrocytes and 
osteoblast leading to the truncation of long bones (Razzaque, Soegiarto et al. 
2005), (St-Jacques, Hammerschmidt et al. 1999). Ihh-/- embryos die around 
1-2 days before birth due to a poorly developed yolk sac (Dyer, Farrington et 
al. 2001). 
 
Although expression of Ihh is generally more restricted than Shh, DN 
thymocytes are highly responsive to Ihh, which regulates T cell development 
and controls thymocytes numbers in both embryos and adult mice.  
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In fetal Ihh-/- thymi, thymocyte numbers and differentiation to DP were 
reduced compared to WT littermates. Surprisingly, however, Ihh+/- thymi 
had increased thymocyte numbers and DP proportions relative to WT, 
indicating that Ihh both promotes and restricts thymocyte differentiation 
(Outram, Hager-Theodorides et al. 2009). In adult thymi, Ihh signaling 
promotes T cell development before pre-TCR signaling but negatively 
regulates T cell development after pre-TCR signaling has taken place. Of 
interest, quantitative PCR (qPCR) analysis on expression levels of Ihh and 
Gli1 showed that Ihh first appears at the DN3 stage and peaks at the DP 
stage where a six-fold increase in expression is observed. However, Gli1 was 
not detectable in DP cells with the highest expression seen in the DN3 stage 
(Outram, Hager-Theodorides et al. 2009). Collectively, these data suggest 
that DP cells produce and secrete Ihh that then feeds back to DN3 and DN4 
cells in order to arrest thymocyte development. Part of this thesis will show 
data that investigates this ‘’feedback loop’’ hypothesis. DP cells are the major 
source of Ihh in the human and mouse thymus. 
 
1.3.6  The role of Dhh in T cell development 
 
The role of Dhh signaling in embryonic development is well defined and its 
function appears to be restricted to testis development (Bitgood, Shen et al. 
1996), Schwann cells (Parmantier, Lynn et al. 1999) and erythropoiesis 
(Lau, Outram et al. 2012).  In the thymus, Dhh is produced by epithelial cells 
in the medulla, sub-capsular region and in the cortico- medullary region 
(Outram, Varas et al. 2000).  
DhhKO mutant mice appear normal and healthy but males are infertile 
(Clark, Garland et al. 2000). 
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Material and methods 
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2.1 Mice 
Strain Origin 
C57BL/6 B&K Universal (UK) 
Ihh+/- 
Gift from Andrew McMahon (Harvard University, Cambridge, 
MA) 
Dhh+/- 
Gift from Andrew McMahon (Harvard University, Cambridge, 
MA) 
Shh+/- 
Gift from Philip Beachy (The John Hopkins University School 
of Medicine, Baltimore, MD) 
Gli3+/- Purchased from Jackson Laboratories (USA) 
Kif7+/- Purchased from Davies, California (USA) 
HY-TCR Purchased from Jackson Laboratories (USA) 
CD4-Cre+ Purchased from Jackson Laboratories (USA) 
Shh Floxed Purchased from Jackson Laboratories (USA) 
Ihh Floxed Gift from Beate Lanske (Harvard School of Dental Medicine) 
FoxN1-Cre+ Gift from George Holländer (Basel, Switzerland) 
GBS-GFP 
Gift from James Briscoe (Balaskas, Ribeiro et al. 2012) 
 
Lck-Gli2Ν2 As described (Rowbotham, 2007)  
Lck-Gli2C2 As described (Rowbotham, 2007)  
Table 2.1: Strains of mice used 
 
All adult mice used were between 4-8 weeks old. Timed mates were 
performed by mating a male with two females and monitoring the females 
for plugs. The day the plug was found was counted as embryonic day 0.5 
(E0.5). Mice were bred and maintained at the Institute of Child Health under 
UK Home Office regulations.  
2.2 Antibodies and Flow Cytometry 
2.2.1 Cell surface staining  
Cell suspensions were prepared by meshing tissue through a 70 μm cell 
strainer (Falcon, US) using the plunger of a 1ml needleless syringe (Terumo, 
Philippines). Cells were stained using combinations of the following directly 
conjugated antibodies (e-Bioscience, US): 
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1. Murine γδ T cell analysis: anti-CD3PE-Cy7, anti-CD4FITC, anti-CD4PE, anti-
CD4PercP-Cy5.5, anti-CD4APC, anti-CD24PercP-Cy5.5, anti-CD25Alexa700, anti-
CD27FITC, anti-CD27PE, anti-CD44eFluor450, anti-CD122FITC, anti-γδTCRPE, 
anti-γδTCRAPC, anti-NK1.1PercP-Cy5.5, anti-Vγ1PE, anti-Vγ2e710, anti-
CCR6e660. 
 
2. Human γδ T cell analysis: anti-CD3 PercP-Cy5.5, anti-CD27eFluor450, anti-
CD45RAPE-Cy7, anti-CD62LAPC-Cy7, anti-γδTCRFITC, anti-Vδ1APC, anti-
Vδ2PE.  
 
3. Ihh feedback loop hypothesis: anti-CD3FITC, anti-CD3PE, anti-CD3PercP-
Cy5.5, anti-CD3APC, anti-CD4FITC, anti-CD4PE, anti-CD4PercP-Cy5.5, anti-
CD4APC, anti-CD5FITC, anti-CD8FITC, anti-CD8PE, anti-CD8PercP-Cy5.5, anti-
CD8APC, anti-Vb6, anti-Vb8.1/8.2FITC, anti-CD25FITC, anti-CD27PE, anti-
CD44PE, anti-CD69FITC, anti-NK1.1PercP-Cy5.5, anti-γδAPC, anti-HSAFITC, 
anti-B220PE, anti-Qa2FITC, anti-HY (T3.70 clone)FITC. 
 
Suspensions were stained for 20 minutes on ice in 100μL Phosphate buffer 
saline (Sigma-Aldrich, US) supplemented with 5% Fetal Calf Serum (FCS). 
Cells were washed in the same medium between incubations and prior to 
analysis by either C6 (BD Biosciences, US) or LSRII (BD Biosciences, US) flow 
cytometer. Events (minimum 106) were collected using FACSDiva software 
(BD Biosciences, US) and analysed using Flowjo 7.6 (Tree Star, US).  
 
2.2.2 Annexin-V apoptosis staining assay 
Annexin-V staining was carried out using an Annexin-V-FITC apoptosis 
detection kit (BD Pharmingen, US) according to the manufacturer’s protocol. 
Prior to Annexin-V staining, cells were stained as described in 2.2.1. 
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2.2.3 Propidium iodide (PI) staining 
For PI staining, 2.5x105 cells were permeabilized in 0.1% Triton X-100 
(Sigma, UK) and incubated with 50μg/ml PI (Sigma, UK) and 0.1M sodium 
citrate (Sigma, UK) in PBS for 30 minutes in the dark and at room 
temperature. 
 
2.2.4 Intracellular stain (ic) for cytokines 
 
2.2.4.1 Activation Assay 
Splenocytes and lymphocytes were isolated and cultured in AIM-V medium 
(Life Technologies, US) supplemented with 50ng/ml PMA (Sigma), 
500ng/ml Ionomycin (Sigma) and 2μg/ml Brefeldin A (eBiosciences) at a 
concentration of 5 x 106 cells/ml in 24 well plate at 37°C and 5% CO2. Cells 
were harvested at 4h.  
 
2.2.4.2 Intracellular stain 
Intracellular cytokine staining for IL-17 and IFN-γ was carried out on cells 
stained for surface markers as described in 2.2.1, following fixation and 
permeabilization with the Fix/Perm solutions (BD Biosciences, US) 
according to the manufacturer’s instructions. Anti-IL-17FITC, anti-IFN-γFITC, 
anti-IFN-γPE were supplied by e-Bioscience. Minimum 106 cells were stained 
for 1h in 100ml ice cold PBS supplemented with 5% FCS. Antibodies were 
used at a 1:25 final ratio. 
 
2.2.5 Cell Sorting  
Thymocytes and splenocytes from adult mice (6-8 weeks) were sorted at the 
ICH/GOSH Flow Cytometry Core facility using a Modular Flow Cytometer 
(MoFlo XDP; Beckman Coulter, US). Staining with anti-CD3FITC and anti-
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CD4PE, anti-CD8PercP-Cy5.5 and anti-CD25APC allowed sorting of the DP, SP and 
DN thymic populations. Sorting of γδ T cells required anti-CD3FITC, anti-
CD4PE, anti-CD8PerCP-Cy5.5 and anti-γδTCRAPC. All cells collected fell within the 
forward scatter/ side scatter (FSC/SSC) live gate.  
 
2.3 Fetal Thymic Organ Cultures (FTOCs)  
E14.5 – Ε19.5 fetal thymi were cultured on 0.8m membrane filters 
(Millipore, US) in 1ml AIM-V medium (Invitrogen, US) in 24-well plates for 5 
days. Cultures were incubated at 37C and 5% CO2. Where appropriate, 1μg 
of rHhip, rShh or rDhh, all purchased by R&D Systems, US, was added in the 
medium. 
 
2.4 Skin digestion 
Skin samples were collected from anatomically matched locations, minced 
with scissors and digested with 150μg/ml Liberase (Roche, UK) and 
500μg/ml DNAse (Roche, UK) in sterile DMEM (Sigma, UK) for 3 hours at 
370 C. Every 30 min, the tube was gently swirled to dissociate cells. The 
sample was filtered through a 70μm filter to obtain a single cell suspension 
and washed twice. 
 
2.5 RNA extraction and cDNA synthesis 
Cell suspensions were pelleted and resuspended in the appropriate amount 
of lysis buffer and β-mercaptoethanol (Stratagene). RNA was extracted using 
the Arctutus PicoPure kit (Life Technologies, US) according to the 
manufacturer’s protocol, including the DNAse digestion step. cDNA was 
synthesized from this RNA using the High Capacity cDNA Reverse 
Transcription (Life Technologies, US)  kit following manufacturer’s protocol. 
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The mix was incubated at 250 C for 10 minutes to allow primer binding 
followed by 370 C for 120 minutes to allow elongation and finally 850 C for 5 
minutes to terminate the reaction. cDNA was stored at -200 C. 
 
2.6 Quantitative Reverse Transcribed-Polymerase Chain 
Reaction (QRT-PCR) 
QRT-PCR was carried out in triplicates on the cDNA samples obtained (as 
described above) on an iCycler (Bio-Rad Laboratories, Hercules, CA) using 
the iQ SYBR Green Supermix (Bio-Rad, UK) according to the manufacturer’s 
protocol. The housekeeping gene Hypoxanthine Guanine Phosphoribosyl 
Transferase (HPRT) was used to allow template quantification. For each 
gene, the amplification was compared to a dilution series of cDNA prepared 
from embryo head RNA using the Absolutely RNA miniprep (Agilent, US) kit. 
QuantiTech Primers were purchased by Qiagen (Germany). Each reaction 
mixture contained: 1μl (1μg) cDNA, 2μl QuantiTech primers, 10μl iQ SYBR 
Green Supermix and 7μl DNAse/RNAse-free distilled water (Life 
Technologies, US). Quantitative Real Time PCR was performed under the 
conditions of the 2StepMelt Quantitect protocol, according to the 
manufacturer’s instructions. 
 
2.7 DNA extraction and genotyping of mutant mice by 
PCR 
DNA from mice was extracted from 2mm ear biopsies by digesting tissue in 
100μL lysis buffer containing 50 mM KCl, 1.5 mM MgCl2, 10 mM Tris-HCl (pH 
8.5), 0.01% gelatin, 0.45% Nonidet P-40, 0.45% Tween 20, and 0.5 µg/ml 
proteinase K (Sigma-Aldrich, US) in ultra-pure water (Invitrogen, US). The 
samples were incubated at 500rpm at 560C overnight for digestion. The 
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samples were then spun briefly and 1μL supernatant containing the DNA 
(~1μg) was used as template. Primers used for amplifying the PCR products 
are listed in Table 2.2. Each PCR reaction consisted of a 20μL mix composed 
of 10μl GreenTaq DNA Polymerase (Sigma-Aldrich, US) and 1μM of each 
relevant primer made in ultra pure water (Invitrogen, US). PCR was carried 
out on a Robocycler (Stratagene, US) or a Prime (Techne, UK) PCR machine 
as follows: 5 min at 940C followed by 30-40 cycles for 90 seconds at 940C, a 
primer-specific step (Table 2.3) and 60 seconds at 720C. The products were 
resolved on 2% agarose (Sigma-Aldrich, US) 1x TBE (Life Technologies, US), 
stained with 1% GelRed (Biotium, US). A 100bp ladder marker (Bioline, UK) 
was electrophorised to estimate band size. The gel was visualized under UV 
light (Herolab, Germany) and a photograph was taken. 
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Table 2.2: The forward (top) and reverse (bottom) primer used for       
genotyping of different mice strains 
 
Strain  
Ihh WT (St-Jacques, 
Hammerschmidt et al. 1999) 
AGGAGGCAGGGACATGGATAGGGTG 
AGGAACAGACAGAACCGCAGTCGGG 
Ihh KO (Outram, Hager-
Theodorides et al. 2009) 
AGGAGGCAGGGACATGGATAGGGTG 
TACCGGTGGATGTGGAATGTGTGCG 
Dhh WT (Lau, Outram et al. 
2012) 
ATCCACGTATCGGTCAAAGC 
GGTCCAGGAAGAGCAGCAC 
Dhh KO (Lau, Outram et al. 
2012) 
GGCATGCTGGGGATGCGGTG 
CCAGGAAGACGAGCACTGGCGTG 
Shh KO (Outram, Hager-
Theodorides et al. 2009) 
CTGTGCTCGACGTTGTACTG 
AAGCCCGAGACTTGTGTGGA 
Gli3 KO  (Hager-Theodorides, 
Dessens et al. 2005) 
GGCCCAAACATCTACCAACACAT 
GTTGGCTGCTGCATGAAGACTGAC 
KiF7 WT (He, Subramanian et 
al. 2014) 
CTGCCTTTCCCAGCCACCTGACAT 
GGGAGAGGACACTGGGCAAGA 
KiF7 KO (He, Subramanian et al. 
2014)  
CTGCCTTTCCCAGCCACCTGACAT 
GCAGCGCATCGCCTTCTATC 
HY-TCR (Kisielow, Teh et al. 
1988) 
CACATGGAGGCTGGTGCATCAG 
GTTTCTGCACTGTTATCACC 
Cre+ (Outram, Hager-
Theodorides et al. 2009) 
CGATGCAACGAGTGATGAGG 
GCATTGCTGTCACTTGGTCGT 
Shh Floxed (Zuklys, Gill et al. 
2009) 
ATGCTGGCTCGCCTGGCTGTGGAA 
GAAGAGATCAAGGCAAGCTCTGGC 
Ihh Floxed (St-Jacques, 
Hammerschmidt et al. 1999) 
AGCACCTTTTTTCTCGACTGCCTG 
TGTTAGGCCGAGAGGGATTTCGTG 
Lck-Gli2N2 / Gli2C2 
(Rowbotham, Hager-
Theodorides et al. 2007) 
CGAACCACTCAGGGTCCTGTG 
GGATTTCTGTTGTGTTTCCTC 
Rag WT (Mombaerts, Iacomini 
et al. 1992) 
TAGACACTTCTGCCGCATCTGTGG 
GGAGTCAACATCTGCCTTCACG 
Rag KO (Mombaerts, Iacomini 
et al. 1992) 
TAGACACTTCTGCCGCATCTGTGG 
TGACCGCTTCCTCGTGCTTTAC 
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   Table 2.3: Specific parameters for genotyping of mutant mice by PCR 
 
2.8 Lipopolysaccharide (LPS) injection 
Littermates of 6-8 weeks were injected intraperitoneally (ip) with a single 
dose of 10-100ng/gram of body weight LPS in 200μl of sterile PBS. The 
control group was injected ip with 200μl sterile PBS. Injections were 
performed with a 1ml syringe (Terumo, Philippines) and a 25G needle (BD 
Microlance, Ireland). Animals were sacrificed 4 days later and blood and 
tissues were collected for further analysis.  
Strain Annealing T Duration No of cycles 
Ihh WT 66 60 33 
Ihh KO 62 60 40 
Dhh WT 58 60 35 
Dhh KO 58 60 35 
Shh KO 58 60 34 
Gli3 KO 59 80 34 
KiF7 WT 59 45 30 
KiF7 KO 59 45 30 
HY-TCR 58 60 35 
Cre+ 61 90 32 
Shh floxed 58 60 35 
Ihh floxed 62 60 40 
Lck-Gli2N2 58 60 30 
Lck-Gli2C2 58 60 30 
Rag WT 58 60 35 
Rag KO 58 60 35 
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2.9 Hydrocortisone (HC) injection 
Ihh+/-, Ihhfl/fl-CD4Cre-HY-, Ihhfl/fl-CD4Cre-HY+ mice and WT littermates 
were injected with a single dose of 0.4mg/gram of body weight pure HC 
(water-soluble HC, Sigma, UK) dissolved in 250μl sterile and filtered PBS 
using a 0.22μm Millex filter (Millipore, Ireland). For each injection, a 1ml 
syringe (Terumo, Philippines) and 25G needle (BD Microlance, Ireland) was 
used. Animals were sacrificed 2, 4 and 6 days later and thymi were collected 
for further analysis. 
 
2.10 Human γδ analysis 
2.10.1 Human γδ selection 
Human thymi were collected at Great Ormond Street Hospital from donors 
undergoing cardiac surgery with informed consent. Thymocyte suspensions 
were obtained by meshing thymi using a 70μm nylon cell strainer (Corning, 
US) in RPMI. Peripheral blood mononuclear cells (PBMCs) were isolated 
from fresh blood donated by healthy donors via the NHS National Blood 
Service. Lymphocytes were isolated using Lymphoprep (Axis-Shield, 
Norway) density gradient separation according to manufacturer’s 
instructions. γδ T cells were isolated using the Anti-TCRγδ MicroBead Kit 
(Miltenyi Biotec, Germany) according to the manufacturer’s protocol. On 
average, starting from a suspension of 108 thymocytes, 5x105 – 106 cells 
were obtained with 95% purity for CD3+ / γδ+ cells, assessed by flow 
cytometry at C6 (BD Biosciences, US) flow cytometer. 
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2.10.2 Human γδ expansion culture 
γδ T cells were expanded from freshly isolated pure populations of γδ T cells 
obtained either from thymocytes or PBMCs (see 2.12.1). Cells were cultured 
at a concentration of 5x105 cells/ml in a 48-well flat bottom plate (Corning, 
US) in RPMI medium containing 10% FCS, 1% Penicillin/ Streptomycin (PS) 
(Sigma, UK), 100U/ml IL-2 (PeproTech, US) and 120U/ml IL-21 (PeproTech, 
US). Irradiated artificial Antigen Presenting Cells (aAPCs), a K562 cell line 
engineered to express CD86, CD137L and IL-15, were added in the medium 
every 7 days at a concentration of 1:2 γδTcell:aAPC, to boost expansion. 
aAPCs were kindly provided by Kenth Gustafsson, Molecular Immunology, 
ICH, UCL. Cells were transferred to a T-75 flask (Corning, US) after 16-21 
days and were harvested 2-3 days later with an average yield of 8x107 cells.  
 
2.10.3 Irradiation 
107cells/ml aAPCs in RPMI medium were given a single dose of 80 Gy from a 
60Co gamma-ray source at a dose rate of 0.28 Gy/min. Irradiated cells were 
stored at -80°C. 
 
2.10.4 Human γδ recombinant hedgehog (rΗh) cultures 
Expanded γδ T cells were transferred to 6-well plates (Corning, US) with a 
concentration of 2x106 cells/well. Each well contained 2ml RPMI 1640 
medium (Life technologies, US) supplemented with 10% FCS, 1% PS, 
100U/ml IL-2 (PeproTech, US) and 120U/ml IL-21 (PeproTech, US). In 
addition, 1μg rShh (R&D Systems, US) or 1μg rHhip (R&D Systems, US) was 
added in each well. An untreated control was included for each time point. 
Cells were collected and analysed in days 1, 2, 4 and 6 as follows: 
 RNA extraction - 106 cells 
 Flow Cytometry - 5 x 105 cells 
 PI stain - 2.5 x 105 cells 
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 Annexin V stain - 2.5 x 105 cells 
 
2.11 Cell Counts 
Single cell suspensions were diluted 1:1 in 0.1% w/v Trypan Blue (Sigma-
Aldrich, US) in PBS and non-blue cells were counted using a 
haemocytometer. For spleenocytes counts, erythrocytes were distinguished 
by their biconcave shape and excluded from the count. 
 
2.12 Experimental Data Analysis 
Statistical analysis using at least three independent experiments was 
performed using GraphPad Prism (GraphPad Inc, US) and Microsoft Excel 
2013 (Microsoft Inc, US). An unpaired two-tailed student’s t test was used to 
test the significance of differences observed in WT, Het and KO littermates, 
unless stated otherwise. Values of p<0.05 were considered to be significant. 
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3. Murine and human γδ cells can transduce Hh signals 
3.1. Introduction 
 
The effect of Hedgehog signalling pathway on the ontogeny, 
differentiation, development, survival, proliferation, localization, function 
and cytokine production of γδ T cells has not been investigated in depth. 
One publication has suggested that Hh signalling affects γδ thymocytes in 
two ways; the first is via Hh’s major role in the differentiation and survival 
of very early T cell progenitors in the thymus, which give rise to both αβ 
and γδ T cells, and the second involves Hh’s interaction with the Wnt 
signalling pathway, which is known to affect γδ thymocytes (El Andaloussi, 
Graves et al. 2006), (Melichar and Kang 2007). T-cell factor 1 (Tcf1) 
deficient mice, a key transcription factor required for Wnt signalling, 
showed impaired development of intestinal intraepithelial γδ lymphocytes 
(Ohteki, Wilson et al. 1996).  
 
In addition, our group published data on γδ cells in a paper that 
investigated the role of Hh signalling in TCR repertoire selection in the 
thymus, and reported that constitutive transgenic expression of Gli2A in 
all T-lineage cells resulted in reduced CD4-CD8-CD3+γδ+ cells in the lymph 
node compared to WT mice (Furmanski, Saldana et al. 2012). 
 
Here, we aim to test the hypothesis that Hh signalling regulates γδ T cell 
development and homeostasis in peripheral tissues. Investigation of γδ T 
cells is challenging because of the scarcity of these cells in different tissues. 
Another difficulty lies in the fact that γδ T cells are still not well 
characterised both in terms of ontogeny and function. In general, murine 
γδ T cells have been described in terms of a dichotomy between T-bet, 
IFNγ, CD27-expressing cells on the one hand and RORγt, IL-17, CCR6-
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expressing cells on the other hand, but our understanding of the ontogeny 
and plasticity of the different γδ T cell populations is incomplete. For 
example, it is unclear whether TH17 γδ cells are developed postnatally or 
arise as a result of extrathymic plasticity of adult γδ T cell populations.  
 
In this chapter we test if murine γδ T cells are capable of transducing Hh 
signals and if they do transduce Hh signals in vivo. We investigate 
expression of Hh pathway components in murine γδ T cell populations in 
the thymus and spleen, and use Hh-reporter mice to investigate the extent 
of Hh pathway activation in γδ T cell populations in different tissues in 
vivo. 
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3.2 Results 
 
3.2.1 Hh signalling components are expressed in thymic γδ T cells 
In order to investigate whether the Hh pathway plays a role in γδ Τ cells, 
we examined the expression of Hh components in γδ T cells from the 
thymus and spleen of 4 week old mice. In the case of the thymus, mRNA for 
qPCR was collected from FACS sorted CD3+γδTCR+ (γδ cells), CD4+CD8+ 
(DP cells), whole thymus and CD3-CD25+ cells (DN2/DN3 cells) (Figure 
3.1). This last population represents the DN2 and DN3 stages during 
thymocyte development and thus allows us to compare the expression of 
Hh components in γδ Τ cells with expression in thymocyte progenitors 
(DN2 and DN3 cells).  
 
We found that in the 4 week old murine thymus, several components of 
the Hh signalling pathway are expressed in γδ cells. We detected Ihh at 
levels higher than in the CD25+ DN population, at similar levels to the 
whole thymus. We failed to detect Shh or Dhh. We also detected 
expression of Gli1 and Gli3, as well as very low expression of Gli2, in all 
three cases.  However, expression was lower than that observed for the 
DN2/DN3 progenitor population (Figure 3.1). We detected expression of 
the Hedgehog pathway’s key receptors required for Hh signalling, Smo and 
Ptch. We also detected expression of Dispatched, which is required to 
secrete Hh proteins, suggesting that γδ Τ cells can secrete Ihh.  Rab23, an 
inhibitor of Hh signalling was also present. Sox13, a γδ-specific 
transcription factor, was used as a positive control, and was detected in 
the γδ+ thymocytes only  (Figure 3.2).  
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3.2.2 Hh signalling components are expressed in splenic γδ T cells 
We then sorted CD4+ T cells, CD8+ T cells and γδTCR+ cells from 4 week 
old WT spleen and made RNA for qPCR analysis (Figure 3.3). Expression of 
several Hh components were also present in the T cell populations in the 
spleen of WT mice.  We detected Ihh in splenic γδ T cells, as well as in 
CD3+γδTCR-CD4+ and CD3+γδTCR-CD8+ cells.  Ihh has previously been 
shown to be expressed in CD4 and CD8 single positive (SP) populations in 
the thymus, and in CD8+ spleen-derived cytotoxic T lymphocytes (Outram, 
Hager-Theodorides et al. 2009), (de la Roche, Ritter et al. 2013). Similarly 
to the thymus, we failed to detect Shh and Dhh.  Gli1, a Hh-target gene, was 
also detected, as was Gli2, but we did not detect Gli3. As found in the 
thymus, Smo, Ptch and Dispatched were expressed in all three populations 
(Figure 3.3). 
 
3.2.3 Hh-reporter mice show active Hh-mediated transcription in γδ 
T cell populations in vivo 
Our expression analysis showed that γδ Τ cells from the thymus and 
spleen express components of the Hh signalling pathway and so are 
capable of transducing Hh signals.  To examine Hh pathway activation 
status in γδ Τ cell populations in vivo, we used a transgenic (tg) Hh-
reporter mouse.  This Gli Binding Site-Green Fluorescent Protein (GBS-
GFP) transgene contains multiple Gli Binding Sites with a minimal 
promoter which drives GFP expression in cells in which Hh-mediated (Gli-
mediated) transcription is active.  Hh proteins are expressed in the spleen 
and thymus, and are also involved in regulating tissue homeostasis in non-
lymphoid organs such as the lung, skin and gut.  The extent of Hh pathway 
activation in a given γδ Τ cell will therefore depend on its localization, 
relative to the source of Hh.  We therefore used flow cytometry to measure 
GFP expression at the single cell level in γδ Τ cell populations from 
different tissues (Figure 3.4).  
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Approximately 6.5% of γδ thymocytes and 8.5% of γδ cells from the spleen 
were positive for GFP, indicating active Hh-dependent transcription. We 
gated on GFP(+) γδ cells and examined cell surface CD27 and CD44 
expression. In the thymus, all GFP(+) γδ cells were CD27+, whereas in the 
spleen the majority of GFP(+) γδ cells were in the CD44+CD27- population. 
When we examined CD24 expression, we found that in both thymus and 
spleen the γδ population that was undergoing active Hh pathway 
activation expressed cell surface CD24. 
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Figure 3.1: Expression of key Hh components in γδ Τ cells of murine WT 
thymus 
Dot plots show the sorting strategy for γδTCR+, DN2 and DN3 thymocytes. A live 
gate (A) was drawn and (B) doublets were excluded. CD3+ γδ T cells were sorted, 
shown in red. From CD3- cells (DN) cells, those who are CD25+ were sorted, 
named DN2 and DN3, here shown in green. Bar charts show relative 
transcription of Ihh, Gli1, Gli2, Gli3 in the FACS sorted thymocyte populations 
described above. We were unable to detect Shh and Dhh in any of the populations 
described above. The scale shows expression normalized to the levels of the 
housekeeping gene HPRT. Error bars represent ±SEM. 
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Figure 3.2: Expression of key Hh components and γδ-specific markers in γδ 
Τ cells of murine WT thymus 
Bar charts show relative transcription of Smo, Ptch, Disptch, Rab23 and the γδ-
specific marker SOX13, in the FACS sorted thymocyte populations described 
above. The scale shows expression normalized to the levels of the housekeeping 
gene HPRT. Error bars represent ±SEM. 
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Figure 3.3: Expression analysis of Hh signaling components in the murine 
spleen 
Dot plots show the sorting strategy of CD4, CD8 and γδTCR+ splenocytes. (A) A 
live gate was drawn and (B) doublets were excluded. CD3+ cells were sorted in 
relation to (D) CD4, (E) CD8 and (F) γδTCR+ cell surface expression. Bar charts 
show relative transcription of Ihh, Gli1, Gli2, Smo, Ptch and Disptch, in the FACS 
sorted splenocyte populations described above. We were unable to detect 
expression of Shh, Dhh and Gli3 in any of the above populations. The scale shows 
expression normalized to the levels of the housekeeping gene HPRT. Error bars 
represent ±SEM. 
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Figure 3.4: Gli Binding Site (GBS) GFP expression in the thymus and the 
spleen of 3 week old mice 
Histogram (A) shows the proportion of thymic and splenic live-gated 
CD3+γδTCR+ cells that are positive for GBS-GFP.  Dot plots (B) show CD27 and 
CD44 expression on GFP(+) γδ T cells from thymus and spleen. Dot plots (C) 
show CD24 staining plotted against GFP.  
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4. The function of the Hh family proteins in γδ T cell 
development in the thymus 
 
4.1 Introduction 
We showed that thymic γδ T cells express components of the Hh signalling 
pathway and transduce Hh signals in vivo.  In this Chapter we aim to 
investigate the specific contribution of each of the three Hh family 
members to γδ T cell development in the thymus. The three family 
members share a common signalling pathway, but have distinct, although 
partially overlapping functions. Their distinct functions in development 
and tissue homeostasis are the result of differences in their temporal and 
tissue restricted expression patterns, and may also reflect strength of 
signal induced by each family member.  All three Hh family members are 
expressed in the thymus. Shh is expressed by thymic epithelial cells (TEC), 
situated mostly at the cortico-medullary junction and subcapsular region 
(Outram, Varas et al. 2000), (Sacedon, Varas et al. 2003), (El Andaloussi, 
Graves et al. 2006, Saldana, Solanki et al. 2016). Ihh is expressed by 
thymocytes and some TEC scattered through out the cortex (Outram, 
Varas et al. 2000), (Sacedon, Varas et al. 2003), (Outram, Hager-
Theodorides et al. 2009)whereas Dhh is expressed by TEC (Sacedon, Varas 
et al. 2003).  Therefore, to investigate the function of each Hh family 
member in γδ T cell development in the thymus, we first analysed thymic 
γδ T cell populations in mice mutant in Shh, Ihh, and Dhh.  
 
4.2 Results 
 
4.2.1 The role of Shh in γδ T cell development in the thymus 
Shh can function as a morphogen, so that a concentration gradient 
specifies distinct cell fates according to concentration and duration of the 
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signal. Our laboratory has previously shown that Shh is an essential 
regulator of T cell development (Crompton, Outram et al. 2007). Shh is 
required for the DN1 to DN2 transition (Hager-Theodorides, Dessens et al. 
2005), (Shah, Hager-Theodorides et al. 2004) and regulates the DN to DP 
transition (Outram, Varas et al. 2000), (Rowbotham, Hager-Theodorides et 
al. 2009) and the DP to SP transition (Rowbotham, Hager-Theodorides et 
al. 2007), (Saldana, Solanki et al. 2016) whereas the function of Shh in γδ Τ 
cells remains unknown. 
 
Here, we used two different mice strains with impaired Shh production to 
test the hypothesis that Shh regulates γδ T cell development in the thymus. 
Shh KO is embryonically lethal, so we used Shh+/- mice and Shhfl/fl-
FoxN1Cre+ tg mice (ShhcoKO) in which Shh is conditionally knocked out in 
TEC. Comparison between these two systems can provide insight into the 
source of Shh affecting γδ cells.  
 
4.2.2 Adult γδ T cell populations in the Shh+/- thymus 
We did not observe any difference in γδ cell numbers in the Shh+/- thymus 
compared to WT (Figure 4.1A). However, in the adult Shh+/- thymus, CD27 
expression was modestly but significantly downregulated (Figure 4.1B). In 
addition, the percentage of the CD44+CD27- γδ population was increased 
(Figure 4.1E), whereas the CD27+CD44+ γδ subset was downregulated 
(Figure 4.1G), and the overall proportion of γδ thymocytes that expressed 
CD44 was decreased, although these changes were not significant.  
 
4.2.3 Shh+/- γδ thymocytes show reduced Hh-mediated transcription 
in vivo 
Our data show that Shh influences γδ cell development and differentiation 
in the thymus. Shh may be signalling directly to γδ cells or its effects may 
be indirect through another cell type. Therefore, to test the impact of Shh-
heterozygosity on Hh pathway activation in γδ thymocyte populations in 
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vivo, we crossed the Shh+/- mice with Hh-reporter mice (GBS-GFP-tg) mice 
and compared GFP expression by flow cytometry in defined γδ thymocyte 
populations from Shh+/+-GBS-GFP-tg and Shh+/--GBS-GFP-tg thymus 
(Figure 4.1H). We found that ~1.5% of γδ thymocytes expressed GFP in 
the Shh+/+ thymus, and this was reduced by approximately two-thirds in 
the Shh+/- mice.  
 
4.2.4 Conditional deletion of Shh from TEC  
Thymic epithelial cells are believed to be the main source of Shh in the 
mouse thymus, so we used Cre-loxP technology to conditionally delete Shh 
from all TEC using TEC-specific FoxN1-Cre (Saldana, Solanki et al. 2016). 
In the ShhcoKO adult thymus, the number of γδ thymocytes was reduced, 
compared to Cre- (WT) littermates (Figure 4.2A and B).  This reduction in 
γδ thymocyte numbers was not observed in the Shh+/- thymus, and 
suggests that TEC are the major source of Shh in the thymus.   
 
4.2.5 Shh-treatment of WT FTOC 
To investigate the impact of recombinant (r) Shh treatment on γδ 
thymocyte numbers and cell surface phenotype, we cultured E14.5 WT 
FTOC with rShh for 5 days.  Addition of rShh increased the proportion of 
γδ cells in the E14.5 + 5 day FTOC and significantly increased the 
proportion of γδ thymocytes that expressed cell surface CD44 (Figure 4.3). 
This was consistent with the observation that the CD44+ γδ thymocytes 
are undergoing active Hh signalling in the GBS-GFP-tg reporter 
experiments.  
 
As the increase in the proportion of γδ thymocytes in the rShh-treated 
cultures may have been the result of the action of rShh to inhibit 
differentiation from DN to DP thymocyte (Outram et al 2000), we also 
carried out FTOC with E16.5 WT thymic lobes in the presence of rShh or 
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rHhip (to neutralize endogenous Hh molecules in the cultures), and 
analysed them after 5 days. We did not find an influence of rShh treatment 
on the number of γδ cells in the E16.5 + 5 day FTOC (Figure 4.4A and B).  
Interestingly, rHhip-treatment of E16.5 WT FTOC led to a significant 
decrease in the number of γδ thymocytes, indicating that endogenous Hh 
proteins present in the fetal thymus are required for normal γδ thymocyte 
production (Figure 4.4C and D). This is consistent with the reduction in γδ 
cell numbers observed in the ShhcoKO adult thymus. We also observed a 
significant down-regulation of CD27 in rShh treated E16.5 + 5 day FTOC 
(Figure 4.4E). 
 
4.2.6 Ihh signalling in γδ T cell development in the thymus 
Ihh is expressed by DP and SP thymocyte populations (Outram, Hager-
Theodorides et al. 2009) and in sorted γδ thymocytes (Figure 4.7). Ihh-
mediated Hh signalling both promotes and restricts T cell development, as 
Ihh, secreted from DP cells, together with Shh, secreted by TEC, promote 
differentiation of DN1 cells to DN2. However, Ihh negatively regulates pre-
TCR-induced differentiation to DP stage. The role of Ihh on the 
development γδ Τ cells had not previously been investigated.  We 
therefore investigated the impact of Ihh-mutation on γδ thymocyte 
development.  
 
We measured γδ thymocyte population number and cell surface 
phenotype in Ihh+/- adult thymus, E14.5 and E15.5 Ihh-mutant thymi and 
CD4Cre+-Ihhf/fl (IhhcoKO) adult mice, in which Ihh is conditionally 
deleted from all cells that have expressed CD4.  
 
Of the three Hh ligands, Ihh affected γδ cells the least.  There was no 
difference in the proportion of γδ thymocytes in adult Ihh+/- thymus 
compared to WT (Figure 4.5A and B) or in E14.5 or E15.5 Ihh-mutant 
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thymus or adult IhhcoKO thymus compared to WT littermates (data not 
shown). We performed a detailed analysis by flow cytometry staining 
against NK1.1, CD4, CD122, CD27, CD44, CD24, CCR6, CCR7, IFNγ and IL-
17, and the only difference we observed was a increase in CD4-expressing 
γδ cells in the adult Ihh+/- thymus, compared to WT (Figure 4.5C). 
 
4.2.7 The role of Dhh in γδ T cell development 
Although not expressed by thymocytes, Dhh is expressed by thymic 
epithelial cells (Sacedon, Varas et al. 2003). The function of Dhh in γδ T 
cells is unknown.  Unlike mutant Ihh and Shh mice, Dhh-/- mice are born 
healthy and viable. Therefore, in order to examine the role of Dhh on γδ T 
cells, we compared WT to Dhh-/- mice.  
 
4.2.8 The adult Dhh-deficient thymus 
The Dhh-/- thymus showed a small and non-significant reduction in γδ T 
cell count and percentage compared to WT (Figure 4.6A,B). The Dhh-/- 
thymus showed a significant reduction in the proportion of CD27+CD44+ γδ 
cells. Virtually all WT γδ thymocytes are CCR7- and only around 3% 
stained positive for CCR6. Deletion of Dhh increased CCR6 expression 
compared to WT (Figure 4.6G). In addition, CD4 expression decreased on 
Dhh KO γδ thymocytes compared to WT (Figure 4.H). 
 
4.2.9 γδ thymocytes in the fetal Dhh-deficient thymus  
We analysed γδ thymocyte populations in E17.5 Dhh-/- thymi. Due to the 
small size of the fetal tissues and the scarcity of γδ cells, our analysis was 
restricted to a few γδ markers. As seen in the adult, we found no overall 
difference in the number of γδ thymocytes (Figure 4.7A) but deletion of 
Dhh resulted in a higher percentage of CD44+CD27- γδ cells and 
downregulation of CD24 expression (Figure 4.7B,C). However, as these 
data were obtained from only one litter, more embryos need to be 
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examined to confirm our findings.  Interestingly, in the fetal spleen Dhh-
deficiency also appeared to decrease cell surface expression of CD27 on γδ 
cells compared to WT, and this observation will also be confirmed when 
more embryos are available.  
 
4.2.10 Treatment of WT FTOC with rDhh and rHHip 
We showed that treatment of WT FTOC with rShh increased the 
proportion of γδ cells recovered, whereas treatment with rHhip (which 
binds to Hh proteins and neutralizes them) decreased γδ cells in FTOC. As 
Dhh and Shh have been suggested to have different binding affinities, we 
also tested the impact of rDhh treatment on γδ cell numbers in FTOC.  We 
treated E17.5 FTOCs with rDhh or rHhip and analysed them after 6 days in 
culture. We retrieved more γδ cells from the rDhh-treated culture than 
control untreated cultures, whereas the rHhip treatment reduced γδ cells, 
as seen in Figure 4.7D.  
 
4.2.11 The effect of Shh and Dhh double deficiency on γδ T cells 
We have investigated the role of the Shh KO and the Dhh KO on γδ T cells 
in the thymus, but as both Shh and Dhh are expressed by TEC, we tested 
the impact of double deficiency.  We crossed Dhh KO with ShhcoKO 
(Shhfl/fl-FoxN1Cre+) mice to generate animals in which both Dhh and Shh 
are knocked out from TEC in the thymus.  
The double KO mice had significantly fewer γδ thymocytes than WT 
littermates (Figure 4.8A,B).  This suggested an additive effect of double 
deficiency, as neither the DhhKO or the ShhcoKO showed significantly 
fewer γδ cells in the thymus. Some small and not significant changes were 
observed on CD27 and CD44 expression (Figure 4.8E).  No change was 
observed in terms of Vγ chain usage (data not shown). In the double KO, 
we also observed ~30% reduction of CD122+NK1.1+ cells, and this change 
was reversed in the DhhKO Shh+/+ littermates (Figure 4.8F). 
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Figure 4.1: Development of γδ T cell subtypes in the adult Shh+/- thymus  
Bar chart (A) shows the proportion of live-gated thymocytes that are CD3+γδTCR+. 
Bar charts show expression of (B) CD27 and (D) CD44 in γδ T cells; (C) shows 
percentage of γδ cells that are CD27+CD44- and (E) CD44+CD27-. (F) shows the ratio 
of CD27+CD44- to CD27-CD44+ γδ T cells. Error bars represent ±SEM. (G) 
Representative dot plots show cell surface expression of CD27 and CD44 on γδ T cells 
from WT and Shh+/- thymus. Bar chart (H) shows expression of GBS-GFP in 
CD27+CD44+, CD27+CD44- and CD44+CD27- γδ T cell populations in the thymus of 
young adult Shh+/- and Shh+/--GBS-GFP+ mice. *p<0.05, n=11 
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Figure 4.2: Percentages of γδ T cells in Shhfl/fl FoxN1-Cre thymus, spleen and 
lymph nodes 
Representative dot plots (A) show percentage of CD3+γδTCR+ thymocytes isolated 
from WT and Shh FoxN1 KO mice. Bar chart (B) show the percentages of γδTCR+ cells 
in thymus of WT and Shh FoxN1 KO mice. n=6 
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Figure 4.3: Numbers of γδ T cells and surface expression of key markers in 
E14.5 fetal thymus organ cultures (FTOC) 
For each experiment, one E14.5 WT thymic lobe was cultured untreated and the other 
thymic lobe of the same thymus was cultured in the presence of rShh for 5 days. 
Histogram (A) shows the percentage of γδ T cells in WT and rShh-treated thymi as 
analysed by flow cytometry, after 5 days of culture.  Histograms show CD27 (B) and 
CD44 (C) expression of γδ T cells, as well as percentage of CD44+CD27- γδ T cells (D). 
Error bars represent ±SEM. *p<0.05, n=14  
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Figure 4.4: Numbers of γδ T cells and surface expression of key markers in 
E16.5 FTOC 
Fetal thymic cells were analysed by flow cytometer to identify the major γδ T 
cells subtypes based on cell surface expression of CD27 and CD44. For each 
experiment, one E16.5 WT thymic lobe was cultured for 5 days untreated and 
the other thymic lobe of the same thymus was cultured for 5 days in the 
presence of rShh. Scatter graphs show the cell number of each individual WT 
untreated and (B) rShh-treated or (D) Hhip-treated E16.5 FTOC cultured for 5 
days. The mean of each group is indicated by a line. Bar charts show γδ T cell 
percentages in WT untreated and WT + rShh (A) or WT + rHhip (C) E16.5 thymic 
lobes, analysed after 5 days in FTOCs. (E) Expression of CD27 in WT and rShh-
treated thymic lobes in 5 days FTOCs. Error bars represent ±SEM. *p<0.05, n=12 
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Figure 4.5: The role of Ihh in thymic γδ T cells 
Bar charts (A) and (B) show the percentage and cell count of γδ cells in the 
thymus. (C) shows a small upregulation of CD4 in the thymus of Ihh+/- mice No 
differences were observed for NK1.1, CD122, CCR6, CCR7, Vγ chains and subtype 
populations as well as IFNγ and IL-17 production (data not shown). n=10 
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Figure 4.6:  The effect of Dhh in γδ T thymocytes 
Bar charts (A) and (B) show the percentage and cell count of CD3+ γδ Τ cells in 
WT and Dhh-/- mice. Bar chartS (C), (D) and (E) show the percentages of the Vγ1, 
CD27+CD44+ and CD44+CD27- populations, respectively. Representative overlaid 
histograms (WT / KO) (F) show that deletion of Dhh increases the CCR6 and 
CCR7 cell surface expression. (G) (WT / KO) shows CD4 expression in WT and 
Dhh KO mice. Dot plots (H) show CD27 and CD44 expression on WT and Dhh-/- 
mice. *p<0.05, n=4 
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Figure 4.7: The effect of Dhh in E17.5 γδ T cell development in the thymus 
and the spleen 
Scatter plot (A) shows the percentage of γδ T thymocytes on WT, Dhh+/- and  
Dhh-/-E17.5 mice. Scatter plots (B) and (C) show percentage of the CD44+CD27- 
γδ subset and expression of CD24, respectively; n=19. Bar chart (D) shows 
percentage of γδ thymocytes in FTOCs after 6 days of culture with rDhh or 
rHhip1, relative to WT. n=6 
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Figure 4.8: The effect of double KO (Dhh-/-Shhfl/fl FoxN1Cre+) on γδ 
thymocytes 
Bar charts show (A) the percentage and (B) cell count of γδ T cells in WT and 
double KO thymocytes from 3 weeks old mice. (C) shows CD24 expression and 
(D) shows CD122+NK1.1+. Representative dot plots (E) show CD27 and CD44 
expression on γδ Τ cells from WT, double KO and Dhh-/- ShhWT (Cre-) 
littermates. Dot plots (F) show CD122 and NK1.1 expression on γδ T cells from 
WT, double KO and Dhh-/- Shh WT (Cre-) littermates. *p<0.05 **p<0.005, n=5 
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4.3 Discussion 
 
We analysed γδ thymocyte populations in fetal and adult Ihh+/-, IhhcoKO 
(CD4Cre), Shh+/-, ShhcoKO (FoxN1Cre), Dhh-/- and Dhh-/-ShhcoKO thymus.  
We detected no impact of Ihh on γδ cells in the thymus.  Both Shh-
heterozygosity and Dhh-deficiency resulted in changes in expression of 
cell surface markers. The Shh+/- thymus showed a significant decrease in 
CD27 expression.  The CD27- γδ T cell population in the thymus is believed 
to give rise to an IL17-producing population, which express high levels of 
the transcription factor RORγt in addition to high levels of the γδ-lineage 
transription factor SOX13. It will therefore be important to investigate this 
population in peripheral tissues in these mice. 
 
The Dhh-/- thymus showed a significant decrease in the CD27+CD44+ 
population, which are the population of γδ cells that express the 
transcription factor T-bet, in addition to lower levels of SOX13, and 
produce IFNγ. In WT FTOC neutralization of endogenous Hh proteins by 
treatment with recombinant Hhip reduced γδ cell numbers, whereas 
treatment with recombinant Shh or recombinant Dhh protein increased 
the proportion of γδ cells. These experiments suggest that Hh signalling 
promotes the production of γδ thymocytes, but we did not detect 
statistically significant differences in γδ cell number in the Shh+/- or Dhh-/- 
thymus, but only in the double knock out Dhh-/- ShhcoKO.  
92 
 
5. Modulation of Hh signalling during γδ T cell 
development in the thymus 
 
5.1 Introduction 
 
We showed that the development of thymic γδ T cells is influenced by Shh 
and Dhh signalling in the fetal and adult thymus.  In this Chapter, we test 
the impact of mutation of negative regulators of Hh pathway activation 
(Gli3 and Kif7) on γδ T cell development in the thymus.  In addition, to test 
the hypothesis that Hh proteins signal directly to thymic γδ cells, we 
investigate the impact of transgenic expression of activator or repressor 
forms of Gli2 in γδ cells.  
 
5.2 Results 
 
5.2.1 The role of Gli3 in γδ T cell development in the thymus 
Gli3 can be modified to function as a transcriptional repressor or as a 
transcriptional activator.  In the absence of Hh signalling, a truncated form 
of Gli3 binds Gli binding sites and represses transcription, thereby 
preventing transcription of Hh target genes. In the presence of Hh 
signalling, Gli3 functions as a transcriptional activator (Sasaki, Nishizaki et 
al. 1999). It has been shown that, in some tissues, Gli3 represses 
transcription of Shh and Gli3 deficient mice show an opposing phenotype 
to Shh deficient mice in many tissues, indicating that Gli3 acts mainly as a 
transcriptional repressor in vivo (te Welscher, Zuniga et al. 2002).  In the 
fetus, the Gli3-mutant thymus shows the opposing phenotype to the Shh-
deficient thymus, and the Gli3-mutant thymus stroma has increased Hh 
pathway activation, indicating that Gli3 functions to limit Hh signalling in 
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the thymic stroma (Hager-Theodorides, Dessens et al. 2005), (Saldana, 
Solanki et al. 2016).  
 
Gli3-/- mice die before birth and exhibit severe developmental defects 
whereas Gli3+/- mice appear normal, although they form an extra digit in 
the interior side of the limb, allowing for easy genotyping, and are known 
as the ‘extra toe’ mutant (Schimmang, Lemaistre et al. 1992). To test the 
impact of Gli3 mutation on γδ cell development and differentiation, we 
analysed the γδ cell population in the adult Gli3+/- thymus. Deletion of one 
copy of Gli3 resulted in increased numbers of γδ cells in the thymus of 
young adult mice, but this effect was not statistically significant (Figure 
5.1A, B), and we also observed a decrease in CD24 expression on 
CD44+CD27- γδ cells (Figure 5.1D, E). 
 
5.2.2 The role of Kif7 in γδ thymocyte development 
It is believed that the kinesin protein Kif7 is a critical regulator of Hh 
signalling (Cheung, Zhang et al. 2009). Kif7, a mammalian equivalent of 
costal2 (Cos2), acts downstream of Smo and physically interacts with Glli 
transcription factors. It acts as a processing hub that recruits multiple 
protein kinases which negatively control Gli’s stability, hence supressing 
Hh activity, although in some tissues it has also been described to be 
required for Hh signal transduction (Zhao, Tong et al. 2007). Of note, mice 
lacking Kif7 display a Gli3-like skeletal phenotype, but with greater 
disorganisation, and Kif7 deficiency has been described to both increase or 
decrease Hh pathway activity, dependent on context (Cheung, Zhang et al. 
2009). Here, we analysed γδ cells in the Kif7+/- thymus, in order to 
investigate the role of Kif7 in γδ T cell development. 
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5.2.3 The adult Kif7+/- thymus 
Kif7-/- mice die before birth and therefore in the adult thymus our 
experiments were restricted to Kif7+/- young adults, which look normal 
and are fertile. Deletion of one copy of Kif7 increased the percentage of γδ 
T cells in the adult thymus (Figure 5.2A, B), but γδ T cell subtypes based on 
CD27 and CD44 expression were not affected by Kif7 heterozygosity 
(Figure 5.2C, D, E and F) and no difference was observed in CD4 
expression (data not shown).  
 
5.2.4 The fetal Kif7-mutant thymus 
In order to investigate the role of Kif7 in early γδ T cell development in the 
thymus and to test the impact of Kif7 deficiency, we time-mated Kif7+/- and 
analysed the embryonic thymus on E17.5. No difference was observed 
between WT and Kif7+/- thymus, although Kif7-/- thymi contained 
significantly more γδ cells than WT littermates, as the thymus contained 
more cells (Figure 5.3A and B). We detected a significant reduction in 
CD44+CD27- γδ thymocyte numbers and an increase in CD27+CD44- γδ 
cells in the Kif7-/-, compared to WT and Kif+/-(Figure 5.3A-D).  
 
The increase in γδ cell numbers in the Kif7-/- fetal thymus are consistent 
with Kif7 functioning as a negative regulator of Hh signalling, as Hh-
neutralisation by Hhip-treatment decreased γδ cell numbers in FTOC and 
the double mutant Dhh-/-ShhcoKO thymus contained fewer γδ cells.  
 
5.2.5 Inhibition of Hh-mediated transcription in γδ thymocytes 
We found a modest impact of mutation of Shh and Dhh, expressed by TEC 
on γδ thymocyte development and in addition, that deletion of Kif7 (which 
is expressed in thymocytes and TEC) significantly increased overall γδ 
cells in the thymus, and increased the CD27+CD44- population. To ask if 
Shh and Dhh signal directly to developing γδ thymocytes, or if the impact 
of Hh signalling on γδ cells is indirect through another cell type, we used 
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the lck-driven Gli2C2-transgenic (Rowbotham, Furmanski et al. 2008). In 
this transgenic a truncated form of Gli2, which acts as a repressor of Hh-
dependent transcription only, is expressed in all T-lineage cells, including 
γδ cells.  
 
In the Gli2C2 transgenic thymus of young adult mice the number of γδ Τ 
cells was reduced compared to WT (Figure 5.4A, B). The CD44+CD27- γδ 
population was increased (Figure 5.4C) and CD24, CD122 and CD4 were 
upregulated (Figure 5.4D-G). Thus, inhibition of physiological Hh-
mediated transcription in γδ thymocytes showed that the Hh signalling 
pathway is active during normal γδ cell development and that it regulates 
subset distribution and cell surface phenotype. 
 
5.2.6 Constitutive activation of Hh-mediated transcription in γδ 
thymocytes  
We then carried out the reciprocal experiment, and investigated the 
impact of transgenic expression of the activator form of Gli2 (Gli2N2) to 
constitutively activate Hh-mediated transcription in γδ thymocytes. 
(Rowbotham, Hager-Theodorides et al. 2009).  
The Gli2N2 transgenic thymus contained significantly more γδ cells than 
WT (Figure 5.5A, B). Gli2N2-tg mice showed a significant upregulation of 
CD44 on γδ thymocytes compared to WT, with a significant decrease in the 
proportion of the CD27+CD44- γδ subset and increase in the CD27+CD44+ 
γδ subset (Figure 5.5D-G). In the Gli2N2-tg thymus we found increased 
CD122 expression on the expanded CD27+CD44+ γδ subset (Figure 5.6F-
H).  In addition, the Gli2N2-tg CD27+CD44+ γδ thymocyte subset expressed 
lower CD24 than their WT counterparts (Figure 5.6A,). 
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Figure 5.1: The effect of Gli3+/- on the expression of CD24 in γδ T cells 
Bar charts show (A) percentages and (B) cell count of thymic γδTCR+ cells. 
Representative dot plots (C) show percentage of γδTCR+ thymocytes isolated from 
WT and Gli3+/- mice. Bar chart (D) shows CD24 expression of the thymic CD44+CD27- 
γδ population. Representative overlaid histogram (E) (WT / Het) of CD44+CD27- γδ 
subtypes that express CD24 in the thymus of WT and Gli3+/- young adult mice.  n=6 
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Figure 5.2: The effect of Kif7+/- on γδ T cells from the thymus  
Bar chart (A) shows percentages of γδTCR+ cells in WT and Kif7+/- in the thymus. 
Representative dot plots (B) show the proportion of live-gated thymocytes that are 
γδTCR+ in WT and Kif7+/- mice. Representative density plots (C) show expression of 
CD27 and CD44 in WT and Kif7+/- mouse thymus. Bar charts (D, E, F) show the 
percentage of three major γδ+ populations based on CD27 and CD44 expression. 
Error bars represent ±SEM. n=6 
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Figure 5.3 The effect of Kif7 on γδ T cells from the thymus of E17.5 
littermates 
Scatter plots (A) and (B) show the percentage and number of γδ Τ cells in WT, 
Kif7+/- and Kif7-/- E17.5 thymi. (C) and (D) show the percentage of γδ T cells that 
are CD44+CD27- and CD27+CD44- respectively. The mean of each group is 
represented with a line. *p<0.05 **p<0.005, n=21 
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Figure 5.4: The effect of Gli2C2 on the γδ Τ cell expression of CD4, CD24, 
CD27, CD44 and CD122 
Bar chart (A) and (B) show the percentage and cell count respectively of γδ T 
cells in the thymus of WT and Gli2C2 mice. (C) shows the thymic CD44+CD27-. Bar 
charts show the percentage of CD44+CD27- γδ T cells that express (D) CD24, (E) 
CD122 and (F) CD4 in the thymus of young adult mice. Representative overlaid 
histograms (G) (WT / Tg) show expression of CD4, CD24 and CD122 in WT and 
Gli2C2 thymus of CD44+CD27- γδ T cells. Representative dot plots (H) show CD27 
and CD44 expression of WT and Gli2C2 γδ T cells from the thymus. Error bars 
represent ±SEM. *p<0.05, n=8 
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Figure 5.5: The effect of Gli2N2 on CD27 and CD44 expression on γδTCR+ 
thymocytes 
Bar charts (A) and (B) show percentage and cell count, respectively, of WT and 
Gli2N2 thymocytes. Bar charts (C) and (E) show expression of CD27 and CD44 
and the percentage of the CD27+CD44- (D) and CD27+CD44+ (F) populations in γδ 
cells from WT and Gli2N2 thymocytes. Error bars represent ±SEM. 
Representative dot plots (G) show CD27 and CD44 on γδ cells (gated on 
CD3+γδ+) in WT and Gli2N2 mouse thymus. *p<0.05, **p<0.005, n=4 
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Figure 5.6: The effect of Gli2N2 on CD24 and CD122 expression on thymic 
γδTCR+ cells. 
Bar charts (A), (C) and (D) show the percentage of thymic γδ T cells that express 
CD24 in each of the three populations: CD27+CD44+, CD44+CD27- and 
CD27+CD44-. Representative overlaid histograms (WT / Tg) (B) show the 
difference between WT and Gli2N2 littermates in CD24 expression on 
CD27+CD44+ γδ thymocytes. Representative overlaid histograms (E) (WT / Tg) 
show the difference in CD122 expression on γδ cells in the thymus of young adult 
WT and Gli2N2 littermate mice, whereas density plots (H) show the CD27 and 
CD44 phenotype of the same CD122+ γδ T cells. Bar charts (G) show the cell 
count of the CD122+ γδTCR+ population. Error bars represent ±SEM. **p<0.005 
***p<0.0001 
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5.3 Discussion 
 
In summary, constitutive Hh-mediated transcription in thymocytes 
promoted γδ thymocyte numbers and increased CD44 expression and the 
CD27+CD44+ γδ subset, whereas inhibition of physiological Hh-mediated 
transcription had the opposite effect, and γδ cell numbers and CD44 
expression were downregulated.  Likewise, cell surface expression of CD24 
(HSA), which is highly expressed in immature cells and down-regulated 
wih maturity, was increased when Hh signalling was inhibited and 
decreased when the Hh pathway was constitutively active in the Gli2N2-tg 
thymus.   
 
Taken together, these experiments show that the Hh proteins positively 
regulate γδ cell development in the thymus, and signal directly to γδ 
thymocytes to promote differentiation of the CD44+CD27+ subset.  It will 
therefore be important to investigate the influence the Hh signalling on the 
homeostasis and subset distribution of peripheral γδ T cells. 
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6. Modulation of Hh signalling influences the 
homeostasis of γδ T cell populations in the periphery 
 
6.1 Introduction 
 
We showed that the development of thymic γδ T cells is influenced by Shh 
and Dhh signalling in the fetal and adult thymus, and that manipulation of 
Hh-mediated transcription in γδ thymocytes also affects their 
development.  In this Chapter we test the impact of mutations in 
components of the Hh signaling pathway on the homeostasis of peripheral 
γδ T cell populations. The mouse models that we will investigate fall into 
three groups:  in some models the Hh pathway will be affected in the same 
way in both the thymic and peripheral γδ T cells (Gli2Ν2 tg and Gli2C2 tg), 
whereas in the mice in which the Hh ligands, or pathway regulators are 
constitutively mutated (Shh+/-, Dhh-/-, Ihh+/-, Gli3+/-, Kif7+/-) the extent of 
impact of the mutation will depend on the pattern of expression of the 
molecule in the different tissues. In the ShhcoKO animals, however, the 
developing γδ thymocytes are exposed to a reduced Hh signal in the 
thymus, but normal levels of Hh signalling in peripheral tissues.  
 
6.2 Results 
 
6.2.1 The influence of the Gli2N2 transgene on peripheral γδ T cell 
biology 
We first examined the impact of constitutive activation of Hh-mediated 
transcription on γδ T cell populations in the spleen and lymph nodes. The 
number of γδ cells was not influenced by the Gli2N2 transgene in the 
spleen and lymph nodes (Figures 6.1A, B and 6.3). However, in contrast to 
the thymus, in the spleen CD44 expression was downregulated in the 
Gli2Ν2 tg γδ T cells, and the CD44+CD27- γδ population was significantly 
104 
 
decreased by ~10-fold compared to WT, indicating that Hh-mediated 
transcription negatively regulates the splenic CD44+CD27- γδ population 
(Figure 6.1C-E). Interestingly, CD4 was significantly upregulated in splenic 
transgenic γδ cells compared to their WT counterparts (Figure 6.2A, B). 
We also observed a reduction in intensity of CD44 staining on the 
CD44+CD27- population in the lymph nodes, and an increase in the 
CD27+CD44+ γδ population compared to WT (Figure 6.3A-D). Gli2N2 tg 
expression also decreased CD122 expression on γδ cells in the spleen and 
lymph nodes compared to WT (Figure 6.2C and 6.4E). This was in contrast 
to our previous observation in the thymus, in which the transgene 
expression increased cell surface CD122 expression on the CD27+CD44+ γδ 
thymocytes.  In the lymph nodes, the Gli2N2 transgene increased cell 
surface CD24 expression significantly on all γδ subtypes, independently of 
CD27 and CD44 expression (Figure 6.4A-D), whereas we did not detect an 
influence of the transgene on CD24 expression in the spleen (data not 
shown). As CD24 is downregulated during T cell maturation, the increase 
in CD24 expression suggests that the γδ cells undergoing active Hh-
mediated signalling were more immature. 
 
6.2.2 Inhibition of physiological Hh-mediated transcription in 
peripheral γδ T cells 
We then carried out the reciprocal experiment and tested the impact of 
inhibition of physiological Hh-mediated transcription on peripheral γδ T 
cell subsets, by analysis of the Gli2C2 transgenic. We did not detect any 
difference in γδ cell numbers compared to WT litter mates in either the 
spleen or lymph nodes (Figure 6.5A-D). No major difference was observed 
in the population distribution in the spleen, but the CD44+CD27- γδ 
population was affected in the lymph nodes, with an increase in the 
proportion of CD122+ cells (Figure 6.5F), the opposing affect on CD122 
expression to that observed in the Gli2N2 tg peripheral γδ T cells. 
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6.2.3 Dhh signalling in peripheral γδ T cells 
Dhh is expressed by epithelial cells distributed throughout the thymus 
(Sacedon, Varas et al. 2003), and it is also expressed by stromal cells in the 
spleen, indicating that it could have a role in T cell activation or peripheral 
maintenance of T cells (Lau, Outram et al. 2012). Dhh expression has not 
been detected in the lymph nodes (our unpublished data). The role of Dhh 
in peripheral γδ T cells is unknown. 
 
As Dhh-deficient mice are viable and appear healthy, we investigated the 
peripheral γδ T cell populations in Dhh KO mice, compared to their WT 
littermates. In the LN, we did not observe significant differences in the 
number, subset distribution or phenotype of the γδ T cell population 
between DhhKO and WT (Figure 6.6A, B), consistent with the fact that we 
have not detected Dhh expression in the LN.  
 
In the spleen, Dhh KO mice had fewer γδ cells and significantly fewer NK-
like γδ cells than their WT littermates (Figure 6.7A, B). We did not observe 
a significant difference in the distribution of the γδ subsets defined by 
CD44 and CD27 (Figure 6.7E, G), and cell surface expression of CCR6 was 
not affected (Figure 6.7F).  
 
In order to investigate if Dhh signals directly to splenic γδ cells, we crossed 
the Dhh-mutant mice with the Hh-reporter transgenic (GBS-GFP-tg), and 
compared GFP expression in the γδ subsets in DhhKO and WT littermates. 
We found that Dhh-deficiency significantly decreased the proportion of 
GFP+ cells in the CD44+CD27- γδ population, indicating that Hh pathway 
activation is reduced in these cells, and therefore that Dhh signals directly 
to this population in the WT spleen (Figure 6.7H, J). Interestingly, 
however, we found that Dhh-deficiency significantly increased the 
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proportion of GFP+ cells in the CD27+CD44+ γδ subset, indicating 
increased Hh pathway activation in these cells in the absence of Dhh 
(Figure 6.7I). This finding is puzzling, and suggests that Dhh functions 
either to repress another Hh family member that signals directly to these 
cells, or that Dhh functions to increase expression of a repressor of the 
pathway in these cells. 
 
We then tested the ability of spleen γδ cells to produce IFNγ and IL17 ex 
vivo, by intracellular cytokine staining following a short activation. IL17 is 
made predominantly by the CD44+CD27- population, whereas IFNγ is 
made predominantly by the CD27+CD44+ population that express NK1.1. 
Dhh did not appear to affect ability of γδ splenocytes to produce IFNγ after 
4h of activation with PMA and ionomycin and subsequent intracellular 
staining, despite the reduction in NK1.1 expression in the DhhKO (Figure 
6.8A). However, production of IL17 was reduced by half in the DhhKO 
compared to WT (Figure 6.8B).  
 
We then investigated the impact of Dhh deficiency on the recovery of the 
splenic γδ subsets following irradiation. Dhh has previously been shown to 
accelerate the recovery of the erythroid lineage in the spleen after non-
lethal irradiation (Lau et al 2012). We irradiated three 3 week old pairs of 
Dhh KO and WT mice and analysed them 14 days after irradiation. Overall, 
the proportion of CD3+ cells was lower in the Dhh KO compared to WT 
(Figure 6.9C), but the proportion of γδ cells was not affected (Figure 6.9D). 
Interestingly, we observed a significant increase in the proportion of the 
CD44+CD27- γδ subset in the Dhh KO compared to WT (Figure 6.9E-G) and 
this was the population that showed increased Hh pathway activation in 
the absence of Dhh in the steady-state spleen. 
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6.2.4 Peripheral γδ T cell populations in Shh+/- mice 
Shh is expressed in the thymus and spleen (Outram et al 2000, Varas et al 
2005) but has not been detected in the lymph node. The Shh+/- spleen had 
fewer γδ cells than WT, whereas the lymph nodes had more (Figure 6.10A, 
B). This finding may be the result of Shh affecting either proliferation of 
tissue-specific γδ cells, or apoptosis or migration of peripheral γδ cells.  
 
In the adult spleen, Shh+/- caused an increase in the CD44+CD27- γδ 
population (Figure 6.11D, F) and a small decrease in overall CD27 
expression compared to WT (Figure 6.11A). Cell surface expression of 
CD24 was also higher in the Shh+/- γδ cells in all subsets, compared to WT 
(Figure 6.11 G-I).  
 
In order to test if Shh is signaling directly to γδ cells in the spleen we 
crossed the Shh+/- mice with the GBS-GFP-tg and compared GFP 
expression in the different γδ subsets between GBS-GFP-tg-Shh+/- and GBS-
GFP-tg-Shh+/+. Deletion of one copy of Shh decreased GFP expression in all 
tissues and subsets of γδ cells, consistent with the idea that Shh signals 
directly to γδ cells (Figure 6.12A). The greatest difference in Hh pathway 
activity in the spleen was observed in the CD27+CD44+ population (Figure 
6.12B). However, the CD44+CD27- γδ population is the most responsive to 
Hh as manifested by the highest proportion of GFP+ cells.  When we gated 
on γδ cells and analysed anti-CD24 staining against GFP-expression, we 
found that all GFP+ γδ cells were CD24+ in both WT and Shh+/-, suggesting 
that it is the more immature cells that are Hh-responsive (Figure 6.12C). 
 
We then tested the ability of spleen and lymph nodes to produce IFNγ and 
IL17 ex vivo, by intracellular cytokine staining following a short activation. 
Shh heterozygosity increased the ability of γδ splenocytes and lymph 
nodes to produce IFNγ and IL-17 after 4h of activation with PMA and 
ionomycin and subsequent intracellular staining (Figure 6.13A-C).  
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6.2.5 Peripheral γδ T cell populations in ShhkoCO mice  
To investigate if deletion of Shh from the thymus only, in our ShhkoCO 
model (Shhfl/fl-FoxN1-Cre-tg), would influence γδ populations in the 
periphery, we analysed ShhcoKO and WT littermate spleen and lymph 
nodes.  No differences were observed in the spleen whereas in the lymph 
nodes, more γδ cells are seen (Figure 6.14A), confirming the findings in the 
Shh+/- mice, and suggesting that the increase is due to reduced Shh 
signaling during γδ cell development in the thymus. No significant 
differences were detected in subset distribution in the ShhFoxN1 KO 
spleen. In lymph nodes, however, both the CD44+CD27- and the 
CD27+CD44+ γδ populations were increased in the ShhcoKO compared to 
WT (Figure 6.14B).  
 
6.2.6 Peripheral γδ T cell populations in ShhcoKODhhKO double 
knockout mice 
In the spleen we found an increase in γδ cells in the double knockout mice, 
although this change was not significant (Figures 5.15A, B). This finding 
was of interest because deletion of neither Shh or Dhh alone influenced the 
percentage of γδ cells in the spleen, and therefore it will be important to 
analyse more ShhcoKO-DhhKO spleens in the future. In terms of the γδ 
subsets, however, the double KO reduced both the CD27+CD44+ and the 
CD44+CD27- population, relative to WT, with an overall reduction in CD44 
expression (Figure 6.15C). The effect was similar to that observed in Dhh 
KO littermates. The CD122+NK1.1- population was increased in the double 
KO spleen (Figure 6.15D), but variation between samples in the 
percentages of CD122+NK1.1+ and NK1.1+CD122- populations do not allow 
us to draw concrete conclusions on these two subsets, indicating that 
analysis of more mice will be important. 
 
In the lymph nodes, the double KO mice had fewer γδ cells both in terms of 
cell count and as a percentage (Figures 6.16A and B). In Shh WT Dhh KO 
109 
 
littermates, the number of γδ cells was even lower, a finding consistent 
with our finding that Shh mutant mice have more γδ cells in the lymph 
nodes. Double KO mice also showed a significant reduction in CD27+CD44+ 
cells with further decrease in Shh WT Dhh KO littermates (Figures 6.16C 
and D). Finally, consistent with our findings in the thymus and spleen, 
double KO mice had fewer NK-like γδ cells in the lymph nodes (Figure 
6.16E). 
 
6.2.7: Peripheral γδ T cells in Kif7+/- mice 
Deletion of one copy of Kif7 increased the percentage of γδ T cells in the 
spleen and lymph nodes of young mice, with the greatest difference 
observed in the spleen where the proportion of γδ Τ cells was doubled 
(Figure 6.17B). In the spleen we also observed an expansion of the 
CD27+CD44+ γδ population and a decrease in the numbers of the 
CD44+CD27- population (Figure 6.17A, C, D). Cell surface CD24 expression 
was decreased in all γδ populations in the Kif7+/- compared to WT, 
although the only significant difference was on CD44+CD27- γδ splenocytes 
(Figure 6.17F).  
 
To test the impact of Kif7 heterozygosity on Hh pathway activation in γδ T 
cell populations, we crossed the Kif7+/- with the GBS-GFP-transgenic mice 
and measured GFP expression. The proportion of GFP+ cells was increased 
in all γδ populations, with the greatest difference seen in the CD44+CD27- 
spleen γδ T cells (Figure 6.17E).  The increase in proportion of GFP+ cells 
indicates that Hh pathway activation is increased in the Kif7+/- 
heterozygote, and that therefore Kif7 is acting as a negative regulator of 
the pathway.  
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Thus, taken together these experiments show that increased Hh signaling 
to peripheral γδ T cells promotes the splenic γδ population and 
particularly increases the CD27+CD44+ subset. 
 
6.2.8: Impact of Gli3-heterozygosity on peripheral γδ T cells  
In the absence of Hh signalling, a truncated form of Gli3 binds GBS 
preventing transcription of Hh target genes. In the presence of Hh 
signalling, Gli3 functions as a transcriptional activator (Sasaki, Nishizaki et 
al. 1999).  
 
Deletion of one copy of Gli3 resulted in increased numbers of γδ cells in 
the spleen and lymph nodes of young adult mice with the effect being 
significant only in the lymph nodes (Figures 6.18A, B). However, it will be 
important to analyse more Gli3+/- spleens to determine if the results in the 
spleen become significant. In the spleen, we observed a significant 
decrease in the percentage of CD44+CD27- γδ cells in the Gli3+/- compared 
to WT (Figures 6.18C and D), similar to that observed in the Kif7+/-. 
Interestingly, the CD27+ CD44+ γδ cell population was not affected by Gli3 
heterozygosity (Figure 6.18D). Furthermore, similarly to Kif7+/- deletion of 
one copy of Gli3 reduced CD4 expression on γδ splenocytes (Figures 6.18E, 
G). Finally, we observed that CD24 expression decreased in the 
CD44+CD27- γδ population (Figures 6.18F, I). 
 
The percentage of NK cells remained constant in the spleens of WT and 
Gli3+/- mice, but the number and percentage of NK-like γδ cells, which are 
positive for both γδTCR and NK1.1 markers, increased significantly, and 
the increase was greater than that of the γδ cells that are negative for 
NK1.1 (Figures 6.20A, B). 
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We then investigated Hh pathway activation by crossing the Gli3+/- mice 
with the GBS-GFP-transgenic Hh-reporter mice. Surprisingly, the 
proportion of cells that expressed GFP decreased in Gli3+/- γδ splenocytes 
compared to WT, although the decrease was significant only in the NK-like 
γδ population (Figures 6.21B). The mean fluorescence intensity of GFP 
fluorescence, which is a measure of the extent of Gli activity in individual 
cells, was also decreased in the Gli3+/- γδ splenocytes compared to WT, and 
this difference was greatest in the NK-like γδ cells (Figure 6.21C). Our data 
thus show that NK-like γδ cells are more sensitive to Hh activity than 
NK1.1- γδ cells.  Although, the Kif7+/- and Gli3+/- γδ populations show 
similar phenotypes in terms of cell number and cell surface markers, the 
Hh-reporter experiments show that in the Kif7+/- γδ splenocytes Hh 
signaling is increased, whereas in the Gli3+/- γδ splenocytes Hh signaling is 
decreased.  It is possible that in Gli3 acts as a transcriptional activator in 
peripheral γδ cells, so that Hh pathway activation is decreased when it is 
decreased.  However, this would presumably give rise to a different 
phenotype from Kif7+/- in which Hh pathway activation is increased, as 
expected.  It would also be interesting in the future to have data on NK-like 
γδ cells from Kif7+/- in order to confirm the resemblance between Gli3 and 
Kif7 mutant’s phenotype. However, when we analysed Kif7+/- mice, NK1.1 
was not included in our analysis. 
 
We activated splenocytes with PMA and Ionomycin ex vivo and 
investigated the effect of Gli3-heterozygosity on key γδ cytokines after 4h 
of activation.  We found that partial deletion of Gli3 decreased intracellular 
IFNγ and IL-17, and the change was significant in the case of IL-17-
producing CD44+CD27- γδ cells (Figures 6.21C, E). 
 
In the peritoneal cavity, the percentage of peritoneal CD44+CD27- γδ cells 
was decreased more than three-fold (Figures 6.19A, B) in the Gli3+/- 
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compared to WT, whereas the number of CD27+CD44+ γδ cells almost 
doubled (Figures 6.19A, B). The number of CD44+CD27+ γδ cells was also 
increased in the lungs of the same littermates (Figures 6.19A, C). 
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Figure 6.1: The effect of Gli2N2 on γδ T cell splenocytes 
Bar charts show (A) the proportion and (B) cell count of γδ T cells in the spleen 
of Gli2Ν2 young mice. Representative dot plots (C) show CD27 and CD44 on 
CD3+γδ+ cells. Bar chart (D) shows CD44 expression and (E) the proportion of 
CD44+CD27- γδ cells in WT and Gli2N2 mouse spleens. *p<0.05, ***p<0.0001, n=4 
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Figure 6.2: The effect of Gli2N2 on CD4 and CD122 expression of γδ T cell 
splenocytes 
Bar chart (A) and representative overlaid histogram (B) (WT / Gli2N2) show the 
proportion of γδ splenocytes that are positive for CD4 in WT and Gli2N2 mice. 
Representative overlaid histogram (C) (WT / Gli2N2) shows CD122 expression 
on γδ splenocytes and density plots (D) show CD27 and CD44 expression of the 
CD122+ γδ splenocytes. **p<0.001, n=4 
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Figure 6.3: The effect of Gli2N2 on γδ T lymphocytes 
Representative dot plots (A) show CD27 and CD44 on CD3+γδ+ cells from WT and 
Gli2N2 LN cells. Bar chart (B, C and D) show proportion of γδ cells that are 
CD27+CD44+, CD44+CD27-, CD27+CD44-, respectively, in WT and Gli2N2 mice.  
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Figure 6.4: The effect of Gli2N2 on CD24 and CD122 expression of γδ T cell 
lymphocytes 
Bar chart (A-C) and representative overlaid histogram (D) (WT / Gli2N2) show 
the proportion of CD44+CD27-, CD27+CD44+ and CD27+CD44- γδ splenocytes, 
respectively, that are positive for CD24 in WT and Gli2N2 mice. Representative 
overlaid histogram (E) (WT / Gli2N2) shows CD122 expression on LN γδ cells 
and density plots (D) show CD27 and CD44 expression of the CD122+ γδ LN cells. 
*p<0.005, **p<0.001, n=6 
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Figure 6.5: The effect of Gli2C2 on γδ T lymphocytes  
Bar charts (A-D) show the proportion and cell number of γδ T cells in the spleen 
and lymph nodes of WT and Gli2C2 young mice. Representative dot plots (C) 
show the CD27 and CD44 expression on γδ T cells from the lymph nodes of WT 
and Gli2C2 young mice. Representative overlaid histogram (F) (WT / Gli2C2) 
shows the proportion of γδ lymphocytes that are positive for CD122. n=8 
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Figure 6.6:  The role of Dhh in γδ T cells from the LN 
Bar charts (A) and (B) show the percentage and cell count of CD3+ γδ Τ cells n 
WT and Dhh-/- mice. Bar chart (C) shows the percentage of CD27+CD44+ γδ T 
cells. Dot plots (D) show CD27 and CD44 expression on γδ cells from LN WT and 
Dhh-/- mice. n=4 
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Figure 6.7:  The role of Dhh in γδ T splenocytes 
Bar charts (A) and (B) show the percentage and cell count of CD3+ γδ Τ cells in 
WT and Dhh-/- spleen. Bar chart (C) shows the percentage of γδ NKT cells and 
(D), (E) and show the percentages of the Vγ1 and CD44+CD27+ populations, 
respectively. Representative overlaid histogram (WT / KO) (F) show that 
deletion of Dhh decreases CCR6 cell surface expression. Dot plots (G) show CD27 
and CD44 expression on  γδ cells from WT and Dhh-/- spleen. Bar charts (H) and 
(I) show GBS-GFP expression of the CD44+CD27- and CD27+CD44+ populations, 
relative to the WT. Representative overlaid histogram (WT / KO) (J) shows GFP 
expression of CD44+CD27- γδ T splenocytes *p<0.05, **p<0.001, n=8 
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Figure 6.8: The effect of Dhh on γδ T cell production of IFNγ and IL-17 in 
the lymph nodes and the spleen of 4 week old mice. 
Representative overlaid histograms (A) show IL-17 and IFNγ expression from 
CD44+CD27- and CD27+CD44+ γδ T cells from the spleen (SP) and the lymph 
nodes (LN) of young mice. Representative density plots (B) show extracellular 
expression of CD44 versus intracellular IL-17 on WT and Dhh-/- γδ splenocytes.  
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 Figure 6.9: Reconstitution of γδ T cell populations in the spleen of 3 week 
old mice, 14 days after irradiation in WT and Dhh-/- littermates. 
Bar chart (A) shows the total cell count of WT and Dhh-/- spleens, 14 days after 
irradiation. (B) shows the percentage of CD3+ T cells and (C) and (D) show the 
percentage and cell count of γδ T cells. Density plots (E) show CD27 and CD44 
expression of WT and Dhh-/- spleens, 14 days after irradiation. Bar charts (F) and 
(G) show the percentage and cell count of CD44+CD27- γδ Τ cells. *p<0.05, 
**p<0.0005, n=8 
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Figure 6.10: γδ T cell subtypes in adult lymph nodes of Shh+/- and WT mice 
Bar charts (A and B) show the percentage and cell count of LN γδ T cells in WT and 
Shh+/- mice. Bar charts (B and C) show percentage of CD27+CD44- and CD27+CD44+ 
γδ T cells, respectively. Overall, CD27 expression is reduced in the Shh+/-, whereas 
overall expression of CD44 is unchanged. Representative dot plots (E) show T cell 
populations in relation to cell surface expression of CD27 and CD44 from WT and 
Shh+/- mice. n=6 
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Figure 6.11: Development of γδ T cell subtypes in the adult spleen Shh+/- 
and WT mice 
Bar charts show (A) expression of CD27 and (C) CD44 in γδ T cells, (B) shows 
percentage of the CD27+CD44+ γδ population and (D) the percentage of 
CD44+CD27- γδ population. (E) shows the ratio of CD27+CD44- to CD44+CD27- γδ 
T cells. Representative dot plots (F) show cell surface expression of CD27 and 
CD44 on γδ T cells from WT and Shh+/- mice. Bar charts (G-I) show the 
proportion of three γδ populations that are CD24+. Error bars represent  ±SEM. 
CD44+ CD27-
WT
Sh
h
+/-
0
5
10
15
20
%
 o
f 
γ
δ
 T
 c
e
lls
CD27:CD44
WT
Sh
h
+/-
2
4
6
8
10
%
 o
f 
γ
δ
 T
 c
e
ll
s
CD27 expression
WT
Sh
h
+/-
0
20
40
60
80
100
%
 o
f 
γ
δ
 T
 c
e
lls
CD44 expression
WT
Sh
h
+/-
0
10
20
30
40
50
%
 o
f 
γ
δ
 T
 c
e
ll
s
CD27+ CD44-
WT
Sh
h
+/-
40
50
60
70
%
 o
f 
γ
δ
 T
 c
e
ll
s
A B C
D E
F
CD44
C
D
2
7
WT Shh+/-
CD27+ CD44-
W
T
Sh
h
+/
-
0
10
20
30
40
%
 o
f 
C
D
2
4
 γ
δ
 T
 c
e
lls
CD44+ CD27-
W
T
Sh
h
+/
-
0
10
20
30
40
%
 o
f 
C
D
2
4
 γ
δ
 T
 c
e
lls
CD27+CD44+
W
T
Sh
h
+/
-
0
5
10
15
20
25
%
 o
f 
C
D
2
4
 γ
δ
 T
 c
e
lls
G IH
125 
 
 
Figure 6.12: Expression of GBS-GFP in Shh+/- and WT spleen on major γδ T 
cell populations according to CD27 and CD44 cell surface expression 
Bar chart (A) shows expression of GBS-GFP in CD27+CD44+, CD27+CD44- and 
CD44+CD27- γδ T cell populations in the spleen of young adult Shh+/- and Shh+/--
GBS-GFP+ mice. Overlaid histogram (B) (WT / Het) shows GFP expression in 
CD27+CD44+ γδ populations. Dot plots (C) show CD24 and GFP expression in γδ T 
cells of WT and Shh+/- splenocytes. n=2 
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Figure 6.13: The effect of Shh in the production of key cytokines IFNγ and 
IL-17 in γδ T cells 
Bar charts show the percentage of CD27+CD44+ cells that produce IFNγ in the 
spleen (A), the percentage of CD44+CD27- γδ T cells that produce IL-17 in the 
spleen (B) and lymph nodes (C). Error bars represent  ±SEM. n=11 
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Figure 6.14: The effect of conditional deletion of Shh on peripheral γδ Τ 
cells 
Dot plots (A) show CD3 and γδTCR expression of live-gated splenocytes and 
lymphocytes of young mice from WT and ShhFoxN1-Cre+ young mice. 
Representative dot plots (B) show CD27 and CD44 expression on LN CD3+ γδ 
cells from the same mice. n=2 
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Figure 6.15: The effect of double Shh and Dhh KO on γδ splenocytes 
Bar charts show (A) the percentage and (B) cell count of γδ T cells in WT and 
double KO splenocytes from 3 weeks old mice. (C) shows the percentage of 
CD27+CD44+ and CD44+CD27- γδ subsets relative to the WT and (D) shows 
CD122 expression. Representative dot plots (E) show CD27 and CD44 expression 
on γδ Τ cells from WT, double KO and Dhh-/- ShhWT (Cre-) littermates. Dot plots 
(F) show CD122 and NK1.1 expression on splenic γδ T cells from WT and double 
KO young littermates. n=6 
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Figure 6.16: The effect of double Shh and Dhh KO on LN γδ  
Bar charts show (A) the percentage and (B) cell count of γδ T cells in WT and 
double KO splenocytes from 3 weeks old mice. (C) shows the percentage of 
CD27+CD44+ and CD44+CD27- γδ subsets relative to the WT. Representative dot 
plots (E) show CD27 and CD44 expression on γδ Τ cells from WT, double KO and 
Dhh-/- ShhWT (Cre-) littermates. Dot plots (F) show CD122 and NK1.1 expression 
on γδ T cells from WT and double KO young littermates. n=4 
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Figure 6.17: Development of γδ T cell subtypes in the adult Kif7+/- spleen 
Representative dot plots (A) show expression of CD27 and CD44 in WT and 
Kif7+/- mouse spleen. Bar charts (B) show percentages of splenic γδTCR+ cells in 
WT and Kif7+/-. Bar charts (C) shows the percentage of CD27+CD44-, CD27+CD44+ 
and (D) CD44+CD27- populations in WT and Kif7+/- spleens. Representative 
overlaid histograms (E) show GBS-GFP expression (WT / Het) in CD44+CD27- 
and CD27+CD44- γδ populations in the spleen of 4 weeks mice. Bar charts (F) 
show the percentage of CD44+CD27- splenic γδ Τ cells that express CD24 and (G) 
shows the percentage of γδTCR+ cells relative to WT in three tissues of Kif7+/- 
mice. Error bars represent ±SEM. *p<0.05 **p<0.01, n=11  
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Figure 6.18: The influence of Gli3 on peripheral γδ populations of young 
adult mice 
Bar charts (A and B) show the number and proportion of γδ cells from the spleen 
of WT and Gli3+/- mice. Representative density plots (D) show CD27 and CD44 
cell surface expression in WT and Gli3+/- γδ splenocytes. Bar chart (C) shows 
percentage of CD44+CD27 γδ cells. Bar charts (E and F) show percentage of γδ T 
cells that express CD4 and CD24 in the spleen of WT and Gli3+/- mice, 
respectively. Representative overlaid histograms (G and I) (WT / Het) show CD4 
and CD24 expression in γδ T cells, respectively. Error bars represent ±SEM. 
*p<0.05, ***p<0.0001, n=6 
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Figure 6.19: The effect of Gli3 on γδ populations in the peritoneal cavity and the 
lungs of young adult mice 
Density plots (A) show CD27 and CD44 expression on WT and Gli3+/- γδ T cells from the 
peritoneal cavity and lungs of young littermates. Bar charts (B) show the γδ cell count 
per million events collected by flow cytometry. n=2
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Figure 6.20: Hedgehog reporter transgenic (GBS-GFP-Tg) show reduced Hh 
pathway activation in γδ cells from Gli3+/- mice.  
Dot plots (A) show the gating strategy from CD3+ thymocytes in order to identify three T 
cell populations: NK cells, NK-like γδ Τ cells and γδ T cells. Bar chart (B) shows 
percentage and GBS-GFP activity of γδ and NK-like γδ T cells, relative to WT and (C) 
shows mean fluorescent intensity (MFI) of γδ, NK-like γδ T cells and the Vγ1 chain, 
relative to WT. Error bars represent ±SEM. *p<0.005, **p<0.0005, n=4 
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Figure 6.21: The role of Gli3 in the production of key γδ T cell cytokines 
Bar charts show the percentage of IL-17-producing CD44+CD27- γδ T cells in the 
(A) spleen and (B) lymph nodes of 4 weeks old mice, upon 4h T cell activation 
with PMA and Ionomycin. (C) shows the difference in splenic γδ IL-17 
production, relative to WT. Bar charts (D) show production of IFNγ in 
CD27+CD44- γδ T cells. Representative overlaid histogram (E) (WT / Tg) shows 
reduction in IL-17 production in splenic Gli3+/- CD44+CD27- γδ T cells compared 
to WT. *p<0.05, n=6 
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7. The effect of Hedgehog signalling on γδ T cells in an 
LPS mouse model 
 
7.1 Introduction 
 
We have investigated the role of Hh signalling in the development and 
differentiation of murine γδ T cells in the thymus and the periphery. 
However, the impact of Hh signalling in the activation and cytokine 
secretion of γδ T cells has been explored only through short PMA / 
Ionomycin activation assays. Therefore, we used a mouse disease model of 
experimental sepsis by injecting Lipopolysaccharide (LPS) 
intraperitoneally (ic) in order to investigate γδ-mediated immune 
responses upon infection and inflammation in more detail. 
 
Toll-like receptors (TLR) are pattern recognition receptors (PRR) that 
recognize various structurally conserved molecules derived from 
microbes and they often lead to indirect activation of the adaptive immune 
responses (Wesch, Peters et al. 2011). LPS consists of a hydrophobic lipid 
A component, a hydrophilic core oligosaccharide and an O-antigen. It is 
believed that murine γδ cells recognize LPS via TLR2 whose ligand is the 
lipid A component of LPS. Murine Vγ6 CCR6+ IL-17-producing γδ T cells 
respond directly to TLR2 resulting in enhanced proliferation and cytokine 
secretion in a TCR-independent manner (Martin, Hirota et al. 2009). In 
humans, γδ T cells respond indirectly to TLR4 (via monocyte-derived 
dendritic cells) in a CD1c/CD1d-restricted manner.  
 
We decided to focus our analysis on the two strains that gave the strongest 
phenotype in previous experiments; the Gli2N2 tg and the Shh deficient 
strains (either Shh+/- or conditional FoxN1 Shh deletion). Since the set of 
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experiments in this chapter followed the ones shown on previous 
chapters, our flow cytometry analysis is expanded further to include more 
makers and can therefore offer better insight into murine γδ T cell biology. 
 
7.2 Results 
 
7.2.1 The effect of Gli2N2 on γδ cells from LPS-injected young adult 
mice 
For our experiment, we used three sex-matched pairs (WT and Gli2N2) of 
6 week old littermate mice. We injected intraperitoneally with a single 
dose of 100ng/gram of body weight LPS in 200μl of sterile PBS. The 
control group was injected ip with 200μl sterile PBS. Mice were sacrificed 
four days later and analysed by flow cytometry. 
 
In the Gli2N2 thymus, we observed a significant increase in the numbers of 
CD27+CD44+ cells (Figure 7.1A,B,D) compared to WT. We also observed a 
significant increase in the number of γδ cells bearing a Vγ1 chain (Figure 
7.1F). This CD27+CD44+ population is negative for CCR6 (Figure 7.1H). A 
more detailed analysis of the phenotype of various Vγ chains revealed that 
the expanding CD27+CD44+ population includes Vγ1 cells (Figure 7.2A), 
most of which were positive for NK1.1 (Figure 7.2B). It also very 
interesting that a shift takes place between Vγ2 and other Vγ chains in 
relation to CD44+CD27- cells. In the Gli2N2 mice, Vγ2-bearing CD44+CD27- 
cells disappear completely, whereas the same subset bearing other Vγ 
chains, shows a 10fold expansion (Figure 7.2A). 
 
In the spleen, we also observed a significant increase in CD27+CD44+ Vγ1 
cells, CCR6- γδ cells (Figures 7.3A, B, D, E) in the Gli2N2 compared to WT. 
Similarly to the thymus, the Vγ2 CD44+CD27- γδ subset virtually 
disappears (Figure 7.3D). A similar effect was observed in γδ cells of the 
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lymph nodes (Figures 7.3), although the γδ cells in the lymph nodes did 
not increase in numbers significantly in the Gli2N2 compared to WT. 
 
Interestingly, when we performed the same analysis in the peripheral 
blood of our samples, we found a massive reduction in CD27-expressing γδ 
cells as well as a great increase in CD44-expressing cells (Figure 7.4C, D) in 
the transgenic compared to WT. Collectively, our data suggest that it is 
likely that in the Gli2N2 mice, CD27+CD44+ Vγ1 cells fail to exit the thymus 
and therefore accumulate in the thymus. Analysis of skin showed a 
reduction in γδ cells (Figure 7.4E, F). Upon activation with PMA and 
ionomycin for 4h, γδ splenocytes from LPS-treated Gli2N2 mice, showed a 
large reduction in both IL-17 and IFNγ expression (Figure 7.5A). IFNγ 
reduction is attributed mostly to Vγ2-bearing cells (Figure 7.5B). 
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Figure 7.1: The effect of transgenic expression of Gli2N2 in LPS-treated γδ 
thymocytes 
Bar chart (A) show the percentage of γδ T cells in the thymus of WT and Gli2N2 
littermates, 4 days after LPS treatment and (B) shows the thymic γδ cell count. 
Overlaid histogram (C) shows CD3 expression in the live gate of WT (untreated / 
LPS-treated WT) littermates. Dot plots (D) show CD27 and CD44 expression on 
untreated and LPS-treated γδ T cells from WT and Gli2N2 littermates. Bar charts 
show (E) the percentage of CD27+CD44+, (F) Vγ1 and (G) Vγ2 γδ thymocytes. Dot 
plots (H) show expression of CD44 and CCR6 in γδ thymocytes. n=5 
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Figure 7.2: The effect of transgenic expression of Gli2N2 on LPS-injected γδ 
subsets 
Dot plots (A) show CD27 and CD44 expression on γδ cells gated on Vγ1, Vγ2 and 
other Vγ chains from untreated and LPS-treated γδ T cells from WT and Gli2N2 
littermates. Overlaid histograms (B) (untreated / WT / Gli2N2) show CCR6, 
NK1.1 and CD5 expression on γδ T cells. n=5 
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Figure 7.3: The effect of transgenic expression of Gli2 on LPS-treated γδ 
splenocytes 
Bar chart (A) show the percentage (from the CD3+ gate) of γδ T cells in the 
spleen of WT and Gli2N2 littermates and (B) shows the γδ cell count per million 
splenocytes, 4 days after LPS treatment. Overlaid histogram (C) (untreated / 
LPS-treated WT) shows live-gated CD3 expression. Dot plots (D) show CD27 and 
CD44 expression on untreated and LPS-treated γδ T cells and Vγ2 bearing γδ Τ 
cells from WT and Gli2N2 littermates. Overlaid histogram (E) (untreated / WT / 
Gli2N2) shows the expression of CCR6 on γδ T cells and dot plots (F) show 
expression of CCR6 and CD44 on γδ T cells. n=5 
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Figure 7.4: The effect of transgenic expression of Gli2 on LPS-treated γδ 
cells in lymph nodes 
Overlaid histogram (A) (untreated / WT / Gli2N2) shows CD3 expression in the 
live gate of 6 weeks old littermates. Bar chart (B) show the percentage (from the 
CD3+ gate) of γδ T cells in the lymph nodes of WT and Gli2N2 littermates and (C) 
shows the percentage of Vγ2+ γδ cells. Density plots (D) show CD27 and CD44 
expression on untreated and LPS-treated γδ T cells and Vγ2 bearing γδ Τ cells 
from WT and Gli2N2 littermates. **p<0.005, n=5 
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Figure 7.5: The effect of transgenic expression of Gli2 on LPS-treated γδ T 
cells from the blood and the skin of young mice. 
Overlaid histogram (A) (untreated / WT /Gli2N2) shows CD3 expression in the 
live gate of young littermates. Bar chart (B) shows the percentage of γδ T cells in 
the blood of WT and Gli2N2 littermates, 4 days after LPS treatment. Bar chart (C) 
shows the percentage of γδ subtype populations, based on CD27 and CD44 cell 
surface expression, in relation to the WT. Dot plots (D) show CD27 and CD44 
expression on untreated and LPS-treated γδ T cells from the blood of WT and 
Gli2N2 littermates. Dot plots (E) show the percentage of CD3+ γδ T cells in the 
skin of WT and Gli2N2 littermates, 4 days after LPS treatment. Bar chart (F) 
shows the cell count of γδ T cells per 106 CD3+ skin cells. **p<0.005, n=5 
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Figure 7.6: The effect of transgenic expression of Gli2 on LPS-treated γδ 
thymocytes 
Density plots show (A) intracellular IL-17 and IFN-γ, (B) Vγ2 and IFN-γ and (C) 
CD44 and Vγ2 expression on untreated and LPS-treated γδ T cells from WT and 
Gli2N2 splenocytes. n=5 
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7.2.2 The effect of Shh on γδ cells from LPS-infected young adult mice 
For this experiment, we used three sex-matched pairs (WT and Shhfl/fl 
FoxN1-Cre+) of 6 week old littermate mice. We injected intraperitoneally with 
a single dose of 100ng/gram of body weight LPS in 200μl of sterile PBS. The 
control group was injected ip with 200μl sterile PBS. Mice were sacrificed four 
days later and analysed by flow cytometry. 
 
In LPS-injected Shh-FoxN1 coKO mice, we observed a reduction in the 
percentage and number of γδ cells compared to WT in all tissues examined 
and most notably in the thymus (Figure 7.7A, B). We also observed a 
reduction in the percentage and number of CD27+CD44+ as well as 
CD44+CD27- γδ cells (Figure 7.7D). A more detailed analysis of γδ cells bearing 
various Vγ chains revealed that the decrease in both subsets is irrelevant to 
Vγ chain (Figure 7.8A, B, C). CD24 expression was not affected (Figure 7.8D).  
 
In the spleen and lymph nodes, we observed only minor changes. Of note, the 
dissapearing thymic Vγ2 CD44+CD27- γδ subset is only slightly decreaed in the 
spleen (Figure 7.9E) and, surprisngly, it is upregulated in the Shh coKO lymph 
nodes (Figure 7.9D), suggesting that the subset is indeed developed in the 
thymus but perhaps leaves the thymus quicker, thus decreasing its thymic 
presence. 
 
In the spleen of LPS-injected mice with conditional deletion of Shh, Vγ2 γδ 
cells showed a reduction in IL-17-producing capacity, upon 4h activation with 
PMA and ionomycin compared to WT (Figure 7.10A) although MFI for IL-17 
for the Vγ2 subset did not change Figure 7.10B). 
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Figure 7.7: Activation of murine γδ T cells with LPS causes important changes 
in the percentage, cell count and surface expression of key γδ markers in the 
thymus of Shh FoxN1 KO mice after 4 days of LPS treatment. 
Bar charts (A) show the percentage of γδ T cells in the thymus, spleen and lymph 
nodes of WT and Shh FoxN1 Cre+ littermates, as measured by flow cytometry from 
the CD3+ gate. Bar chart (B) shows the γδ cell count from the same organs. Overlaid 
histogram (C) shows CD3 expression in WT (untreated / LPS-treated WT) 
littermates Dot plots (D) show CD27 and CD44 expression on untreated and LPS-
treated γδ T cells from WT and conditional Shh KO littermates. n=4 
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Figure 7.8: The effect of Shh FoxN1 coKO on subtype populations of γδ 
thymocytes after 4 days of LPS treatment. 
Dot plots show the effect of conditional Shh KO on untreated and LPS-treated γδ 
thymocytes bearing different Vγ chains; (A) Vγ chains other than Vγ1 and Vγ2 (named 
‘’Other Vγs”), (B) Vγ1 chain and (C) Vγ2 chain. Overlaid histogram (D) (WT/Gli2N2) 
shows that conditional Shh KO does not have an impact on CD24 surface expression. 
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Figure 7.9: The effect of Shh FoxN1 KO on several subsets of γδ T cells in the 
spleen and lymph nodes after 4 days of LPS treatment. 
Overlaid histogram (A) shows CD3 expression from the live gate of spleen of WT 
(untreated / LPS-treated WT) littermates. Dot plots (B) show CD27 and CD44 
expression on LPS-treated splenic γδ T cells from WT and conditional Shh KO 
littermates. Dot plots show the effect on CD27 and CD44 of conditional Shh KO on 
untreated and LPS-treated γδ cells in the lymph nodes (C) and Vγ2 γδ cells in the 
lymph nodes (D) and spleen (E). n=4 
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Figure 7.10: The effect of conditional Shh KO on IL-17 secretion on LPS-
treated spleens. 
Density plots (A) show that conditional deletion of Shh reduces IL-17 secretion. 
Bar chart (B) shows the MFI of IL-17+ γδ cells. n=4 
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8. The role of Hh signalling in human γδ T cells 
 
8.1 Introduction 
 
There are three reasons why we decided to study the effect of Hh 
signalling on human γδ T cells. Firstly, the role of Hh signalling in human 
γδ T cell biology has not been investigated yet. Secondly, our detailed 
analysis of murine γδ cells made us question what parallels could be 
drawn between murine and human γδ T cells in relation to Hh signalling. 
Last, our team collaborates with clinicians at Great Ormond Street Hospital 
who provide us with whole fresh human thymi obtained from young 
children who undergo corrective heart surgery.  Therefore, we are given 
the unique opportunity to study human γδ T cell thymopoiesis using fresh 
human tissues. 
 
Due to this collaboration, I decided to try to expand fresh human γδ 
thymocytes using artificial antigen presenting cells (aAPCs) loaded with 
anti-γδTCR antibodies, a method that allows the expansion of the complete 
γδ T cell repertoire from human blood, without bias towards specific TCRs 
(Fisher, Yan et al. 2014). All samples were processed immediately upon 
arrival and approximately three weeks after setting up the expansion 
cultures, 107 γδ cells were washed in RPMI and transferred to new culture 
plates. The cultures were supplemented with either rHhip or rShh. We 
followed their development for 6 days by Annexin V-including 
immunophenotyping, PI stain and qPCR for crucial components of the Hh 
pathway. Here, we report the results of one experiment, although three 
additional expansion cultures using different samples had been previously 
set up while optimizing the expansion protocol for fresh γδ thymocytes.  Of 
note, expansion of thymic samples seem to be more efficient than PBMC-
derived γδ cells as addition of aAPCs at the beginning of the expansion 
150 
 
cultures suffices to expand them to the desired level whereas addition of 
aAPC every approximately two weeks is required in the case of peripheral 
γδ cells. 
 
8.2 Results 
 
8.2.1 γδ expansion cultures from human thymocytes 
In order to set up the expansion cultures, we meshed the human thymus 
and stained 107 thymocytes for CD3, γδTCR, Vδ1 and Vδ2 chains (Figure 
1A, B). Flow cytometry analysis showed that approximately half of all 
γδTCR+ cells were stained bright for CD3 (Figure 8.1C). All CD3- γδTCR+ 
cells were also negative for Vδ1 and Vδ2 chains (Figure 8.1D), suggesting 
that some of these cells are not ‘’real’’ γδ cells. Around 85% of the CD3+ 
γδTCR+ cells were also bearing a delta chain other than Vδ1 and Vδ2. 
(Figure 1D).  
 
We then collected 109 thymocytes for positive selection using the Milltenyi 
kit. Selection resulted in the acquisition of around 2x105 cells. A small 
fraction was taken to analyse by flow cytometry using the same panel and 
parameter as we did in the whole thymus. After selection, 98% of the live 
gate consisted of γδTCR+ cells (Figure 8.1F) that were all positive for CD3 
(Figure 8.1I). Only a quarter now expressed a delta chain other than Vδ1 
or Vδ2, while the majority of γδ cells expressed a Vδ1 chain (Figure 8.1G). 
 
8.2.2 The effect of Hh signalling on cell surface markers 
In Figure 8.2, we see the immunophenotypic analysis of the untreated 
sample on day 2. Our culture contained approximately 72% live cells, all of 
which were expanded CD3+ γδ cells (Figure 8.1A, B). In further analysis, 
we separated γδ cells according to Vδ-bearing chain and then plotted 
CD62L versus CD45RA in order to identify the activation state of those 
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cells (Figure 8.2C). Figure 8.3 shows the complete immuophenotypic 
profile of our samples over the course of a week. Left column (Figures 
8.3A, C and E) shows the proportion of naive γδ cells  in relation to their 
Vδ chain, whereas the right column (Figures 8.3B, D and F) shows the 
proportion of terminally differentiated γδ cells  Overall, we observed that 
γδ cells treated with rHhip differentiated slightly quicker to the Td state, 
independently of Vδ chain expressed. 
 
8.2.3 The effect of Hh signalling on proliferation of human γδ T cells 
In order to assess the effect of Hh signalling on human thymic γδ T cell 
proliferation and apoptosis, we performed cell count (Figure 4A), Annevin 
V stain (Figure 4B) as well as PI stain which revealed the cell cycle status 
of the expanded human γδ cells (Figure 4C, D) over the course of a week. 
Although results on the cell count are inconclusive, inhibition of the Hh 
pathway using rHhip resulted in reduced programmed cell death. A 
representative example of the PI and Annexin V analysis is also given 
(Figures 4E, F, G, I).  
 
8.2.4 Expression analysis of key Hh components 
For each condition and time point, we continued our analysis by extracting 
mRNA from 2,5 x105 cultured cells in order to perfrom qPCR and 
expression analysis for basic components of the Hh pathway. Cells treated 
with rHhip immediately decreased Gli1 expression, indicating γδ cells 
responded to the Hh inhibitor (Figure 8.5A, B). In rShh-treated γδ cells, 
Gli1, Gli2 as well as Shh expression were higher than the untreated or the 
Hhip-treated γδ cells for the first 2 days of culture, a trend that reverses on 
later time points, when rHhip-treated γδ cells show higher expression for 
the same genes. 
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Figure 8.1: Positive selection of γδTCR+ cells prior to expansion culture 
Dot plot (A) shows the live gate and (B) the γδTCR+ cells from the live gate 
of a fresh human thymus. (C) shows that approximately half of all γδ cells 
are CD3low and (D) shows the Vδ1 and Vδ2 phenotype of the CD3low and 
CD3+ γδ populations. The rest of the figures shows the γδ cells collected 
after one round of positive selection. (E) and (F) show the live gate and the 
γδTCR cells, respectively that are (I) all CD3+. Dot plot (G) displays the Vδ1 
and Vδ2 phenotype. 
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Figure 8.2: Hh signalling and the effector fate of expanded human γδ 
thymocytes  
Dot plot (A) shows a representative example of the live gate of the 
expanded cells and (B) the proportion of CD3+ γδTCR+ cells, exhibiting the 
characteristic two populations, commonly observed in expanded γδ cells. 
Representative dot plots (C) show CD62L and CD45RA expression of CD3+ 
γδTCR+ cells. 
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Figure 8.3: Hh signalling and the effector fate of expanded human γδ 
thymocytes 
Plots (A, C, E) and (B, D, F) show the proportion of naïve and terminally 
differentiated γδ cells, respectively, gated on Vδ1, Vδ2 and other Vδ chains 
over the course of a week of treatment with rShh or rHhip1 compared 
with control untreated culture. 
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Figure 8.4: The effect of Hh signalling on the cell cycle and apoptosis of 
human expanded γδ thymocytes 
Plots (A) and (B) show the cell count and apoptosis of expanded human γδ 
cells over the course of 6 days after treatment with either rHhip or rShh. 
(C) and (D) show synthesis and G2/Mitosis in the same cells and under the 
same conditions.  Representative dot plot (E) shows the untreated live 
gate on day 2 and the subsequent strategy for (F) aggregate exclusion, (G) 
PI stain and (I) Annexin V stain in order to assess apoptosis. 
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Figure 8.5:  The effect of Hh signalling on the transcription of several 
components of the Hh pathway as assessed by mRNA expression analysis 
from expanded human γδ cells, treated with rHhip or rShh over the course 
of 6 days. 
Plots (A, C and E) show the relative expression of Gli1, Gli2 and Shh, 
respectively, for rHhip and rShh-treated expanded γδ thymocytes, relative 
to the untreated sample, over the course of 6 days. Bar charts (B, D and F) 
show the expression of the same genes in arbitrary units at four different 
time points. 
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8.3. Discussion 
 
The purpose of this chapter is two-fold. First, to demonstrate the 
successful expansion of fresh human γδ thymocytes using aAPCs. Secondly, 
it displays a template for future work. We anticipate that our strategy to 
identify any potential impact of Hh signalling in these cells, based on deep 
immunophenotyping (Vδ chains and memory phenotype according to 
CD62L and CD45RA expression), together with cell cycle and apoptosis 
assessment and mRNA expression analysis for several Hh components, is a 
strategy that we aim to apply in future experiments. 
 
Using this experimental methodology, we intend to continue analyzing 
human thymi using aAPCs as well as other expansion protocols with 
skewed Vδ outcomes, such as IL-2 plus Zoledronate-based expansion 
(Kondo, Izumi et al. 2011), which, as a nonpeptide phosphoantigen, shows 
a preference for Vδ2+ γδ cells.  
 
We observed that by day 2, the last naïve cells had become Ttd cells, 
minimizing the chance of being responsive to Hh signalling. This is a 
problem that cannot be overcome using our current technologies for 
sorting or positively selecting γδ cells. There are, therefore, two ways to 
overcome this problem. The first involves using kits that enrich γδ cell 
populations by negative selection, keeping the γδTCR intact and hence 
inactivated. The second option relies on culture of small fresh thymic 
chunks on filters and then identifying γδ cells by flow cytometry, therefore 
avoiding any selection. The first option is expensive and unreliable, as 
commercially available kits use for their exclusion, markers that are 
present in some γδ cells (such as CD56 in the case of Milltenyi’s γδTCR 
negative selection kit), and γδ cells would anyway be activated during 
consequent expansion culture in the presence of aAPCs. The second option 
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would only allow us to carry out immunophenotyping as the number of γδ 
cells extracted from our filter cultures would not suffice to sort γδ cells for 
expression analysis or even carry out PI and Annexin V stains.  
 
This particular experiment that we present here puzzled us as we would 
expect to find many γδ cells showing an effector memory or central 
memory phenotype, similar to γδ cells derived from PBMCs after positive 
selection using the same kit and same protocol (Fisher, Yan et al. 2014). 
Nevertheless, I found virtually no CD45RA- γδ cells, manifesting that γδ 
thymocytes could either potentially ‘’jump’’ from a naïve phenotype to a 
terminally differentiated one, without upregulation of CD45RA or naïve 
cells simply died and Td cells acquired their terminal phenotype during 
the 3 weeks of expansion. Future replications of this experiment will shed 
light on the mechanism. 
 
In terms of cell cycle, we found that untreated and rShh-treated cultures 
results were always remarkably identical whereas γδ cells treated with 
rHhip were slightly different. The major change was observed in Vδ1 cells, 
followed by Vδ2, suggesting that Vδ1 are potentially more highly 
responsive to Hh signalling. rHhip-treated γδ cells also showed reduced 
apoptosis but no definite conclusion could be drawn about Hh’s impact on 
cell cycle progression or cell count until the experiment is repeated at least 
twice. Overall, the final rHhip and rShh treatment cultures seemed to have 
worked well, as manifested by the sharp downregulation in Gli1 
expression in Hhip-treated γδ cells.  
 
Overall, there has been increasing interest in human γδ T cells over the 
last 5 – 10 years, primarily due to their potent antitumor cytotoxic 
properties. γδ T cells can exhibit IFNγ-mediated antitumor responses 
whereas IL17-producing γδ cells have shown unanticipated tumor-
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promoting functions  (Silva-Santos, Serre et al. 2015). We believe that 
further elucidation of the role of the Hh signalling pathway in γδ cells will 
provide a better insight into this developmentally and functionally 
complex subtype of T cells and could also be translationally useful as it 
could potentially improve in vitro methods for the production of γδ T cells 
for therapeutic applications.  
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9. The Investigation of an Ihh-mediated feedback loop 
that controls thymus size 
 
9.1 Introduction 
 
Hh signalling plays an important role in regulating several stages of 
survival, proliferation and differentiation during T cell development. Here, 
based on published findings from our laboratory, we aim to further 
investigate the role of Ihh ιn T cell development.  
 
In 2009, our lab showed that Ihh both promotes and restricts T cell 
development (Outram, Hager-Theodorides et al. 2009). Hh signalling is 
known to affect DN1 to DN2 transition and Shh, Gli3 and Smo have been 
shown to play a role in this transition. Analysis of Ihh-/- (and Shh+/-) thymi 
on days E13.5 and E14.5, when the transition from DN1 to DN2 first 
happens, did not reveal a significantly smaller thymus, whereas in Shh-/- 
and Shh+/-Ihh-/- mutants mice, the proportion of DN2 cells was significantly 
reduced, indicating that Ihh plays a positive regulatory role at the DN1 to 
DN2 transition that, in the absence of Ihh, can be compensated by Shh. 
 
In later stages of T cell development, Ihh seems to both negatively and 
positively regulate the transition from DN to DP cells. Analysis of E16.5 
Ihh-/- thymi, when the transition first occurs, revealed a reduction in 
thymus size by half, however, the Ihh+/- thymus was 1.4 times larger, 
containing 2.4 times more DP cells. 
 
Moreover, treatment with exogenous rHh protein promoted thymocyte 
development in Ihh-/- FTOCs but inhibited thymocyte development in 
Ihh+/- FTOCs. The data suggest that Ihh promotes DN thymocyte 
 161 
development before pre-TCR signal transduction but becomes a negative 
regulator after pre-TCR signalling. This finding was also confirmed with 
anti-CD3 treatment of of Rag-/-Ihh+/- FTOCs. 
 
As Ihh is produced at low levels in DN populations, we believe that Ihh is 
secreted from DP cells, which are known to produce more Ihh, and feeds 
back to DN progenitors in order to regulate differentiation and control cell 
number. This hypothesis is important because very little is known about 
the intrinsic thymic processes that control thymus size. The control of the 
thymus has been assumed to rely on competition between thymocyte 
precursors for limiting concentrations of mitogenic or survival factors. Our 
lab has suggested that Ihh restricts thymus size by providing a negative 
regulatory feedback from the Ihh-producing DP cells to their DN 
progenitors.  
 
This project aims to investigate the proposed negative feedback loop in 
greater detail as well as to test if Ihh also regulates differentiation from DP 
to SP cell. For this purpose, in addition to the Ihh mutant mice, we also 
used Ihhfl/fl-CD4Cre+ tg mice to specifically delete Ihh from all thymocytes 
that have expressed CD4 (hence CD4SP, CD8SP and DP cells), thereby 
losing the potential negative regulatory feedback. This will test the 
hypothesis directly that Ihh secreted by DP and SP cells regulates the rate 
of differentiation of their DN progenitors.  
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9.2 Results 
 
9.2.1 Conditional deletion of Ihh from thymocytes 
In order to investigate in more detail the proposed negative regulatory 
effect of Ihh on the DN to DP transition, we analysed 3 week old mice with 
conditional deletion of Ihh from all CD4+ thymocytes (Ihhfl/fl-CD4Cre+, Ihh 
coKO) and compared them to WT littermates. The Ihh coKO thymus was 
marginally smaller (Figure 9.1C) but no other difference was observed in 
the CD4SP, CD8SP, DP or DN populations (Figure 9.1B, D, E, F). DP cells 
expressed less CD3 but this was not significant (Figure 9.1G) and there 
was no difference in CD5 expression. Finally, we did not detect differences 
in HSA and B220 expression (Figure 9.1H). Analysis of the DN population 
revealed that the coKO thymus showed more DN3 and less DN4 cells than 
WT (Figure 9.2A). 
 
We also investigated the effect of conditional deletion of Ihh in T cells from 
the spleen and lymph nodes of young mice. In both tissues, we observed a 
small increase in the proportion of CD4SP and CD8SP cells (Figures 9.3A, 
4A). which were positive for CD3 (Figures 9.3C, D, 4B, C).Ihh coKO spleens 
and lymph nodes showed higher MFI for CD5 on both CD4 and CD8 T cells 
(Figure 9.3F, 4D). Surprisingly, the coHet spleen contained significantly 
less and the coKO significantly more T cells than the WT (Figure 9.3B).  
 
To assess the role of Ihh in TCR-β rearrangement and expression, we 
analysed DN3 and DN4 thymocytes for intracellular (ic) expression of the 
TCRβ chain. We found that conditional deletion of Ihh led to an increase in 
the proportion of TCRβ cells in both DN3 and DN4 thymocytes. This 
increase in ic TCRβ expression could be a result of increased TCRβ 
rearrangement or because cells that have rearranged their TCRβ chain are 
arrested at the DN stage. This is consistent with the published observation 
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that the proportion of TCRβ+ cells was increased in the DN3 population of 
Ihh-/- fetal thymus compared to WT (Outram et al 2009). 
 
9.2.2 Introduction of a transgenic TCR 
We then crossed the Ihhfl/fl-CD4-Cre+ tg to the male specific antigen HY in 
order to test if the transgenic TCR influenced differentiation from DN to 
DP and to assess the effect of Ihh on negative selection. As HY is a male 
specific antigen, analysis by flow cytometry was performed in a gender 
specific manner. Contrary to the HY- mice, analysis of Ihh coKO HY+ male 
mice revealed a larger thymus and the Ihhfl/WT-Cre+ thymus (coHet) was 
larger than the WT and the coKO (Figure 9.6A). We also observed a small 
decrease in the proportion of CD8SP and CD4SP cells (Figure 9.6D, E, F, G) 
as well as the DN population (Figure 9.6B), which also contained more CD3 
and Vβ8.1/8.2 (Figure 9.6H). The coKO also exhibited higher T3.70 
expression on DP, CD4SP and CD8SP cells (Figure 9.7A, B).  
 
Peripheral T cell analysis revealed significantly higher CD3 expression in 
splenic CD4SP cells (Figure 9.8A) but no other difference was detected in 
the spleen or the lymph nodes (Figure 9.8). 
 
We have only had the opportunity to analyse a single female pair of 
Ihhfl/fl-CD4-Cre+-HY+ and WT-HY mice due to problems with re-
derivation and more analysis will be carried out as soon as we have more 
pairs available. Further investigation of these mice is crucial as it can 
elucidate Ihh’s effect on positive selection. 
 
The IhhcoKO-HY thymus was smaller than the WT (Figure 9.9A) and it also 
showed more DN and fewer DP cells (Figures 9.9C, D), whereas no change 
was observed in the DN populations or CD3 expression (Figures 9.9D, E).  
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The Ihh coKO-HY spleen was smaller with a smaller live gate (Figure 
9.10A) and there was no difference in CD3 or CD5 expression (Figure 
9.10B, C). We observed less CD3+ CD4SP and more CD3+ CD8SP cells but 
more pairs need to be analysed to draw firm conclusion.  
 
9.2.3 The impact of Ihh deficiency on thymocyte differentiation in the 
fetal thymus 
We analysed E16.5 Ihh mutant thymi after 6 days in FTOCs. As DP cells 
first appear in E16.5, we expect our analysis to reveal the rate of 
progression from DN to DP and DP to SP cells. We found that IhhHet mice 
showed a significant increase in thymus size (Figure 9.11A). Interestingly, 
WT thymi were on average slightly smaller than the KO. Previous analysis 
from our lab has shown that E16.5 Ihh+/- thymi contained on average 1.4 
more thymocytes than WT thymi, a difference that is increased further 
after 6 days in culture. We also discovered that IhhKO thymi contained 
more CD4SP and DN cells than WT thymi (Figure 9.11C, D) whereas the 
proportion of CD8SP cells was not affected (Figure 9.11E). The difference 
in CD4SP cells increased dramatically in CD3+-only thymocytes, indicating 
that deletion of Ihh results in a much faster rate of differentiation from the 
DP to SP stage of development (Figure 9.11I). Conditional KO DP cells 
showed reduced CD3 expression (Figure 9.11H). 
 
We then time-mated Ihh coKO HY+ mice and analysed E18.5 male 
littermates. The Ihhfl/fl-CD4-Cre+ HY+ thymus was 50% smaller than the 
WT (Figure 9.12B), a result attributed to the remarkable decrease in the 
live gate (Figure 9.12A). We also observed a reduction in the proportion of 
DN cells coupled with an increase in the DP in the conditional null thymus 
(Figure 9.12B). Conditional deletion of Ihh resulted in a higher expression 
of T3.70 (Figures 9.13B, 14A) and HSA (Figure 9.14C) on DN cells and 
CD8SP cells (Figure 9.14C). However, HSA expression on CD4SP cells was 
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not affected. We also detected lower Vβ6 expression on CD4SP cells in the 
coKO compared to WT (Figure 9.14B).  
 
9.2.4 Recovery of DP and SP populations following Hydrocortisone 
(HC) treatment in Ihh deficient thymus 
In order to assess the developmental progression of Ihh+/- thymocytes in a 
synchronized wave in adults, we injected intraperitoneal HC and observed 
the recovery of the thymocyte populations during the week after the 
injection. Four days after the injection, we observed that the Ihh+/- thymus 
was larger (Figure 9.15A). CD4SP and CD8SP proportions were increased 
with a decreased proportion of DP cells (Figure 9.15F). We also detected 
increased thymic CD5 expression (Figure 9.15D). There was an increase in 
Qa2 and CD3 expression for the CD4SP population (Figure 9.17B, C), 
whereas expression of CD24 was decreased for the same population 
(Figure 9.15F). Thus, the CD4SP population seemed more mature in the 
Ihh+/- compared to WT. Analysis of the DN population revealed that the 
Ihh+/- thymi contained overall more DN cells than WT but the distribution 
of subsets was quite similar between Ihh+/- and WT (Figure 9.16A). 
Moreover, we observed higher Qa-2 expression in Ihh+/- DN cells 
compared to WT (Figure 9.16B, C).   
 
Six days after ip HC treatment, the Ihh+/- thymus was still larger than the 
WT (Figure 9.17A) and showed higher CD5 expression (Figure 9.17B). 
Furthermore, the Ihh+/- thymus contains fewer DN and more DP cells, 
whereas CD4SP and CD8SP cells do not show any difference in proportion 
between mutants and WT littermates and the DN subset distribution was 
similar in both genotypes (Figure 9.17D).  
 
Overall, we observed a faster thymic recovery in the Ihh+/- thymus (Figure 
9.18A). CD8SP cells showed reduced CD3 expression four days after 
injection and the effect disappeared two days later (Figure 9.18C). We also 
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analysed a triplet (WT, coHet, coKO) of HY+ 4 week old female mice, four 
days after ip HC injection. Remarkably, the coKO thymus displayed a 
thymus size that was about ten times larger than the WT and coHet 
littermates (Figure 9.18B) but it was nevertheless smaller than its HY- 
counterparts. The DP population showed decreased CD3 and the DN 
decreased CD25 expression (Figure 9.18D).  
 
9.2.5 Reconstitution of DP and SP populations following anti-CD3 
treatment in Ihh deficient Rag-/- thymus 
To determine the regulatory effect of Ihh after pre-TCR signalling, we 
generated a Ihhfl/fl-CD4-Cre+ Rag-/- mouse strain and set up anti-CD3-
treated FTOCs that mimic pre-TCR signalling. We analysed the FTOCs 
seven days after treatment. The coKO thymus showed a 5fold increase in 
size compared to WT (Figure 9.19A). It also contained a higher proportion 
of DN cells (Figure 9.19B), which displayed higher HSA expression (Figure 
9.19D). We also observed an increased in the proportion of CD8SP cells 
(Figure 9.19F). 
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Figure 9.1: The effect of conditional Ihh deletion (CD4Cre+) on thymocytes 
of young adult mice 
Dot plots (A) show the live gate and (B) the CD4 and CD8 expression of WT, 
Ihhfl/WT and Ihhfl/fl Cre+ thymocytes. Bar charts (C) shows the cell count and (D), 
(E) and (F) show the percentage of CD4SP, DP and CD8SP thymocyte 
populations, respectively. Bar charts (G) shows the CD3 expression of DP cells. 
Dot plots (H) shows HSA and B220 expression of live-gated WT, Ihhfl/WT and 
Ihhfl/fl thymocytes and overlaid histograms (I) (WT / coHet / coKO) shows CD5 
expression on DP cells. n=12 
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Figure 9.2: The effect of conditional Ihh deletion (CD4-Cre+) on DN 
thymocytes of young adult mice 
Dot plots (A) show CD44 and CD25 expression of WT, Ihhfl/WT and Ihhfl/fl DN 
thymocytes. Bar charts (B) show the proportion of DN cells and overlaid 
histogram (C) (WT / coHet / coKO) shows CD5 expression in DN cells.  n=11 
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Figure 9.3: The effect of conditional Ihh deletion (CD4-Cre+) on T 
splenocytes of young adult mice  
Dot plots (A) show the live gate and CD4 and CD8 expression of WT, Ihhfl/WT and 
Ihhfl/fl  Cre+ T splenocytes. Bar charts (B) shows the T cell count, (C) and (F) show 
the proportion of CD4SP and CD8SP populations that express CD3, respectively. 
Overlaid histogram (E) (WT / coHet / coKO) shows B220 expression of live gate 
and (F) shows MFI of CD5 of WT, Ihhfl/WT and Ihhfl/fl CD4SP and CD8SP 
splenocytes. n=6 
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Figure 9.4: The effect of conditional Ihh deletion (CD4-Cre+) on T cells from 
the lymph nodes of young adult mice  
Dot plots (A) show the CD4 and CD8 expression of WT, Ihhfl/WT and Ihhfl/fl T 
lymphocytes. Bar charts (B) and (C) show the proportion of CD4SP and CD8SP 
cells. Bar charts (D) and (E) show that conditional deletion of Ihh does not affect 
CD3 expression of CD4SP and CD8SP populations, respectively. Table (F) shows 
MFI of CD5 of WT, Ihhfl/WT and Ihhfl/fl CD4SP and CD8SP lymphocytes. 
Overlaid histogram (G) (WT / coHet / coKO) shows B220 expression of the live 
gate. n=6 
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Figure 9.5: The effect of conditional Ihh deletion on intracellular TCRβ 
expression in DN cells 
Dot plots show the gating strategy for intracellular detection of TCRβ on WT, 
Ihhfl/WT and Ihhfl/fl Cre+ mice. (Α) shows selection of thymocytes negative for CD3, 
CD4, CD8, CD44 and NK1.1 cells, so that DN3 and DN4 cells are represented in 
the negative gate. (B) shows density plots for CD25, thus allowing the distinction 
between DN3 and DN4 cells and histograms (C) show the percentage of DN4 and 
DN3 thymocytes that are positive for TCRβ.  n=3 
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Figure 9.6: The effect of conditional Ihh deletion on thymocytes of young 
adult male mice crossed with the male-specific HY TCR. 
Bar chart (A) shows the cell count of WT-HY, CD4-Cre+ Ihhfl/WT-HY and CD4-Cre+ 
Ihhfl/fl-HY thymocytes. Bar charts (B), (C), (D) and (E) show the percentage of 
DN, DP, CD4SP and CD8SP, thymocytes, respectively. Bar chart (F) shows coKO-
HY CD4SP and CD8SP proportions relative to WT. Representative dot plots (H) 
show Vβ8.1/8.2 and CD3 expression of DN CD4-Cre+ Ihhfl/fl-HY cells compared to 
WT-HY. *p<0.05, **p<0.005, ***p<0.0001, n=10 
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Figure 9.7: The effect of conditional Ihh deletion on thymic T3.70 
expression in young adult male mice crossed with the male-specific HY 
TCR. 
Dot plots (A) show Qa-2 and T3.70 expression of WT-HY and coKO-HY DN, DP, 
CD4SP and CD8SP populations. Dot plots (B) show the proportion of WT-HY and 
coKO-HY thymocytes in the live gate that express T3.70. Expresion of CD4 and 
CD8 from T3.70+ and T3.70- thymocytes is also shown.  
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Figure 9.8: The effect of conditional Ihh deletion on T cells from the spleen 
and lymph nodes of young adult male mice crossed with the male-specific 
HY TCR. 
Bar charts (A) and (B) show the proportion of CD4SP and CD8SP splenocytes, 
respectively and expression of Vβ8.1/8.2 and CD3 for the same populations. Dot 
plots (C) and (D) show CD4 and CD8 expression from the spleen and lymph 
nodes of WT-HY, coHet-HY and coKO-HY live gates, respectively. Bar charts (E) 
and (F) show the proportion of CD4SP and CD8SP lymphocytes, respectively and 
expression of Vβ8.1/8.2 and CD3 for the same populations. **p<0.005, 
***p<0.0001
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 Figure 9.9: The effect of conditional Ihh deletion on thymocytes of young 
adult female mice crossed with the male-specific HY TCR. 
Table (A) shows the cell count of WT-HY and CD4-Cre+ Ihhfl/fl-HY thymocytes in 
the thymus, spleen and lymph node. Dot plots (B) show the live gate and (C) 
shows CD4 and CD8 expression of WT-HY and Ihh coKO-HY littermates. (D) 
shows CD44 and CD25 expresison of DN cells. Overlaid histogram (E) shows live-
gated CD3 expression.  n=2 
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Figure 9.10: The effect of conditional Ihh deletion on T cells from the 
spleen of young adult female mice crossed with the male-specific antigen 
HY. 
Dot plots (A) show live gate of WT-HY and CD4-Cre+ Ihhfl/fl-HY thymocytes in the 
spleen of 6 week old female littermates. Overlaid histograms (B and C) show CD3 
and CD3-gated CD5 expression, respectively. n=2 
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Figure 9.11:  The effect of Ihh on E16.5 FTOC + 6 days in culture 
Bar chart (A) shows the cell count of WT, Ihh+/- and Ihh-/- E16.5 thymus after 6 
days in culture. Dot plots (B) show the live gate. Scatter graphs show the 
percentage of (C) DN, (D) CD4SP and (E) CD8SP cells. The percentage of CD25+ 
SP CD4 and SP CD8 cells is shown in scatter plots (F) and (G) respectively and 
plot H shows the proportion of DP cells that are positive for CD3. Dot plots (I) 
show CD4 and CD8 expression of thymocytes from the live gate and the CD3hi 
compartment. n=10 
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Figure 9.12:  The effect of conditional Ihh deletion on HY+ E18.5 thymocytes 
in male mice 
Dot plots show (A) the live gate and (B) CD4 and CD8 expression. Bar chart (C) 
shows the cell count of WT, Ihhfl/WT and Ihhfl/fl E18.5 thymus.  n=3 
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Figure 9.13:  The effect of conditional Ihh deletion on HY+ E18.5 thymocytes 
in male mice 
Dot plots (A) show T3.70 expression from the live gate of WT, Ihhfl/WT and Ihhfl/fl 
E18.5 thymus and (B) shows CD4 and CD8 expression of the T3.70-, T3.70low and 
T3.70high gates. n=3
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Figure 9.14:  The effect of conditional Ihh HY+ on E18.5 thymocytes in male 
mice 
Dot plots (A) show Qa-2 and HY expression on DN cells. Histograms (B) show 
Vβ6 expression on CD4 SP cells. Overlaid histogram (C) shows HSA expression 
on (WT / het / KO) DN, CD4SP and CD8SP cells.  
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Figure 9.15: Thymocyte recovery of DP and SP populations 4 days after HC 
injection on Ihh+/- 4 weeks old mice 
Bar chart (A) shows the cell count on live-gated thymocytes, 4 days after HC 
injection. Bar charts (B) and (C) show Qa-2 and CD3 expression on CD4SP cells. 
(D) shows CD5 expression in the thymus. Representative dot plots (E) show CD4 
and CD8 expression and histogram (F) (WT / het) shows CD24 expression on 
CD4 SP cells. *p<0.05, n=6 
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Figure 9.16: Thymocyte recovery of DN populations 4 days after HC 
injection on Ihh+/- 4 weeks old mice 
Representative dot plots (A) show the gating strategy for the DN thymic 
populations. Bar chart (B) shows Qa2 expression on DN cells and histogram (C) 
(WT / het) shows CD3 expression on the same population. *p<0.05, n=6 
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Figure 9.17: Thymocyte recovery 6 days after HC injection on Ihh+/- 4 weeks 
old mice 
Bar chart (A) shows the cell count of thymocytes, 6 days after HC injection. (B) 
shows CD5 expression on live-gated thymocytes and (C) shows CD25 expression 
on CD4SP. Representative dot plots (D) show CD4 and CD8 expression and (E) 
shows the gating strategy for the (F) DN thymic populations. *p<0.05, n=4 
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Figure 9.18: Thymocyte recovery in HC-injected Ihh+/- and conditional Ihh 
KO mice. 
Graph (A) shows thymus size post HC injection in WT and Ihh+/- mice. Chart (B) 
shows cell count of HY-crossed WT, Ihhfl/WT CD4Cre+ and Ihhfl/fl CD4Cre+ 3 
weeks old mice, 4 days after HC injection. Overlaid histogram (C) shows CD3 
expression on WT CD4SP, WT CD8SP and Ihh+/- CD8SP cells, 4 and 6 days after 
HC injection. (D) shows CD25 expression on DN and CD3 expression on DP cells 
on HY-crossed WT, coHet and coKO young mice 4 days after HC injection.
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Figure 9.19: Thymocyte populations 7 days after α-CD3 stimulation on   
Rag-/- conditional Ihh KO FTOCs. 
Bar chart (A) shows the cell count of thymocytes per thymic lobe, 7 days after α-
CD3 treatment on FTOCs. Bar charts (B), (C), (E) show the percentage of DN, DP, 
CD8SP cells. Bar chart (D) shows the percentage of DN cells positive for HSA. 
Representative dot plots (F) show CD4 and CD8 expression of live-gated 
thymocytes. n=4 
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9.3 Discussion 
 
9.3.1 Transition from DN to DP stage of development 
Our hypothesis predicted that Ihh, secreted by DP cells, feeds back to DN 
progenitors and restricts their development, providing a negative 
feedback loop that controls the size of the thymus. According to this 
hypothesis, we expected that conditional deletion of Ihh from DP cells 
would result in loss of negative feedback and a significant expansion in 
thymus growth and size, accompanied with an expansion of the DP 
population. Nevertheless, our data revealed that the adult conditional null 
mice display a smaller thymus and unchanged proportions of DP cells 
compared to the WT. However, male conditional mice that were HY+, 
displayed an enlarged thymus that contained a higher proportion of DP 
cells. We also observed larger thymi in HC experiments as well as Ihhfl/fl-
CD4Cre+Rag-/- FTOCs treated with anti-CD3. It seemed, however, that 
although we could clearly observe the negative impact that Ihh has on 
thymus size, we could not understand why this was not manifested on the 
conditional null HY- mice due to what seems to be an arrest on the DN3 
stage. As ic TCRβ expression is higher in the Ihh coKO, this arrest is not 
caused by decreased rearrangement. Nevertheless, the reason for this 
increased TCRβ expression is not clear as it could be a result of thymocytes 
being arrested on the DN stage or it can be a manifestation of genuine 
higher capacity for rearrangement.  
 
Analysis of male IhhcoKO-HY+ mice revealed that male coKO mice showed 
less deletion and higher T3.70 DN cells in the thymus, suggesting that 
deletion of Ihh results in partial reduction in negative selection. We plan to 
carry out TCR sequencing on these mice, which will test if Ihh is 
influencing extent of endogenous TCR rearrangement.  
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We report several signs that collectively suggest that conditional deletion 
of Ihh results in a quicker transition from DN to DP stage. In a number of 
experiments, we observed higher CD5 expression on DN populations as 
well as the whole thymus. Another piece of evidence arises from HSA 
expression, which is downregulated as thymocytes mature. HSA levels are 
high on DN cells and gradually decrease in DP cells until they become 
undetectable in SP cells. High HSA expression of thymocytes results in 
pronounced reduction in DP and SP cell numbers, suggesting that 
downregulation of HSA is a critical event in thymocyte development that 
can act as an indicator of progression to the DP stage (Hough, Takei et al. 
1994). In the absence of Ihh, DN cells seem to downregulate HSA quicker, 
as seen on the E18.5 Ihh coKO HY+ experiment, consistent with accelerated 
maturation.  
 
Furthermore, we detected much higher HY-TCR expression on DN cells in 
E18.5 IhhcoKO male mice as well as weaker CD3 expression on DP cells on 
E16.5 thymocytes after 6 days in FTOCs as well as during reconstitution of 
the DP population in HC-treated Ihh coKO HY+ male mice. The narrowed 
time period that DN cells have to express CD3 during an accelerated 
progression from the DN to DP stage could explain the above finding. Our 
hypothesis is also backed by our observation that commonly in our Ihh KO 
or Ihh coKO experiments, where the thymus size is reduced, the live gate is 
also significantly smaller, suggesting increased apoptosis. 
 
Overall, we believe that deletion of Ihh causes a significant acceleration of 
thymocyte development after the pre-TCR signal transduction. It is 
possible that this quick transition from DN to DP cells does not give 
thymocytes the necessary time to undergo normal TCR rearrangement, 
resulting in elimination of these faulty thymocytes during selection 
processes in later steps of T cell development and overall reduction in 
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thymus size. Despite the quicker transition, having an already rearranged 
TCR, the HY+ thymocytes can pass selection successfully, which allows us 
to observe a larger thymus. 
 
In order to test the expected higher apoptotic rate of DP cells in the 
absence of Ihh and a rearranged TCR, we are planning to use Annexin V 
stain on DP populations from WT and Ihhfl/fl-CD4Cre+HY- mice. We are 
also planning to carry out TCR sequencing on sorted DP, CD4SP and CD8SP 
from WT and Ihhfl/fl-CD4Cre+HY- mice. As T cells progress faster in the 
absence of Ihh, we expect to find a limited diversity of TCRs on the 
conditional null mice. Finally, we will carry out RNA sequencing on DN3, 
DN4, as well as DP cells on the same strain, in order to identify sets of 
genes which could provide an explanation for the accelerated transition 
from DN to DP cells and the increased thymic growth triggered by Ihh’s 
deletion.   
 
9.3.2 Transition from DP to SP stage of development 
Our lab has previously shown that Shh and Gli2 affect later stages of T cell 
development, affecting TCR signal strength, positive and negative selection 
as well as CD4 versus CD8 lineage commitment (Crompton, Outram et al. 
2007). However, the role of Ihh on later stages of T cell development has 
not been investigated yet. Here, we showed that Ihh is a negative regulator 
of the latest stages of thymic T cell development. In our experiments (eg. 
E16.5 and mutant Ihh 6 days FTOCs, anti-CD3-treated Ihh coKO   Rag-/-), 
we observed an increase in the proportions of CD4SP and CD8SP cell 
populations. The phenotype was even stronger in analysis of CD3+ 
thymocytes. 
 
Interestingly, this increase in the CD4SP and CD8SP populations was not 
clear in adult IhhcoKO and IhhcoKOHY+ experiments. We believe that 
development of thymocytes in the adult thymus has reached a steady state 
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which limits the observation of events that need a synchronized 
progression to be manifested. We are planning to investigate the way Ihh 
regulates DP to SP progression further and we also intend to perform RNA 
sequencing on DP, CD4SP and CD8SP cells from WT and Ihhfl/fl-CD4Cre+ 
mice to elucidate those genes downstream Ihh which influence the DP to 
SP transition. 
 
Overall, our research has revealed some interesting findings and even 
more interesting ideas that we can test in the near future. However, mice 
with conditional deletion of Ihh are very bad breeders and the subsequent 
lack of a constant supply of litters hindered our project. We will need to 
analyse more animals from these strains to confirm our results. 
 
9.3.3 Effect of Ihh in periphery 
Delaroche et al recently proposed that peripheral CD8 cells produce and 
secrete Ihh. Therefore, changes in peripheral T cells can be a result of 
either intrathymic processes that take place before T cell migration and 
persist in the periphery or a direct consequence of Ihh’s absence in the 
periphery. 
 
Interestingly, the conditional KO spleen contained more T cells than the 
WT, which is the opposite of what we saw in the thymus but no other 
difference was observed. Introduction of the HY antigen caused a 
significant upregulation of CD3 in the male spleen, consistent with the 
thymus. Finally, conditional deletion of Ihh did not affect B cell numbers, 
as shown by B220 analysis. 
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Discussion
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10.1 Μurine γδ T cells 
 
10.1.1 Effect of Hh signalling on γδ cell numbers 
We believe that Hh signalling positively regulates γδ Τ cells in the thymus 
during early developmental stages. Our lab has previously shown that Gli3 
deletion blocks DN1 to DN2 transition, therefore we hypothesize that this 
finding is γδ-exclusive. In mutant strains in which inhibition of Hh activity 
is lifted and so overall Hh signalling is increased, such as Gli3 and Kif7, we 
detected a significant increase in the numbers of γδ T cells. We showed a 
similar effect in Gli2N2-tg mice in which Hh-mediated transcription is 
increased in T lineage cells. Our results were confirmed by double Dhh and 
Shh mutants as well as E16.5 FTOCs + 5 days in the presence of Hhip.  
 
Interestingly, E17.5 Kif7 KO spleens have more γδ cells, although this is 
not the case in the E17.5 KO thymus. Furthermore, Kif7 mice show their 
highest increase in γδ count in the spleen and Gli3 in the lymph nodes. 
Overall, our data indicate that the rise in γδ cell numbers must be 
attributed to either an increased intrathymic turnover or to increased 
peripheral proliferation. In addition, the fact that in Kif7 and Gli3 mutant 
mice all γδ populations increase, suggests that the effect mediated by these 
mutant mice occurs early in γδ T cell development and affects γδ cells 
independently of subtype and effector fate. 
 
Both Dhh KO and Shh+/- thymi show a small reduction in the numbers of γδ 
cells, which are not comparable to the phenotype observed in Kif7 or Gli3 
heterozygotes. However, in the double Shh and Dhh KO, the reduction in 
total thymic γδ cell numbers becomes significant, indicating that, at least 
in terms of cell numbers, loss of Shh is largely compensated by Dhh and 
vice versa.  
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10.1.2 The effect of Hh signalling on the CD27+CD44+ γδ subset 
In the thymus, constitutive Gli2 activity causes an increase in the number 
of CD27+CD44+ γδ cells, although we have not yet concluded whether this 
effect is the result of expansion of the existing CD27+CD44+ population or a 
biased differentiation towards this lineage, neither have we investigated 
yet the exact nature of this subtype and its cytokine secretion capacity. We 
found that Kif7 and Gli3 do not influence this phenotype, as differences 
between WT and mutant littermates were not significant. Nevertheless, 
mutant Shh and Dhh mice show a significant downregulation of this 
population, indicating that these two ligands directly control the size of the 
thymic CD27+CD44+ γδ population. We have little doubt that Hh signalling 
is a key positive regulator of this γδ subtype, which is known to be skewed 
for the Vγ1 chain, overall indicating that increased Hh activity supports the 
development of CD27+CD44+ cells. There are three possible explanations 
for the increase in CD27+CD44+ γδ subset. 
 
Firstly, this population may appear by upregulating CD44 on Vγ1-biased 
CD27+CD44- γδ cells. This naïve CD27+CD44- (and CD122-) γδ population is 
associated with an absence of TCR ligation during development (Ribot, 
Chaves-Ferreira et al. 2010). CD44 plays a role in adhesion and is known 
as an indicator for Ag-experienced cells and acquisition of a effector 
memory phenotype (Baaten, Tinoco et al. 2012). Details about the role of 
CD44 on γδ T cells remain unclear but it is possible that increased Hh 
activity leads to increased CD44 expression on the otherwise CD27+CD44- 
γδ population. 
 
Secondly, this population may represent an expansion in the NK-like γδ 
population. We observed a strong upregulation on LPS-infected GliN2 
mice. Our data point towards the idea that increased Hh activity promotes 
the development of ΝΚ-like γδ thymocytes. Several experiments support 
this hypothesis. For example, Gli3+/- mice showed a small increase in the 
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thymic numbers of NK-like γδ cells. Similarly, in double conditional Shh 
and Dhh, the percentage of NK-like γδ cells decreased, overall signifying 
that Hh signalling is likely to be a positive regulator of NK1.1-expressing 
γδ cells in the thymus. It will be important to add this marker when we 
carry out further analysis of the Gli2N2 tg strain, although in LPS-injected 
Gli2N2 tg mice, NK1.1 was sharply upregulated and in non-LPS-injected 
Gli2N2 tg mice, CD122, a marker strongly associated with NK-like γδ cells, 
increased significantly. Upregulation of CD122 expression suggests 
dependence on IL-15 (Sumaria, Roediger et al. 2011). The fact that NK-like 
γδ cells are Vγ1(Vδ6.3/6.4)-biased supports our hypothesis as we have 
shown that Hh signalling is a positive regulator of Vγ1 cells. However, 
most NK-like T cells residue in the murine liver and bone marrow (Lees, 
Ferrero et al. 2001), tissues which are beyond the scope of this project but 
which will investigate in the future. It is possible that differentiation of 
γδTCR-expressing cells towards an NK-like cell fate requires a specific 
extent, in terms of duration and strength, of TCR signalling. It is therefore 
possible that upregulation of the Hh pathway as exhibited by constitutive 
Gli2 activity or deletion of one copy of Gli3 promotes stronger or longer 
TCR signals which result in an upregulation of Vγ1-skewed, CD27+CD44+ 
NK-like γδ cells, which would have become naïve CD44- γδ cells in the 
absence of the increased TCR signals. In addition, Vγ1+CD27+CD44+ NK-
like γδ cells are one of the few γδ subtypes that require a γδTCR-ligand 
binding during their generation from thymic progenitors (Azuara, Levraud 
et al. 1997), and it is, alternatively possible, that Hh signalling increases 
the proliferation of this small pre-existing NK-like γδ population. Based on 
the above indirect evidence and published data from our lab that showed 
that Hh signalling affects TCR signal strength in αβ T cells, our next step 
will test this hypothesis and the implication of TCR signal strength in γδ T 
cells and more specifically in the upregulation of NK1.1+ γδ cells in Gli2N2 
and Shh mutant mice.  
 194 
 
A third hypothesis implicates δ/αβ T cells, a newly identified and very 
enigmatic γδ T subset in humans, expressing TCRs comprised of a TCR-δ 
variable gene (Vδ1) fused to Joining α and Constant α domains, paired 
with an array of TCRβ chains (Pellicci, Uldrich et al. 2014). Within the Vδ1+ 
population, the ratio of δ/αβ to γδ T cells varied widely with a mean of 
about 45%. Since this population is abundant in human PBMCs, we would 
not be surprised if we identify a murine population with similar 
characteristics. Currently, the focus on human δ/αβ cells lies on revealing 
the function of its TCR and recognising its antigens and therefore little is 
known about its ontogeny. A stronger TCR signal during β-selection can 
induce the production of δ chains which can then join the rearranging 
αβTCR, creating a surrogate δ/αβ TCR. 
 
In LPS experiments that we performed on Gli2N2 tg mice and included 
NK1.1, the expanding population was NK1.1 positive, strongly suggesting 
that the expansion involves NK-like γδ cells. In the near future, we will 
explore the exact phenotype of this subtype using various readily available 
experimental ways. We have already shown that this population is unable 
to produce IL-17 and has a limited capacity for IFNγ production but we 
suspect that more key γδ cytokines are implicated which will help us 
identify the nature of this subset. Hence, we will test its cytokine 
production capacity for IL-4, IL-10 and IL-15 upon short PMA/Ionomycin 
activation. Furthermore, we will dissect and analyse the thymus and the 
periphery, including the liver and bone marrow, for NK-like γδ Τ cells. 
Additionally, co-staining with γδTCR and αβTCR antibodies will elucidate 
whether δ/αβ surrogate TCR T cells are present in the murine thymus. If 
we find this to be the case, we will sort this population from the adult 
thymus and sequence its TCR in order to identify its exact TCR 
configuration and its clonal diversity. We will perform RNAseq on sorted 
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CD27+CD44+ γδ cells from Gli2N2 tg and Shhfl/fl-FoxN1Cre+ tg mice in 
order to reveal the Hh target genes and molecular pathways implicated in 
this phenotype.  
 
10.1.3 The effect of Hh signalling on the CD44+ CD27- γδ subset 
IL-17-producing γδ cells derive directly from DN2 cells  (DN3 cells give 
rise to IFNγ-producing γδ cells exclusively) (Shibata, Yamada et al. 2014), 
relying on ligand-independent TCR signals in the thymus (Jensen, Su et al. 
2008) and their ontogeny is restricted in embryonic development (Haas, 
Ravens et al. 2012, Michel, Pang et al. 2012) so that adult mice rely on 
lifelong peripheral maintenance for this γδ subtype.  
 
In the fetal thymus, E14.5 FTOCs + rShh for 5 days showed an increase in 
the CD44+CD27- γδ subset. This contradicts all other relevant experiments 
that showed that Hh activity negatively regulates this population in the 
thymus. Adult Shh mutant mice show an increase in the percentage of this 
population and Kif7 and Gli3 mutant mice, which are expected to enhance 
Hh-mediated signals, show a strong downregulation of this population. 
The same applies in Kif7 fetal thymus, indicating that Hh signalling 
regulates γδ development already from the DN2 stage in around E15-E16, 
when IL-17-producing γδ cells first appear. 
 
Shh-mediated Hh activity causes a downregulation of CD27 expression, 
together with an upregulation of CD44 expression as shown in adult and 
fetal thymi, spleens and lymph nodes. The upregulation of CD44 should be 
attributed to an expansion of the CD27+CD44+ γδ subset. The CD44+CD27- 
population is actually reduced significantly, despite the overall 
upregulation of CD44.  
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In the Gli2N2 mice, CD44 expression increased dramatically but this is 
attributed exclusively to a remarkable upregulation of the CD27+CD44+ 
population and the CD44+CD27- is not affected, indicating that Gli2 is not 
directly implicated to this thymic subset. 
 
10.1.4 The effect of Hh signalling on splenic γδ T cells 
In the spleen, Hh signalling causes a dramatic decrease in the CD44+CD27- 
γδ cell population, as exhibited by Gli3, Kif7, Shh, Dhh and Gli2N2 
experiments, indicating that Ηh strongly suppresses this population, most 
likely directly via Gli2 signalling.  
 
Concerning the CD27+CD44+ subtype, Ihh, Shh, Gli3 and Gli2 have no 
impact whereas Kif7+/- mice show a significant increase on the same 
population, suggesting that Kif7 acts independently of Gli2 and Gli3.  
 
10.1.5 The effect of Hh signalling on cytokine production of splenic γδ 
cells 
Hh activity also shows to weaken IL-17-secreting capacity as displayed on 
Gli3 and Shh mutant mice, upon 4h of PMA and Ionomycin activation. 
Interestingly, Dhh shows the opposite effect as we showed Dhh to be a 
positive regulator of IL-17 production on γδ splenic cells. Again, this 
constitutes another indication that Dhh may influence γδ T cells by acting 
as a suppressor of overall Hh activity in the spleen. 
 
10.1.6 The effect of Hh signalling on CD24 expression of γδ cells 
CD24 is considered to be a maturity marker for γδ thymocytes, with 
mature cells downregulating CD24 before entering the periphery. We 
discovered that Hh activity reduces significantly the percentage of CD24+ 
γδ thymocytes, as exhibited by our Gli2N2 and Gli3 mice strains. Of note, 
according to our GBS-GFP data, CD24- γδ thymocytes are not responsive to 
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Hh signalling. Around 90% of CD27-expressing and 50% of CD44-
expressing γδ thymocytes are positive for CD24 (Li, Zheng et al. 2004). We 
hypothesize that Hh activity promotes γδ cell maturation and a faster 
turnout rate, downregulating thymic CD24. Similarly, data on Shh, 
consistently with Gli3, Kif7 and Gli2N2 experiments in the spleen, suggest 
that increased Hh activity reduces percentage of peripheral γδ T cells that 
are positive for CD24.  
 
CD24 has been implicated in homeostatic proliferation in αβ Τ cells. We 
noticed that there is a correlation between CD24 expression and cytokine-
secreting capacity in the spleen as increased Hh signalling downregulates 
both CD24 and IL-17 production. However, we need further investigation 
to understand if and how the two observations affect each other. It is 
possible that strong Hh activity results in a stronger TCR signal which 
downregulates CD24 and favors an IFNγ-secreting capacity. In fact, a 
recent publication that elegantly tested the effect of TCR signal strength on 
the DN lineage commitment in a Rag2-/- mouse model in which both TCR-β 
and γδ-TCR are simultaneously expressed via retroviral transduction, 
showed that a strong TCR signal favored differentiation towards a γδ Τ cell 
lineage with a significant decrease in CD24 expression (Zarin, Wong et al. 
2014). 
 
Alternatively, we also hypothesize that Hh’s negative effect on IL-17-
producing cells can be CD24-mediated in a direct manner. The connection 
between CD24 and IL-17 production could be explain If Hh signalling 
causes a reduction in CD24 expression on CD44+CD27- γδ cells which rely 
on CD24 for their peripheral proliferation and postnatal maintenance. 
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10.1.7 The effect of Hh signalling on γδ cells residing in the murine 
lymph nodes 
The lymph nodes do not show GBS-GFP activity, however, Hh signalling 
influences γδ cell numbers in the lymph nodes. More specifically, Gli3 and 
Kif7 positively regulate γδ cells as mutant mice of both strains show 
increased γδ cell numbers. Interestingly, Gli3 displays a very strong 
phenotype, doubling the number of γδ cells.  
 
Dhh seems to slightly promote γδ cells in the lymph nodes and Shh clearly 
suppresses it as Shh+/- and ShhcoKO show an increase in the numbers of 
γδ cells. The mechanism is not elucidated although we believe that the 
observed phenotype relies on events that occur prior to γδ cells homing to 
the lymph nodes. In any case, the opposing effects of Dhh and Shh on the 
LN γδ cells can be seen at the double Shh and Dhh KO experiments where 
rescue of Shh partly reverses the phenotype seen on the double KO (data 
not shown).  
 
10.2 The effect of Hh signalling on γδ cells upon LPS infection 
 
In the GliN2 mice, we saw an expansion of the CD27+CD44+ thymic 
population, which becomes NK1.1+, CCR6- and Vγ1-biased, thus displaying 
all the typical characteristics of the NK-like γδ cells. We could not 
determine the peripheral destination of this subtype, as the thymic cell 
count increase was not reflected in the spleen, lymph nodes, blood or skin. 
It is believed that tissue localization of NK-like γδ cells relies on properties 
intrinsic to NKT cells, independently of the nature of TCR, hence we may 
find the expanding population occupying mainly the liver and bone 
marrow, in a way similar to NKT cells (Lees, Ferrero et al. 2001). In 
ShhcoKO LPS-injected mice, this population is downregulated, strongly 
suggesting that observed expansion of this population upon T cell 
activation is controlled by Shh upstream of Gli2. Interestingly, half of 
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splenic WT CD27+CD44+ γδ cells produce IFNγ upon PMA and ionomycin 
activation, whereas in the tg mice, the ratio drops to 3:1, indicating that 
the expanded cell population is not capable of IFNγ production.  It has 
been shown that NK-like γδ cells can also secrete IL-4 or IL-15 upon 
activation (Vicari, Mocci et al. 1996), so we aim to investigate this in the 
near future.  
 
In the Gli2 tg mice, the Vγ2-bearing CD44+CD27- population disappears 
whereas CD44+CD27- γδ cells bearing a Vγ chain other than Vγ1 and Vγ2 
expand massively, overall increasing the number of CD44+CD27- γδ cells. 
We are unable to explain this Gli2-induced substitution from Vγ2 to other 
Vγ-bearing CD44+CD27- γδ cells, a finding which is also reflected in the 
spleen and lymph nodes, where the number of Vγ2+ CD44+CD27- γδ cells 
decreases dramatically. We found that Gli2 triggers the CD44+CD27- γδ 
subtype to remain in the peripheral blood, suggesting that LPS treatment 
changes cell migration. It has been shown that splenic murine γδ T cells 
recognize a B cell antigen called phycoerythrin, which triggers expansion 
of the IL17-producing CD44+CD27- γδ subtype, together with reduction in 
CCR7 and upregulation of CCR2 expression (Zeng, Wei et al. 2012). This 
pattern is commonly associated with the acquisition of a new cell 
migration pattern in antigen-activated naïve αβ T cells (Meneghin and 
Hogaboam 2007). We are therefore interested to investigate whether a 
similar mechanism exists in γδ cells and how Gli2 activity can affect 
expression of the chemokine receptors, allowing CD44+CD27- γδ cells to 
remain in blood circulation. Finally, Shh promotes IL-17 production, 
overall indicating that in LPS infection, despite the outstanding 
CD27+CD44+ NK-like γδ expansion, Hh signalling is likely to favor a TH17 
response. This hypothesis, if proven correct, is translationally important as 
γδ T cells are the major IL-17 producers for a large number of infectious 
disease models, including E.coli infection.  
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Summary 
 
This thesis focused on the role of Hh signalling and its mediators in the 
development and function of two distinct T cell subtype populations, γδ 
and αβ T cells. Here, we provided evidence that underline the importance 
of Hh signalling in these populations. 
 
In terms of γδ T cells, we showed that Hh signalling both positively and 
negatively regulates distinct populations in the fetal and adult thymus, 
depending on numerous factors including functional capacity and tissue 
localization (Figure 10.1). Using an array of mutant mouse strains (Gli3+/-, 
Kif7+/-, Gli2N2, Shh+/- and Dhh-/-) we showed that increased Hh signalling 
increased the proportion of γδ T cells in all tissues examined, both fetal 
and adult. In the adult thymus, Hh signalling, mediated directly via Shh and 
Gli2, promoted the intrathymic proliferation of Vγ1-biased NK-like γδ T 
lineage, possibly by providing a strong TCR signal that is required for the 
development of this subtype. Interestingly, loss of Shh significantly 
increased the numbers of γδ cells in the lymph nodes. Depending on tissue 
and γδ subtype population, Shh and Dhh showed overlapping or opposing 
effects, highlighting the diverse plasticity and fluidity of Hh-mediated 
signals and Hh ligands. In LPS treatment experiments, increased Hh 
activity as mediated by Gli2N2-tg, caused Vγ2+ IL-17-producing cells to 
remain in peripheral blood.  
 
We are the first to expand human γδ T thymocytes in a Vδ-unbiased way 
using an expansion protocol based on co-culturing with irradiated 
artificial antigen presenting cells (aAPCs). However, expanded γδ cells 
were activated en masse during expansion, becoming unresponsive to Hh 
signalling. Therefore, our subsequent preliminary analysis failed to 
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provide insight into the function of Hh signalling in human γδ T cell 
development. 
 
DP αβ thymocytes produce Ihh that feeds back to DN progenitors to 
restrict their development, overall controlling thymus size. Despite 
published evidence on the existence of this negative feedback loop, little is 
known about its exact mode of action. Our investigation revealed that, 
contrary to our hypothesis, conditional deletion of Ihh from all CD4-
expressing cells did not result in a larger thymus. Further investigation 
using the male specific HY TCR revealed that deletion of Ihh negatively 
affects negative selection whereas HC and Rag KO experiments showed 
that the feedback loop is manifested when requirement for TCR 
rearrangement is overcome in developing thymocytes and when 
developing thymocytes progress in a synchronized way. Overall, we 
hypothesize that deletion of Ihh accelerates differentiation so that 
thymocytes progress without a correct TCR rearrangement, followed by 
apoptosis of these cells, resulting in a small thymus.  
 
Mice with conditional deletion of Ihh are bad breeders and the lack of 
samples delays the progress of this research and many details remained to 
be elucidated. 
 
We also discovered that Ihh plays a role in DP to SP transition. 
Experiments where progression from DP to SP stage of development has 
not reached a steady state (analysis of fetal thymi as well as HC and RagKO 
experiments) showed that deletion of Ihh increased the proportion of 
mature CD4SP and CD8SP populations. 
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Figure 10.1: The effect of Hh signalling on murine γδ T cell biology 
 
The figure summarizes the effect or Hh signalling on murine γδ subtypes in the 
fetal and adult thymus and periphery.  Red arrows symbolize promotion and 
dashed arrows symbolize inhibition. Mouse strains on top of red arrows indicate 
experiments where the effect was observed. 
 
DN – Double negative, DP – double positive, γδ – γδTCR, Hh – Hedgehog 
signalling, IL – Interleukin, IFNγ – Interferon gamma.
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Future directions 
 
In the near future, we will analyse the liver and bone marrow of untreated 
and LPS-injected Gli2N2 and Shhfl/fl-FoxN1Cre adult mice for proportions 
of γδ cells and capacity for IL-10 and IL-4 production, in order to 
investigate the role of Hh signalling on NK-like γδ cells directly in the 
tissue where this subtype resides. Furthermore, we will investigate the 
strength of TCR signalling on developing γδ cells from the same mouse 
strains in order to understand whether Hh signalling promotes the NK-like 
γδ phenotype by directly influencing TCR signal strength. In order to 
identify the Hh target genes and molecular pathways which promote the 
NK-like γδ phenotype, we will carry out RNA sequencing on sorted NK-like 
γδ cells.  
 
We will also investigate further the inability of Vγ2-biased IL-17-
producing CD44+CD27- γδ cells to harbor in secondary lymphoid organs as 
observed in LPS experiments. Using a flow cytometry-based technique, we 
aim to perform an extensive analysis of chemokine receptors, hoping to 
identify what triggers this γδ subtype to remain in blood circulation in 
Gli2N2 mice. 
 
Finally, we showed that IL-17-producing CD44+CD24+CD27- γδ cells are 
particularly responsive to Hh signalling but their response varies 
according to tissue localization and other parameters which are not clear. 
As this population is abundant and important in the protection of skin and 
peritoneal cavity, we aim to explore the effect of Gli2C2 and Gli2N2-
mediated altered Hh signalling by immunofluorescent staining on skin γδ 
cells and flow cytometry on peritoneal γδ cells. 
 205 
We hope that our research will provide the evidence for new insights on 
Hh signalling and murine γδ T cell biology and identify novel factors which 
affect γδ lineage determination, tissue localization and functional capacity. 
 
In terms of the role of Ihh on the development of αβ T cells, there is much 
to be done in order to test our hypothesis and confirm that deletion of Ihh 
causes increased apoptosis due to inability of developing thymocytes to 
successfully rearrange a functional TCR. 
  
First of all, we need to continue analyzing E16.5/E18.5 and E16.5/E18.5 + 
6 days FTOCs conditional Ihh embryos for markers that can indicate faster 
TCR rearrangement and DN to DP transition as well as apoptosis. Similar 
analysis must be performed on HC and additional anti-CD3-treated RagKO 
experiments. In order to confirm the dramatic increase in thymus size in 
HC-treated Ihh coKo HY+ mice, we aim to inject HC to more pairs of Ihh 
coKo HY+ and WT littermates. 
 
Finally, we predict to detect oligoclonal diversity of TCRs in the conditional 
Ihh thymi because we expect that death of developing thymocytes in these 
transgenics correlates with time taken to successfully rearrange their TCR, 
controlling the size of TCR of surviving cells. Therefore, we aim to carry 
out TCR sequencing expecting to identify a restricted TCR repertoire 
consisting of long TCR chains. 
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